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CHAPTER 1
INTRODUCTION
1.1 Significance of RNA Research and Historic Landmarks
Nucleic acids are important biomolecules for all living organisms [1].
Deoxyribonucleic acid, or DNA, carries the genetic code for cellular functions.
Although earlier considered only as information transporters, ribonucleic acids, or
RNAs, are now proven to play major roles in many diverse biological processes.
RNA brings the genetic information stored in DNA to make proteins, catalyzes
biological reactions, and regulates gene expressions in cells. The versatile roles
played by RNAs make them ideal therapeutics, as well as therapeutic targets.
Some historical landmarks in the field of RNA research will be discussed.
FranÇois Jacob, André Lowff, and Jacques Monod were awarded the Nobel
Price in 1965 for their discoveries on genetic control of enzyme and virus
synthesis [2]. Their findings were valuable for understanding the nature and
function of messenger RNAs [3,4]. In 1968, Robert W. Holley, Har Gobind
Khorana, and Marshall W. Nirenberg won the Nobel Prize for their interpretation
of the genetic code and its function in protein synthesis. Their contributions to the
RNA field included determination of the first sequence of a nucleic acid (yeast
alanine-tRNAAla), determining the genetic code, and showing that proteins can be
synthesized in a cell-free system using synthetic RNA [5-7]. One interesting idea
put forward after discovery of the catalytic properties of RNA was the RNA-world
hypothesis. The capability of RNA to carry out self-splicing reactions was
suggested to provide recombined molecules that have functional diversity. These
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findings showed that RNA plays a dual role, which includes storage of
information and performance of chemical reactions [8]. Another major
breakthrough in RNA research was the discovery of introns and RNA splicing in
1977 by Phillip Sharp and Richard Roberts, who were awarded the Nobel Prize
in 1993 [9]. Until the early 1980s when Thomas Cech and Sidney Altman first
discovered RNA's catalytic properties, it was considered merely as a messenger
of DNA. They won the Nobel Prize in 1989 for this finding [10,11]. The discovery
of RNA-interference gene silencing by double-stranded RNA was another major
breakthrough in RNA research [12]. The contribution from Andrew Fire and Craig
Mello was acknowledged by the Nobel Price in 2006. A very recent Nobel award
in the area of RNA research went to Venkatraman Ramakrishnan, Thomas A.
Steiz, and Ada E. Yonath in 2009 for their invaluable contributions to determining
the structure and function of ribosomes [13-15]. With these many exciting
discoveries and a greater appreciation from the scientific community, the RNA
research field is growing with still much to be learned about these fascinating
molecules.
1.2 Introduction to Ribonucleic Acids
RNA is a polymer of ribonucleotides. These RNA oligonucleotides are formed
either

biologically

by

polymerization

of

ribonucleotides,

through

RNA

polymerases, or synthetically through phosphoramidite chemistry. An RNA strand
containing four standard ribonucleotides is shown in Figure 1.1. One of the main
features that distinguishes RNA from DNA is the presence of the 2'-OH group in
the sugar ring. This functional group plays a major role in RNA structure and
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Figure 1.1. An RNA fragment with the four standard ribonucleotides is shown.
The bases adenine (A), guanine (G), cytosine (C), and uracil (U) are indicated.
The sugar ring is numbered on the adenosine nucleoside.
function [16]. The 2'-OH functionality makes RNA more susceptible to hydrolysis
than DNA; however, the 2'-OH group also provides RNA with extra H-bonding
capabilities and allows for specific interactions and catalysis [17].
Each ribonucleotide contains a base, ribose sugar, and phosphate group. The
base and sugar components together are called nucleosides, and combined with
phosphate groups make nucleotides. The four most common bases found in
RNA are adenine, guanine, uracil, and cytosine (Figure 1.1). Adenine and
guanine are purine bases. Purines connect to the sugar rings through the N9
position of the imidazole ring. Cytosine and uracil are pyrimidines with
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connections to the sugar ring through the N1 position. The bases are connected
to the sugar ring through a glycosidic bond. The orientation of the base around
the glycosidic bond can be either syn or anti (Figure 1.2). The anti conformation
is most commonly found in RNA. The base in the syn conformation is more
sterically hindered, yet not uncommon. The syn conformation is favored when a
bulky group is present at the 8 position of purines (e.g., 8-bromoguanosine), or
the 6 position of pyrimidines (e.g., 6-methyluridine) [17].
The sugar conformation in RNA is typically 3'-endo (Figure 1.3) particularly in
double-helical regions [16]. In contrast, B-type nucleic acids (generally DNA)
have a 2'-endo sugar pucker. The 3'-endo configuration in A DNA or RNA brings
the adjacent phosphate groups closer (about 5.9 Å) compared to B DNA (7.0 Å).
Another important feature in RNA is the presence of an open cylinder along the
helix axis because of the dislocation of the base pairs to the periphery. This
results in a very deep and narrow major groove, and a shallow and wide minor
groove in A-type nucleic acids such as RNA. The major groove in A-type helices
is more electronegative than the minor groove [18]. It is observed that metal
cations tend to bind to these electronegative regions in RNA [19,20]. Such
interactions between cationic ligands and electronegative regions are critical for
the structure, dynamics, and function of RNA [17].
RNA performs versatile functions in cells. A diverse array of RNA structures
are involved in these functions. After folding of the polynucleotide backbone, the
bases in single-standard regions of RNA interact to form various secondary and
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Figure 1.2. Ribonucleosides in the anti and syn conformations are shown. The
anti conformation is more favored and common. Although steric interference
between the base and sugar can occur, the presence of bulky groups on base
rings can still favor the syn conformation.

Figure 1.3. The different sugar pucker conformations are shown. The A-type
nucleic acids have a 3'-endo conformation, while B types have a 2'-endo
conformation.
tertiary structure elements [21,22]. Some of the RNA secondary and tertiary
structural motifs are shown in Figure 1.4. The hairpins or stem-loop structures
have unpaired nucleotides at the top of a double-stranded stem. Bulges have
one or more unpaired nucleotides on one strand, which are either stacked into or
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Figure 1.4. Common examples of RNA secondary and tertiary structural motifs
are shown.
out of the strand. In internal loops, one or more unpaired nucleotides are present
on both strands. If the number of unpaired nucleotides on the two strands are
equal, the loop is symmetrical; otherwise it is asymmetrical. The unpaired
nucleotides in internal loops are often involved in non-Watson-Crick base pairing
[23]. A branch point or junction in a nucleic acid is a connection point between
multiple helical segments [24]. The three- and four-way junctions are common
elements in RNA and important for the global architecture and long-range
interactions of large, complex systems [25,26].
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The production of higher-order structures in RNA is hierarchical. A tertiary

structure in RNA is formed by the association of pre-formed secondary structures
with specific geometrical and topological arrangements [22]. A kissing hairpin is
made by base pairing between two hairpin loops (Figure 1.4) [27]. The "kissing"
interactions between RNA molecules are implicated in human immunodeficiency
virus replication [27]. The minimal structure for an RNA pseudoknot is two helical
segments that are connected by single-stranded regions [28]. Pseudoknots can
form complex and stable structures, and therefore are found in many catalytic
cores of ribozymes, self-splicing introns, and telomeres [28].
Cellular functions are complex and highly regulated. RNA is a component in
many of these biological reactions. A variety of RNAs are dedicated to different
functions in a cell. Transfer RNA (tRNA), messenger RNA (mRNA), and
ribosomal RNA (rRNA) are well-known RNA molecules, all of which participate in
protein biosynthesis. The tRNAs carry the correct amino acids corresponding to
the anticodons. The codons of mRNA indicate the order of amino acid assembly
after correct pairing with the tRNA anticodons. The peptidyl transferase center of
the ribosome catalyzes peptide-bond formation between amino acids. The
structure and function of ribosomes will be discussed later in this chapter. With
the realization that only 1.5-2% of the genome accounts for protein-coding
sequences, examination of the function of non-protein-coding regions revealed
the presence of non-coding RNAs [29]. Some of these RNAs include microRNA
(miRNA), small nucleolar RNA (snoRNA), PIWI-interacting RNA (piRNA), and
long non-coding RNA (lncRNA). These RNAs are involved in regulation of gene
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expression and post-transcriptional modifications [30-32]. In addition, other RNAs
such as ribozymes (e.g., hammerhead, Hepatitis Delta Virus (HDV) hairpin,
group I intron, and group II intron) carry out catalytic reactions, and riboswitches
that bind to adenosylcobalamin, thiamin pyrophosphate (TPP), lysine, glysine,
flavin mononucleotide (FMN), guanine, adenine, and S-adenosylmethionine
(SAM) are involved in regulatory functions [33].
1.3 The Ribosome
A cell depends on many biological functions for survival. The central dogma
of molecular biology states that DNA is transcribed into mRNA, which is then
translated to proteins [34]. The ribosomes that carry out protein synthesis are
therefore crucial for a cell. The RNA component of ribosomes is essential for
many steps in translation, including catalysis of peptide-bond formation. A
detailed view of the structure, dynamics, and function of bacterial ribosome is
discussed below.
1.3.1 The Structure of Bacterial Ribosomes
The ribosome is the protein synthesis machinery in a cell [35]. Its primary
function is translation of the genetic code into functional proteins in all living
organisms. The ribosome is a ribonucleoprotein complex composed of both RNA
and proteins. The bacterial ribosome is about 25 nm in diameter with a molecular
mass of 2.4 x 106 Da and sedimentation coefficient of 70S [36-38]. The size of
archaeal ribosomes is similar to bacterial ribosomes, whereas eukaryotic
ribosomes are larger.
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The 70S bacterial ribosome contains two subunits (Figure 1.5). The interface

between the subunits mainly contains RNA [35]. The basic architecture of the
30S subunit (also called the small subunit) is shown in Figure 1.6. The molecular
mass of the 30S subunit is 0.8 x 106 Da. This subunit contains 20 ribosomal
polypeptides and a single 16S rRNA composed of 1541 ribonucleotides [37].
About one third of the mass of 30S is in the so-called "head region". The "body"
contains the remaining two thirds [35]. The broad shelf-like protrusion in the
upper body is called the "platform". The mRNA binds to the cleft between the
head and platform. Generally, the small subunit ribosomal proteins are
concentrated in the head, shoulder, and platform regions [39]. The secondary

Figure 1.5. A crystal structure of the E. coli 70S ribosome is shown (PDB 2AVY,
2AW4) [40]. RNA and proteins in the subunits are indicated as follows: large
subunit rRNA (red) and proteins (brown); small subunit rRNA (blue) and proteins
(cyan).
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Figure 1.6. The small ribosomal subunit (E. coli) is shown from the interface
side. The small 30S subunit (PDB 2AVY) rRNA (16S) is shown in blue. The
ribosomal proteins are shown in gray. Distinct landmarks on the subunit are
indicated [40].
structure of 16S rRNA is shown in Figure 1.7 [41]. The 16S rRNA can be divided
into four domains. The 5' domain forms the 30S body, the central domain forms
the platform, the 3' major domain forms the head, and the 3' minor domain runs
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Figure 1.7. The secondary structure of E. coli 16S rRNA is shown. The domains
in each rRNA are color coded and the helix numbers are also indicated. The 790
loop (h24) studied in this thesis work is highlighted [42-44].
along the intersubunit face [35]. The 790 loop studied in this dissertation work is
located in helix 24 (h24) of the central domain.
The large 50S subunit has a molecular mass of 1.6 x 106 Da. It contains 23S
rRNA with 2904 nucleotides, 5S rRNA with 120 nucleotides, and 34 polypeptides
[37]. When viewed from the interface side, the 50S subunit has three
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protuberances, which gives it a crown-like shape (Figure 1.8). The L1 stalk is on
the left protuberance, 5S rRNA is on the central protuberance, and the flexible
L7/L12 stalk protuberance is on the right. The interface canyon is a deep groove
that runs across the entire flat side of the 50S subunit [45]. The tRNA molecules
fit into this space of the 50S subunit [43]. The large ribosomal proteins are evenly
scattered on the solvent surface [46]. The secondary structures of the 23S and
5S rRNAs of E. coli ribosomes are shown in Figure 1.9. The 23S rRNA contains
six domains. Helix 69 (H69) studied in this thesis work is located in domain IV.

Figure 1.8. The large ribosomal subunit (E. coli) is shown from the interface side.
The large 50S subunit (2AW4) rRNA (23S) is shown in red. The ribosomal
proteins are shown in gray. Distinct landmarks on each subunit are indicated
[40].
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Figure 1.9. The secondary structure of E. coli 23S and 5S rRNA are shown. The
domains in each rRNA are color coded and the helix numbers are also indicated.
Helix 69 (H69), studied in this thesis work, is indicated [42-44].
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1.3.2 Protein Synthesis
The biosynthesis of proteins is an essential process for all living organisms.
The ribosome is the molecular machinery that catalyzes peptide-bond formation
between amino acids to produce proteins. Perhaps not surprisingly, translation is
a complex process that uses many factors during the catalytic cycle (Figure 1.10)
[47]. The peptidyl transferase center (PTC) in the large subunit is the catalytic
core of the ribosome. The decoding center (DC) located in the small subunit

Figure 1.10. The basic components involved in protein synthesis are highlighted.
The tRNA molecules occupying the A, P, and E sites in the ribosome are shown.
The A-site tRNA (purple), P-site tRNA (blue), and E-site tRNA (red) are indicated.
The mRNA (black) is shown in the 30S subunit. The peptidyl transferase center
(PTC) and decoding center (DC) are indicated. This figure represents the
Thermus thermophilus ribosome made from PDB files 3I8F and 3I8G [48].
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checks for correct base pairing between the mRNA codon and tRNA anticodon,
and is responsible for accurate translation [47]. The tRNA molecules that bring
amino acids to the translational machinery occupy three regions in the ribosome.
The A site binds the aminoacyl tRNA (aa tRNA), whereas the growing nascent
peptide chain is attached to the peptidyl tRNA in the P site, and the E site is
occupied by the deacylated tRNA before it leaves the ribosome. Motifs in the 50S
subunit also play a role in decoding. Residue A1913 in H69 projects into the
codon-anticodon minihelix and hydrogen bonds to the 2'-OH of A37 of the A-site
tRNA [13]. A Mg2+ ion also connects A1913 to residue 38 of the A-site tRNA [13].
All of these contacts between H69 and the A-site tRNA are suggested to signal
50S for correct decoding. In addition to these basic molecules, many protein
factors also participate in translation. A detailed discussion of the translation
mechanism is given below (Figure 1.11).
Bacterial translation can be roughly categorized into three main steps:
initiation, elongation, and termination. In translation initiation, the initiator MettRNAfMet is positioned over the start codon of mRNA in the P site. Correct
placement of the start codon on the ribosome is accomplished by base pairing
between the Shine-Dalgarno sequence upstream of the start codon and the antiShine-Dalgarno sequence at the 3' end of the 16S rRNA [47]. The binding of MettRNAfMet and initiation factors 1-3 precisely position the start codon in the P site
[47]. The first step in initiation is recycling of the 30S subunit, which dissociates
from the 50S in the previous translation cycle [47]. Initiation factor 3
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Figure 1.11. The basic steps of protein translation are shown. This figure is
adapted from ref. [47].
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(IF3) binding releases the mRNA and deacylated tRNA on 30S remaining from
the previous translation cycle. The 30S-IF3 complex binds to mRNA, IF1, IF2,
and initiator tRNA to form the 30S initiation complex (30S-IC). Initiation factor 2
promotes binding of the 50S subunit to 30S-IC to form the 70S initiation complex
(70S-IC) accompanied by IF3 release [49-51]. After GTP hydrolysis of IF2, MettRNAfMet moves to the PTC and the ribosome is ready for elongation.
In the elongation cycle of protein synthesis, the polypeptide chain is extended
from the N to the C terminus by sequential addition of amino acids. This process
is facilitated by two elongation factors. Elongation factor Tu (EF-Tu) delivers the
aminoacyl-tRNA to the ribosomal A site, and elongation factor G (EF-G)
catalyzes translocation of the tRNA and mRNA with respect to the ribosome [37].
Delivery of the correct aminoacyl-tRNA by EF-Tu to the A site involves two steps.
The first step is the anticodon/codon interaction, which is followed by GTP
hydrolysis. Three bases on 16S rRNA, A1493, A1492, and G530, are involved in
determining the specificity of the anticodon-codon interaction [52]. In the absence
of a correct mRNA codon and tRNA anticodon interaction, these residues are
flipped out and point away from the ribosomal A site [52]. When Watson-Crick
base pairs are formed between the cognate anticodon and codon bases, the Asite residues re-orient towards the major groove and interact with the minor
groove of the codon-anticodon helix [13,52].
During translation, residue A1492 interacts with the first of the triple codonanticodon base pairs, which occurs for all four Watson-Crick base pairs, but not
for any non-cognate base pairs [53]. Residues A1942 and G530 interact with the	
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second position of the anticodon-codon helix. The interaction of 16S rRNA with
the third anticodon-codon paired site is not as specific, consistent with the
occurrence of wobble base pairs at this position [52].
The complete accommodation of tRNA in the A site requires GTP hydrolysis
on EF-Tu. This step takes place at the GTPase center on the 50S subunit.
Studies have shown that tRNA plays an active role in this process [54]. The
elbow region of tRNA appears in contact with the GTPase center of the 50S
subunit. After transmitting information regarding the correct anticodon-codon
interaction, GTP hydrolysis leads to dissociation of EF-Tu from the ribosome.
The tRNA aminoacyl end orients itself into the PTC. The P-site tRNA is buried in
ribosomal proteins and RNA for tight and stable binding [55].
The next step in protein synthesis is peptide-bond formation. In the peptidyltransfer reaction, the α-amino group of the aminoacyl tRNA attacks the carbon
atom of the ester linkage of the peptidyl tRNA (Figure 1.12). Protein synthesis is
an efficient process. The rate of translation in vivo is about 22 amino acid
additions per second, coupled with >106 accuracy [56].

Figure 1.12. A schematic of peptide-bond formation is shown. The aminoacyl
tRNA α-amino group attacks the carbonyl carbon of the peptidyl tRNA. Finally,
the extended peptide chain is hydrolyzed from the P-site tRNA [47].
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The step that follows peptidyl transfer is translocation. After peptide-bond

formation, the P-site tRNA becomes deacylated and the peptide chain is
transferred to the A-site tRNA. Translocation shifts the mRNA exactly by one
codon, and tRNAs from the P to E site and A to P site. This movement forms the
tRNA hybrid states, P/E and A/P, for deacylated tRNA and peptidyl tRNA,
respectively [57]. During this process, the ribosome undergoes a ratcheted-like
rotation in which the subunits rotate ~6° relative to each other [58]. EF-G assists
with the passage of tRNA anticodon ends and mRNA on the small subunit [57].
The E site traps the hybrid P/E tRNA efficiently and facilitates translocation.
Another feature of the ribosomes is the polypeptide exit tunnel, which starts
from the PTC and extends through to the center of the 50S subunit, with the exit
on the back. The tunnel is about 80 Å long and 12-20 Å in diameter [14,59]. The
addition of amino acids to the polypeptide chain continues until a stop codon
reaches the A site. In bacteria, release factors RF1, RF2, and RF3 hydrolyze the
nascent polypeptide chain from the P-site tRNA. Ribosome recycling factor
(RRF) and EF-G cause subunit dissociation [60]. IF3 binding then removes
mRNA and tRNA from the 30S subunit and prepares the ribosome for the next
protein synthesis cycle.
1.3.3 The Helix 69 and 790 Loop Motifs of Escherichia coli Ribosomes
As explained in the previous section, protein synthesis is a complex process.
Many rRNA motifs play crucial roles during translation and have therefore
become drug targets [36]. This thesis work focused on two such rRNA regions,
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namely, helix 69 (H69) and the 790 loop (h24). The following section discusses
the structure and function of these regions in detail.
The H69 RNA is a 19-nucleotide hairpin located in domain IV of 23S rRNA
(Figure 1.9). The secondary structure, location on the 50S subunit, and the
tertiary structure of H69 in bacterial ribosomes are shown in Figure 1.13. Many
nucleotides in the loop region of H69 are conserved, indicating their significance
for ribosome structure and function [41]. Three post-transcriptionally modified
nucleotides, namely pseudouridine (Ψ) at positions 1911, 1915, and 1917 (E. coli
numbering), are found in the loop region of H69. In bacteria, the conversion of
uridine to Ψ in H69 is carried out by a single pseudouridine synthase RluD [61].
Pseudouridylation is an isomerization reaction that involves conversion of an N1C1' glycosidic bond to a C5-C1' glycosidic bond (Figure 1.13) [62]. In addition,
the Ψ at residue 1917 is methylated at the N3 position. The H69 RNA also
contains a G•U mismatch in the stem region. The G•U wobble pairs have been
reported to have strong electronegative potentials in the major groove to which
divalent ion binding occurs [63].
Helix 69 is located in the subunit interface along with helix 44 (h44) of the
small subunit to form bridge B2a [43]. The A1919 and A1912 residues of H69
project towards h44 of the small subunit. These H69–h44 interactions are
stabilized by reverse-Hoogsteen base pairs formed with the H69 loop residues
[40]. As a structural element connecting the two subunits, it is not surprising that
H69 is a dynamic motif in the ribosome. It is involved in many steps during
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Figure 1.13. Bacterial H69 and structures of uridine and pseudouridine are
shown. A) The secondary structure of H69 is given with the residues numbered
according to E. coli 23S rRNA. B) H69 (purple) is displayed from a side view of
the 50S subunit. H69 interacts with h44 (green) of the 30S subunit to form bridge
B2a. C) A closer view of the tertiary structure of H69 is given [64]. The figures
were created using PDB files 2AVY and 2AW4. D) The base structures of uridine
and pseudouridine are shown.
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translation, including subunit association, initiation, elongation, termination, and
recycling [65]. Helix 69 interacts with both aminoacyl and peptidyl tRNAs [43,48].
The deletion of H69 has been shown to cause defects in subunit association [66].
During the translocation step, residues 1914 and 1915 in H69 interact with hybrid
tRNA complexed with EF-Tu.
During the last steps of protein synthesis, H69 interacts with the release
factors and the ribosome recycling factor [67-69]. In stop codon recognition,
nucleotides 1914 and 1915 of H69 interact with RF1 and contribute to its
conformational changes [68]. Crystallographic studies revealed that H69 is the
only 23S rRNA component that interacts with RRF, and this motif undergoes
significant conformational changes in the loop region. As such an integral part of
the ribosome, mutations or deletions of residues or the complete H69 show
deleterious effects to bacteria [65]. Deletion of H69 residues lead to defects in
peptide synthesis, translational processivity, internal-codon frame shifting, and
stop-codon read-through [70,71].
Nucleotide modifications in rRNA mostly occur in the functionally important
regions, highlighting their significance in ribosome function [72]. Pseudouridine is
the most commonly found nucleotide modification in the ribosome and is a key
component in H69 [73]. It is important for the rigidity of the loop region [74], and
slow-growing phenotypes result from the absence of pseudouridine [61].
Biophysical studies carried out using truncated models have shown Ψ's impact
on H69 structure. The pH-dependent CD experiments revealed that Ψ-containing
H69 undergoes a structural change with an apparent pKa of 6.3 ± 0.2 [75]. The
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same study suggested that at low pH, a protonation may be occurring near 1911
or causing a structural change at the loop-closing base pair in Ψ–modified H69.
Biochemical studies performed on ribosomes revealed that pseudouridylated
H69

undergoes

a

base-stacked

("closed")

to

a

base-flipped

("open")

conformation in response to increased pH, temperature, and Mg2+ [76]. Biological
studies revealed that Ψ-deficient H69 could affect subunit association [77].
The 790 loop (h24) is a hairpin structure located in the central domain of 16S
rRNA (Figure 1.7) [78]. In the secondary structure of 16S rRNA, the 790 loop
resides on the tip of h24. The loop motif comprises nine nucleotides, in which six
of them are universally conserved and two are highly conserved (Figure 1.14)
[78]. The 790 loop is a functionally important region of the ribosome that has
been implicated in initiation factor binding, subunit association, and tRNA binding
[79-82]. Chemical probing experiments carried out using 1-cyclohexyl-3-(2morpholinoethyl) carbodiimide metho-p-toluene sulfonate, or CMCT, showed that
initiation factor 3 binding protects U793 [79]. Site-directed mutagenesis of the
universally conserved G791 to A showed reduced cell growth, IF3 binding, and
subunit association [83]. Kethoxal modification experiments revealed that G790
is protected after tight coupling of the subunits [81]. Other studies showed that
residues 787-795 are protected by cDNA probes after subunit association [80].
Perhaps the 790-loop connection to subunit association is not surprising, since it
is involved in an intersubunit bridge confirmed by crystallographic studies (Figure
1.14B) [43]. The 790-loop residues 784-785 and 794 form the bridge B2b through
interactions with H67 and H69 of the large subunit [43].
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Figure 1.14. The bacterial 790
loop is shown. A) The secondary
structure of 790 loop is given
with the E. coli numbering. The
790 loop motif used in this study
contains an additional GC base
pair (782-800). B) The 790 loop
forms an intersubunit bridge with
H69 and H67 of the 50S subunit.
C) Interaction of the 790 loop
with tRNA is shown. The figures
are made from PDB files 2AVY,
2AW4, 3I8G, and 3I8G.

Another important involvement of the 790 loop in protein synthesis is its
interaction with tRNAs (Figure 1.14C) [82]. Residue A790 contacts the anticodon
stem loop of the P-site tRNA. The E. coli ribosome structure at 3.5 Å resolution
also shows the importance of the 790 loop in translocation [40]. Together with
G1338 and U1314, A790 forms a 12-13 Å gap that prevents tRNA from passing
through. This feature allows for formation of the P/E tRNA hybrid state [40].
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Random mutagenesis and selection of functional ribosomes also revealed that
positions 787 and 795 are important for the 790-loop structure and strongly affect
subunit association [84]. Of note, the 790 loop has an identical size and
nucleotide composition, but altered sequence, compared to unmodified H69, and
was therefore used to examine the effect of nucleotide arrangement on cisplatin
reactions in this thesis work.
Collectively, these two chosen regions of rRNA, H69 and the 790 loop, are
integral for the translation process. Ligand binding to these regions may be a
promising approach for antibacterial therapies. Although less is known about the
roles of H69 and the 790 loop in eukaryotic ribosome systems, these essential
components might also serve as target sites for anticancer drugs. Therefore,
studying the local environments of these assemblies and how such atmospheres
control ligand interactions is important.
1.4 RNA Microenvironments
RNAs are essential biomolecules. The complex three-dimensional RNA
scaffolds are necessary for their activity. RNA microenvironments and their
interactions with other ligands such as cations are important for producing
functional molecules. Computational studies have revealed the significance of
the RNA microenvironments in molecular recognition and ligand binding [18,85].
Understanding the local environments of these biomolecules and their changes
in response to the bulk medium is therefore important for recognition of unique
RNA regions by small molecules and for future drug development. Further,
identification of probes that can interpret these microenvironments, especially
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when currently applied methods are mostly based on computational work, will be
invaluable for RNA biochemists.
1.4.1 Electrostatic Interactions with RNA
RNA is a highly charged anionic biopolymer. Therefore, electrostatics play a
major role in RNA biology. Many RNAs have been identified that possess regions
with characteristic electrostatic potentials where biological reactions take place.
Some examples include yeast tRNAPhe, mouse mammary tumor virus (MMTV)
pseudoknot, 5S rRNA, and G•U tandem basepairs (Figure 1.15) [18].
Computational analyses applied to yeast tRNAPhe have shown distinct
electrostatic patches on the aminoacyl end and anticodon loop (Figure 1.15) [18].
These regions are suggested to facilitate the association of other negativelycharged molecules such as mRNA [86]. The potential hole on MMTV occurs over
residue G7 where the structure is bent [18]. This region is implicated in playing a
role in ribosome recognition, and further supports the concept of minimizing
electrostatic repulsions. Moreover, the study on MMTV suggested that the
connection between potential hole location and molecular shape may indicate
evolution

of

RNAs

to

modulate

electrostatic

potentials.

Computational

calculations further showed an unusually large electronegative region on 5S
rRNA. This region corresponds to a site referred as the "metal ion zipper" [18].
The presence of several magnesium ions in this region cause a narrowing of the
major groove [87]. In the last example, wobble pairs have also been implicated
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Figure 1.15. Examples of RNAs with varying electrostatic potentials on their
surfaces are given. A) Yeast tRNAPhe, B) mouse mammary tumor virus (MMTV)
pseudoknot, C) 5S rRNA with the metal zipper region, and D) RNA with tandem
G•U base pairs are shown. The regions with either potential holes or high
electronegative surfaces are indicated with dotted circles or boxes, respectively.
The figures are made from PDB files 1TRA, 1RNK, 364D, and 1QES and
adapted from ref. [18].
in RNA function. The most common non-Watson-Crick pair in RNA is G•U [63].
Analysis of the surface potential of an RNA with tandem G•U pairs also revealed
a major groove with increased negative potential where metal binding occurs
[63].
The electrostatic characteristics of the major and minor grooves of nucleic
acids are important. These regions are implicated in drug binding and cation
accumulation. Analysis of the electrostatic potential on A-form nucleic acids
(typically RNA) has revealed that the major groove is more negative than the
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minor groove [18]. This result is supported by the observation that cations tend to
bind to the major groove of RNA [20]. In contrast, the minor groove of B-form
nucleic acids was found to be more electronegative, but also supporting cationic
drug binding [18].
Calculation of the electrostatic potentials on rRNA revealed that the codonbinding region is surrounded by positive potentials, which suggested a stabilizing
effect on mRNA and tRNA binding [88]. Electrostatics are important for many
RNA-protein interactions. An arginine-rich motif in the Rev peptide has been
suggested to play a role in stabilizing unfavorable electrostatic interactions in a
bulge region of the Rev response element (RRE) RNA of HIV [89]. Similarly, the
specific binding of transcription activating (Tat) protein to the trans-acting
responsive element (TAR) RNA was shown to require an arginine residue that
participated in electrostatic interactions [90]. Other examples of electrostatics in
protein-RNA interactions include tRNA-EF-Tu and tRNA-tRNA synthetase
binding [91].
1.4.2. The Influence of Salts and Divalent Ions on RNA Structure and
Electrostatics
Biomolecules in cellular environments are immersed in a mixture of ions.
Concentrations of different cations found in a variety of cellular environments are
listed in Table 1.1. The most common ions in vivo are K+ and Mg2+. The most
abundant cation in the extracellular fluid is Na+; however, an increase in E. coli
cytoplasm Na+ concentrations in response to external conditions has also been
reported [92]. Therefore, cations are in constant contact with biomolecules and
can play important roles in ligand interactions [93,94].
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Table 1.1. Concentrations of cations in biological fluids are shown [92,95,96].
Ionic
species

Mammalian
cells (mM)

Mammalian
extracellular
fluid (mM)

Blood
plasma
(mM)

E. coli
cytoplasm
(mM)

Na+
K+
Mg2+
Ca2+
Fe2+

10
140
30
1

145
5
1
4

138
4
1
3
2x10-2

42
230-930
23

The high negative charge of RNA acts against its folding. Many different
cations including Na+, K+, NH4+, and Mg2+ have been identified to bind to various
types of RNA [97]. Cations neutralize the negative charge of RNA and assist in
folding and stabilization. There are different types of cation-RNA interactions
(Figure 1.16). The diffusely bound ions, classically described by Manning and
Record, screen electrostatic repulsions between RNA backbone charges [98,99].
The behavior of diffuse ions or the "ion atmosphere" is determined by the longrange electrostatic interactions with RNA [93]. The concentration of diffuse ions is
proportional to the magnitude of the local RNA electrostatic potential. The ionic
cloud comprises group I monovalent ions such as Na+ and K+, which often
remain well hydrated. Diffusely bound divalent cations such as Mg2+ are reported
to play a dominant role in RNA tertiary structure stabilization [100,101]. The Mg2+
ion is small with an ionic radius of ~0.60 Å. Given the higher charge compared to
the larger K+ (~1.3 Å) and Na+ (~1.0 Å) ions, Mg2+ carries a higher charge
density.

These differences in monovalent versus divalent cations lead to a

strong RNA-Mg2+ electrostatic interaction [93]. Therefore, the entropic effects in
which one Mg2+ ion releases RNA electrostatic stress in a similar manner as two
K+ ions explains the dominant role of Mg2+ in RNA stabilization [93].
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Figure 1.16. Different modes of ion-RNA interactions are shown. A) Diffuse
binding, B) outer-sphere site binding, and C) inner-sphere site binding are
represented with cations in blue, RNA in red, and water in green. The figure is
adapted from refs. [93,94].
The evaluation of salt-dependent platination rates by electrostatic models in this
thesis work also emphasizes the significant impact of such ionic atmospheres for
RNA-ligand interactions.
In addition to diffuse binding, metal ions interact with RNA through outersphere and inner-sphere complexes [93,94]. In outer-sphere binding, metal ions
often interact with RNA through water molecules [94]. One example of this
binding occurs in the Tetrahymena pre-ribosomal RNA intron [102]. In the crystal
structure, docking of the tetraloop to the receptor motif is facilitated by binding of
Mg(II)(H2O)62+ to tandem G•U pairs [103]. One of the studied RNAs in this thesis
work, H69, contains a G•U mismatch (Figure 1.13). Therefore, similar Mg2+ ion
binding near this pair is likely and could impact ligand-binding reactions. In
contrast, the formation of inner-sphere complexes occurs through direct contacts
between the metal and nucleic acid ligands [93,94,102].
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One of the bacterial rRNA motifs that was studied in this thesis work is H69.

Crystal structures revealed Mg2+ ions binding to the stem, loop, and stem-loop
junction of H69 [65]. Figure 1.17 shows Mg2+ ions bound to these regions of H69
[104]. A 2-aminopurine-substituted H69 construct revealed high exposure of
residue 1913 in the presence of >0.8 mM Mg2+ [105]. Chemical- probing studies
carried out on E. coli 50S subunits and complete ribosomes further supported
Mg2+-induced A1913 conformational changes in H69 [76,77]. The binding of
cationic antibiotics such as neomycin and Mg2+ to the G1921 and G1922
residues have also been observed [104,106]. Collectively, these observations
suggest that H69 in bacterial ribosomes should possess electronegative surfaces
to which cationic ligands prefer to bind.

Figure 1.17. The Mg2+ ions (magenta) bound to the loop and stem regions of
Thermus thermophilus H69 are highlighted [104]. PDB entry 3HUX.
High Mg2+ concentrations (>6 mM) and low NH4Cl (30 mM) are necessary for the
isolation of complete ribosomes with proteins in vitro [107].
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1.4.3. The Impact of pH on Structure and Dynamics of RNA
Local environments impact biochemical reactions. The concentrations of
reactants, temperature, ionic strength, cofactors (e.g., Mg2+), and pH influence
bimolecular interactions as well as chemical reactions and rates. The oxygen and
nitrogen atoms in nucleobases act as H-bond acceptors, and hydrogens are
donors (Figure 1.18). Complementary donors and acceptors interact to form
Watson-Crick base pairs [108]. The pKa values of nucleotide bases are well
outside of the neutral pH range, and therefore are not charged at physiological
pH [16]. The pKa values of nucleosides and their ionizations are shown in Figure
1.19 [109,110].
The pKa values of nucleotides increase by 0.3-0.5 units due to the addition of
a phosphate group [110]. In a polynucleotide where the electrostatic field is

Figure 1.18. The H-bonding donors (d) and acceptors (a) of the nucleobases
found in RNA are shown.
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Figure 1.19. The pKa values and sites of ionization of ribonucleosides are
shown. The figure is adapted from ref. [17].
higher, the pKa values further increase [17]. Other ionizable groups present in the
RNA include phosphates and 2'-OH of the ribose ring [110]. The phosphate
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groups on the ends of oligonucleotides have two ionizable groups; the second
ionization has a pKa close to physiological pH. The phosphodiester ionizable
group is very acidic with a pKa value of ~1. In contrast, the sugar 2'-OH has a pKa
of ≥ 12.5 [110]. The apparent pKa values are dependent on the temperature and
the ionic strength [17].
As discussed previously, counterion condensations are crucial for nucleic
acid-ligand interactions. However, little is known about H+ ion condensations and
their concomitant release upon ligand binding to nucleic acids [111].
Computational calculations carried out on poly(dG)•poly(dC) revealed that high
concentrations of H+ are localized in the major groove near the N7 of
deoxyguanosine in the G•C pairs [111]. The pH near the van der Waals surface
was about 1.9-3.5 units lower than the bulk pH [111,112]. The authors suggested
that this increase in H+ concentration results from an effective increase in the
pKas of water molecules near high negative electrostatic potentials of nucleic
acids. Moreover, the study revealed an interesting contrast between counterion
condensation and H+ condensation. In counterion condensation, the number of
counterions bound to the polyelectrolyte does not depend on bulk salt
concentration. In contrast, the H+ ions on nucleic acid surfaces are proportional
to the bulk pH. Overall, these studies showed that the high electrostatic potential
surfaces

of

nucleic

acid

polyelectrolytes

could

generate

acidic

microenvironments. Such environments can therefore impact pH-dependent
nucleic acid interactions.

	
  

	
  
1.5

35
Small Molecule Binding to Ribosomal RNA
Finding solutions to medical challenges, drug-resistant bacteria, lethal and

life-threatening infections (e.g., Ebola, HIV), cancers, and genetic disorders are
some major interests in scientific research. The imperative function, structural
complexity, and little-known repair mechanisms of RNA make ribosomes a
versatile target for drug development [36,113-115]. Not surprisingly, there are
many drugs that target ribosomes; more than half of the clinically used antibiotics
target this macromolecule [114,116]. Some examples of compounds used in
clinical treatments include macrolides, ketolides, lincosamides, oxazolidines,
aminoglycosides, and tetracyclines [113].
Many clinically used drugs such as aminoglycosides, tetracyclines, and cyclic
peptides target the small ribosomal subunit (Figure 1.20A) [36]. The chemical
structures of some of these drugs are shown in Figure 1.20B. Aminoglycosides,
e.g., paromomycin and neomycin, target the decoding site and lead to amino
acid misincorporation, and also impact EF-G-catalyzed translocation [52,117119]. The pKa values of the amino groups on aminoglycosides are approximately
5.7-9.5, hence they are charged at physiological pH [120,121]. Electrostatic
interactions between cationic amino groups and anionic RNA are important for
aminoglycoside binding [122-126]. Helix 69, one of the rRNA motifs studied in
this thesis work, has shown interactions with aminoglycosides [127]. Edeine is a
peptide-like antibiotic that has been identified to bind near the E site of 16S rRNA
and interfere with translation initiation [128,129]. The 790 loop studied in this
thesis work has shown interactions with edeine [129].
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Figure 1.20. Antibiotic binding to the small subunit of the ribosome is shown. A)
The locations of some 30S subunit targeting compounds are indicated. The
figure was created from PDB file 1FJG and adapted from ref. [36]. B) The
chemical structures of some of the small subunit binding drugs are shown. The
amino groups of neomycin and paromomycin are shown at pH 7, with their pKa
values listed [130,131].
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The large 50S subunit catalyzes peptide-bond formation and not surprisingly

many

antibiotics,

including

chloramphenicol,

puromycin,

macrolides,

streptogramin A and B, and lincosamides, target 23S rRNA (Figure 1.21) [36].
Most of these compounds bind to the PTC of the ribosome. The large subunit
targeting drugs interfere with A-site tRNA binding and elongation, or block
nascent peptide chain growth [36,132,133].
The ribosomal RNAs that were investigated in this thesis work, H69 and the
790 loop, are also targets of antibiotics. Although well known to bind to h44 of the
small subunit, aminoglycosides were revealed by crystallographic studies to also
interact with H69 (Figure 1.22) [127]. In this binding, neomycin bridges the
subunit interface and substantially alters subunit rotation [127]. The H69neomycin interactions have also been shown to interfere with the ribosomerecycling process [106]. Neomycin makes specific interactions with G1921,
G1922, U1923, and also the RNA backbone [127]. Biochemical footprinting
assays on complete ribosomes also revealed aminoglycoside binding to H69
[134]. Another region that was of interest in this study, the 790 loop, is a target of
the antibiotic edeine (Figure 1.23) [129]. Edeine is a peptide-like compound
(Figure 1.23B) that interacts with RNA residues 790-792 in the loop of h24 and
affects translation initiation [135].
The chemical structures of RNA-binding molecules shown in Figures 1.20 and
1.21 reveal polar, H-bonding, and possibly protonating functional groups. Some
of the examples are hydroxyl, carbonyl, amine and guanidinium groups. These
moieties can form electrostatic interactions with their targets. Kinetic studies
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Figure 1.21. The antibiotics targeting the large ribosomal subunit are shown. A)
The regions where 50S targeting antibiotics bind are indicated. The figure was
created from PDB file 3CC4 and adapted from ref. [36]. B) The chemical
structures of some 50S binding compounds are shown [130].
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Figure 1.22. Neomycin binding to the bacterial ribosome is shown. A) Neomycin
binding sites in h44 and H69 are indicated. B) A closer view of neomycin
interactions with H69 residues is shown. The figures are generated from PDB
files 4GAQ and 4GAR [127].

Figure 1.23. The edeine-790 loop interaction is shown. A) The binding of edeine
to the 790 loop is shown. B) Specific interactions of edeine with the 790 loop
residues are indicated. The figure was created using PDB file 1I95 from ref.
[129].
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showed the importance of amino groups on aminoglycosides on the inhibition of
hammerhead ribozyme catalytic rates [124]. Computational docking experiments
provided further evidence for aminoglycoside-hammerhead ribozyme recognition
through electrostatic interactions [136]. An array of interactions, including
electrostatic forces, was shown to govern tobramycin-RNA recognition [137].
Mapping 30S electrostatic potential onto the paromomycin surface revealed good
agreement between the placement of charged functional groups and the rRNA
environment

[125].

These

electrostatic

correlations

between

drug-target

interactions have also been applied to design RNA inhibitors by stabilizing
electrostatic "hot spots" [138]. In the aggregate, these reports provide evidence
for an imperative role played by electrostatics in drug-inhibition kinetics, drugtarget affinities, binding modes, recognition, and docking.
1.6 Cisplatin
1.6.1 Introduction to Cisplatin
Cisplatin, initially known as “Peyrone salt” was first synthesized by Michel
Peyrone in 1845 [139]. In 1913, Alfred Werner proposed the square-planar
configuration for the compound, and distinguished between cis and trans
isomers, cisplatin and transplatin, respectively [140]. For this finding Alfred
Werner won the Nobel Prize in Chemistry [140]. However, not until the 1960s
was the anticancer property of cisplatin discovered. In 1965, Barnett Rosenberg
carried out an experiment designed to monitor the effects of electromagnetic
fields on bacterial growth [141]. The observation that bacteria grew filamentous,
but had not divided, hinted that a compound produced during the experiment
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could be a potential tumor-cell-growth inhibitor. The agent responsible for this
effect was eventually identified as cis-diamminedichloridoplatinum(II) [142]. After
successful demonstration of its anticancer activity, the FDA approved cisplatin in
1979 [143]. Since then, cisplatin and related platinum compounds (Figure 1.24)
have been used to treat many carcinomas, including testicular, ovarian, bladder,
colorectal, head and neck cancers, and lung cancers [144].
The cytotoxicity of cisplatin, the platinum compound used in this thesis work,
is believed to originate from coordination to the nucleobases in DNA [145]. A
general pathway for binding is shown in Figure 1.25 [146]. Once given as an
intravenous drug, the labile chlorido ligands in cisplatin stay intact due to the high
chloride concentration in blood plasma. Experimental results suggest that
cisplatin is up taken by cells by both active transport and passive diffusion [147].
Once inside a cell, the chlorido ligands on cisplatin are displaced and the
aquated, positively charged, activated form of cisplatin is generated. This active
species then reacts with nucleic acids, and the resulting platinated adducts then
lead to cell death [148].

Figure 1.24. Structures of cisplatin and related platinum compounds are shown.
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Figure 1.25. A general pathway of cisplatin mechanism of action is shown [146].
Cisplatin forms different adducts with DNA (Figure 1.26A). It coordinates to
the N7 position of purine bases, which is exposed in the major groove of DNA, to
generate stable adducts (Figure 1.26B) [149]. In early studies, platination and
characterization of cisplatin-treated salmon sperm DNA revealed 1,2-intrastrand
cross-links as the major adducts, followed by 1,3-intrastrand and interstrand
cross-links as the minor adducts [150]. The major 1,2-intrastrand cross-links are
cis-[Pt(NH3)2{d(GpG)}] (or cis-GpG; 47-50%) and cis-[Pt(NH3)2{d(ApG)}] (or cisApG; 23-28%) [150]. The 1,3-intrastrand and interstrand cross-links are 8-10%
percent of all adducts and monofunctional guanine comprises 2-3% of the
damaged sites.
Cisplatin

binding

to

DNA

leads

to

significant

structural

effects.

Crystallographic studies have shown that cisplatin binding bends the duplex
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Figure 1.26. Cisplatin binding to nucleic acids is shown. A) Some of the cisplatin
binding modes to a double helix are illustrated. B) The coordination of cisplatin to
the N7 position of nucleobases is shown [151,152].
toward the major groove by about 35° [152]. The change in supercoiling of
circular DNA suggests unwinding of the double helix [153]. NMR studies on a
1,3-intrastrand cross-linked adduct on DNA further supports the idea that the
platination site is locally unwound and kinked [154]. Studies revealed that
cisplatin adduct formation results in duplex destabilization and loss of helix
stability [155,156]. Crystallographic studies revealed that the ammine ligands on
cisplatin hydrogen bond to the oxygen atoms on the 5'-phosphate group,
potentially stabilizing the adduct [152]. Collectively, these studies show that
stable cisplatin adduct formation can induce structural changes to nucleic acids.
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1.6.2. Kinetic Studies of Cisplatin-Nucleic Acid Interactions
Cisplatin can react with many targets such as nucleic acids, proteins, and
small S-containing molecules in a cell [151]. Formation of different cisplatin
adducts would depend on the reaction kinetics. The ligand-exchange reactions of
square-planer compounds are slow [157]. This leads to kinetically controlled
platination reactions of cisplatin binding to nucleic acids [158,159]. The proposed
mechanism of cisplatin binding to double-stranded DNA is shown in Figure 1.27.
The rate-limiting step for initial binding is hydrolysis of the first chlorido ligand.
[160,161]. The aquated species then rapidly coordinates to DNA specifically at
the N7 of purine bases. Loss of the second chlorido is the rate-determining step
in the closure of the monoadduct [158].
Kinetic studies have given detailed insight to the primary reactive species,
sequence-dependent reactivities, and the mechanism of cisplatin binding to
nucleic acids [162]. Determination of reaction rates of phosphorothioatesubstituted oligomers using

31

P NMR showed that increased local concentrations

of Pt(II) complexes, combined with higher mobility along the polymer backbone
increases the platination rate [163,164]. Kinetic studies also demonstrated that
target sites located at the ends of an oligomer platinate more slowly compared to
the ones in the middle, indicating the importance of target location in platination
reactions [165,166]. Flanking bases at the target site and nucleotide sequence
also impact the platination rate [167,168]. Some of these observations were
explained by a combined effect from electrostatic potential and N7 accessibility
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Figure 1.27. Proposed mechanism of cisplatin binding to double helical DNA is
shown [158].
of the target [169]. Kinetic studies have also shown that cisplatin discriminates
between the 5' and 3' dGs in a dGG sequence for platination [170]. While the first
platination is faster on 5' dG than on 3' dG, the chelation rates are opposite for
the two Gs. The cisplatin preference for dAG adduct formation over dGA has also
been explained by kinetic studies [171]. The higher rates of monoadduct
formation, hydrolysis of the second chlorido ligand, and closure to form chelates
on dAG compared to those of dGA have contributed to the increased platination
of the former sequence. The platination kinetics also revealed that adduct
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formation is dependent on whether the target sequence (dGG) is in a single- or
double-stranded region [172].
Solution ionic strength and the type of cations present also determine the
platination rates. Increasing pH, concentrations of salt, or divalent ions compared
to monovalent ions reduce the platination rates [166,173,174]. Evaluation of saltdependent kinetic data revealed that metal-complex binding releases cations
from the nucleic-acid surface [173,175]. Interestingly, comparison of DNA and
RNA reactions showed a more pronounced salt dependence in the platination
rate of the latter [176]. Kinetic studies using full-length tRNA also showed a
preference for G-C–rich and wobble base-pair regions in the platination reactions
[177].
Platination kinetic studies can reveal much insight into nucleic acid-platinum
complexes reactions. In addition, platination kinetics can be used to investigate
the impact of RNA microenvironments on ligand interactions, which was a major
focus of this thesis work. RNAs with natural nucleotide modifications
(pseudouridine, Ψ, in H69) or altered sequences (the 790 loop) were selected to
examine the impact of local environments on platination reactions. The
evaluation of salt-dependent platination rates by the Brønsted-Debye-Hückel and
polyelectrolyte theories allowed determination of the impact of global
electrostatics on RNA-ligand interactions. The role of bulk solutions containing
different monovalent and divalent cation concentrations or varying and pH values
on selected RNA platination rates was determined. Platination kinetics were also
applied to evaluate aminoglycoside-RNA interactions.
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1.7 Specific Aims of the Research and Thesis Overview
Many studies have examined the characteristics of RNA molecular
interactions. RNAs are central for various cellular functions; therefore, their
interactions with small drug molecules can have a significant impact on cell
biology. Characterization of RNA-drug interactions and investigation of their
dynamics in response to changes in local environments are important. These
studies are useful to identify unique RNA targets and to develop effective small
molecule-based therapeutics.
This dissertation work was designed to investigate the kinetics of ribosomal
RNA interactions with a platinum(II) complex, cisplatin. Many structural,
biological, computational, and kinetic studies on DNA-cisplatin interactions have
been reported to date [148,151,162,178]. Specifically, kinetic studies have
provided valuable insight on the mechanism of drug binding [158,163168,173,175,176,179,180]. Many RNAs are also targeted by cisplatin [181-187];
however, kinetic studies on RNA-cisplatin interactions are largely unexplored and
the binding mechanisms with RNA are largely unknown. Furthermore, salts,
divalent ions, and pH play significant roles in biological interactions in a cell.
Therefore, one of the main objectives of this thesis work was to carry out a broad
kinetic study on cisplatin coordination to RNA. Analysis of the kinetic data with
two different electrostatic models was done to reveal the impact of RNA
microenvironments on drug binding. These findings are significant for expanding
our knowledge on the mechanisms of platinum drug-RNA interactions.
Importantly, this study reveals the impact of bulk conditions on RNA
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electrostatics, which govern the platinum complexation reactions. Findings from
the current study are valuable for identifying distinctive "druggable" RNA targets
on bacterial ribosomes and their interactions with metal-based compounds. This
knowledge could be further expanded to understand general cationic interactions
with RNA.
The cationic cloud plays a significant role in RNA electrostatics, hence could
impact structure, function, and ligand interactions [93,188-190]. The primary
methods for studying these local environments are often based on computational
approaches [85,191]. However, such theoretical methods may not reflect the true
biological environments of molecules. Applications of some solution-based
methods such as small-angle x-ray scattering and spectroscopic techniques to
investigate the ionic cloud around DNA and RNA have been reported [192-195].
However, specific details on the RNA charge density and counterion
displacement by ligand binding cannot be obtained from these studies. The use
of chemical tools to interrogate RNA electrostatics is even rarer. Therefore, a gap
in the field with respect to the development of chemical tools that can provide
detailed information on microenvironments of structured RNA still exists. Another
objective of this thesis work was to show the use of platination kinetics as an
experimental tool to examine local environments of RNA, as it is sensitive to
electrostatics illustrated by the binding mechanism. Platination kinetics was
further applied as a tool to probe a known aminoglycoside-RNA interaction.
An overview of the dissertation work is as follows. Chapter 1 has introduced
RNA and discussed its functions with respect to a key cellular activity, namely
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protein synthesis. An introduction to ribosomes, RNA constructs studied in this
thesis work, H69 and the 790 loop, RNA electrostatics, salt and pH influence on
RNA, RNA-ligand interactions, and cisplatin was also provided in this chapter.
The various techniques used in this thesis work and a description of the data
analyses are provided in Chapter 2. Chapter 3 reports on cisplatin targeting of
rRNA hairpins and site determination. The remaining chapters then focus on
kinetic studies between cisplatin and the rRNA hairpins. The impact of
monovalent cations on reaction rates (Chapter 4), the influence of monovalent
and divalent cations on kinetics (Chapter 5), the sensitivity of cisplatin-ribosomal
RNA binding rates to pH (Chapter 6), and probing aminoglycoside-ribosomal
RNA interactions using cisplatin kinetics (Chapter 7) are reported. Finally,
Chapter 8 gives some overall conclusions of the study and future directions.
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CHAPTER 2
BIOCHEMICAL METHODS, KINETIC MEASURMENTS, AND DATA
ANAYSIS
A variety of biochemical methods and analytical/biophysical approaches are
used in RNA research. This chapter provides a detailed background on the
biochemical and biophysical techniques used to study cisplatin binding to
ribosomal RNA. Data analysis methods used to determine platination rates and
electrostatics of rRNA will be discussed in this chapter; whereas, specific
experimental details will be given at the end of each section.
2.1 Matrix Assisted Laser Desorption Ionization Mass Spectrometry
(MALDI MS)
Matrix assisted laser desorption ionization mass spectrometry (MALDI MS) is
a technique used to analyze biomolecules such as peptides, proteins,
oligonucleotides, and carbohydrates [196,197]. In a typical MALDI experiment,
the analyte is first dissolved in a suitable solvent and mixed with an appropriate
matrix. The sample is then spotted onto a MALDI plate and solidified by air
drying. The analyte is then irradiated with a laser beam to bring the molecules
into the gas phase. The most commonly used wavelength is 337 nm from a
nitrogen laser [198]. The analyte ions are then separated and directed to a
detector. The mass analyzer is a part of the mass instrument, in which ions are
separated based on their m/z values [199]. The mass analyzer in a TOF
instrument is the time-of-flight tube. A schematic of a MALDI-TOF instrument is
shown in Figure 2.1. The three main components, ionization source, mass
analyzer, and detector, are illustrated.
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The matrix used to co-crystallize the sample in MALDI plays an important

role. The ideal matrix absorbs energy from the laser and relays it to the analyte in
a controlled manner to produce gas-phase ions. Some commonly used matrices
for nucleic acids and proteins are shown in Figure 2.2. The most effective matrix
for nucleic acids is 3-hydroxypicolinic acid (3-HPA) [200]. The 3-HPA matrix,
discovered in the early 1900s, causes minimal ion fragmentation and has a
suitable signal-to-noise ratio for nucleic acid detection [201,202]. Unlike other
matrices, in which poor signals are obtained in the positive-ion mode, 3-HPA
shows comparable results for positive- or negative-ion modes [201]. The
absorption of laser energy by the matrix results in ionization of both matrix and
analyte molecules [200]. In this desorption step, rapid heating of the matrix
follows a phase change of the matrix-analyte mixture from a solid to a gas [200].

Figure 2.1. A schematic diagram of MALDI-TOF instrumentation with the basic
components is shown [203].
.
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Figure 2.2. Chemical structures of commonly used matrices in MALDI are
shown. The top half shows the matrices typically used in nucleic acid analysis
and the bottom half shows the matrices commonly used in protein analysis.
The next ion formation step is assumed to occur promptly after the desorption
step [200]. The gas-phase interactions between matrix and analyte molecules
are suggested to produce ions [200]. The dominant species in MALDI are singly
charged ions, but doubly and triply charged ions may also be present [200]. The
sensitivity of the peaks can be lower and the mass range is restricted to lower
(<10,000) m/z values [204,205]. Typically the mass accuracy of MALDI-TOF
instruments is on the order of 0.2 to 0.005% with an internal calibrant [205].
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For nucleic acids, the ion-detection mode in MALDI can be negative or

positive. The mechanisms of positive- or negative-ion formation in MALDI are not
yet well understood [200]; however, many pathways have been proposed for ion
formation in MALDI, which involve excited and radical matrix intermediates that
form charged analyte molecules [198]. For a negative-ion mode MALDI DNA
mass spectrum, the authors explained that the observed negatively charged ions
most likely resulted from the loss of hydrogens, presumably from the phosphate
backbone [200]. In contrast, the positive ions are generated through protonation
of the nucleobases [200].
In the case of nucleic acids, the high preference of phosphate charges for
alkali cations such as sodium and potassium can limit the quality of the mass
spectrum. The peaks are broadened as a result of unresolved multiple salt
adducts. The removal of salt peaks in MALDI spectra is primarily achieved by
using ammonium salts. High concentrations (~100 mM) of ammonium citrate or
tartrate are mixed with the analyte [201]. The ammonium salts transfer protons to
the phosphate groups giving off neutral ammonia, and thus preventing alkali
metal binding to the oligonucleotides. Substitution of metal cations with
ammonium salts by cation-exchange resins, or by addition of ammonium salts in
sample preparations, have helped to produce high quality MALDI results. The
low ionization efficiency, poor incorporation of analyte into matrix crystals, and
fragmentation are some other problems associated with nucleic acid MALDI
experiments [200]. Fragmentation of nucleic acids can also result due to base
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loss and subsequent backbone cleavage or removal of nucleotides from the 3′
and 5′ ends [200,201].
The predominant singly charged mass peaks have made MALDI MS an
effective tool in nucleic acid analysis. Many RNA molecules such as tRNA, RNA
transcripts, and ribosomal RNA have been detected by MALDI [206-208].
Similarly, MALDI has been utilized to characterize oligonucleotide sequences
after exonuclease digestions. In these studies, the oligonucleotide ladders
generated after treating the nucleic acids with bovine spleen phosphodiesterase,
a 5′ to 3′ exonuclease, and snake venom phosphodiesterase, a 3′ to 5′
exonuclease, were subjected to MALDI analysis. RNase T1 digestions combined
with MALDI MS have also been used to quantify RNA [209]. Similar approaches
are applied for identification of tRNAs from a total tRNA pool based on unique or
"signature" digestion product(s) [210]. Nucleotide modifications such as
pseudouridine have been mapped using MALDI MS combined with chemical
modification and RNase T1 digestion [211]. Nucleic acids modified by platinum
complexes have also been detected by MALDI MS [184,212].
2.2 Structure Probing of RNA
RNAs adopt highly structured biologically active scaffolds to carry out their
functions. Therefore, identifying key RNA structural features at the nucleotide
level is crucial for understanding their biological roles and to develop RNAtargeting therapeutics.
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2.2.1 Basic Approaches of RNA Structure Probing
Two basic tools, chemical and enzymatic, can be used to interrogate RNA
structures (Figure 2.3) [213,214]. Ideally, chemical and enzyme treatments
should lead to less than one cleavage or modification per RNA molecule, with a
statistical distribution such that the added chemicals don't cause structural
alterations [213]. In chemical probing, reagents react with compatible nucleotide
functional groups such as nitrogens on bases or 2'-OH groups, and either
introduce modifications or lead to strand scission at the modified residue. In
enzymatic probing, RNases that are specific for nucleobases (or non-specifically
digest RNA at all positions) are used to produce RNA fragments.
Both chemical and enzymatic modifications can be applied to small or large
RNA molecules. The detection methods used in such techniques are dependent
on the length of the RNA molecule and the nature of the probe used. The first
method detects modified or cleaved nucleotide stops during cDNA synthesis
[214]. Modifications on the Watson-Crick face that interfere with reverse
transcriptase produce stops in primer extension. The primers are radiolabeled,
allowing for the determination of electrophoretically separated cDNA fragments
by autoradiography. Identity of the modified nucleotides is determined by running
dideoxy sequencing reactions in parallel. Analysis of RNA modifications via
chemical probing and nucleotides by primer extensions can be applied to larger
RNA molecules such as ribosomal RNA. The number of nucleotides that can be
read depends on the gel resolution, which is typically about 150-200 nucleotides
[215]. Read-throughs of up to 650-1000 nucleotides per experiment are feasible
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Figure 2.3. A general overview of RNA probing methods is shown. A) An outline
of chemical probing and detection of large and small RNA molecules is
illustrated. Chemical treatments on large RNA molecules can either lead to
nucleotide modifications or RNA strand scission at locations that can be
determined by using primer extension. Chemical modifications of end-labeled
small RNA molecules are detected by gel electrophoresis after strand scission.
B) The enzymatic hydrolysis in large RNA molecules is detected by primer
extension. The enzyme target sites in small RNA are determined by the
separation of end-labeled oligonucleotides by gel electrophoresis.
with capillary electrophoresis and fluorescently labeled cDNAs [215].
The second approach in chemical probing uses end-labeled RNA, in which
strand scissions are directly identified on sequencing gels, and is limited to about
200 nucleotides [214]. Strand cleavage resulting from enzymatic digestion or
RNase hydrolysis can also be detected using end-labeled RNA. RNA labeling
can be done at either the 5' or 3' end. Labeling at the 5' end is carried out by
transferring a γ-32P phosphate group from [γ-32P]-ATP to the 5'-OH end of RNA
using T4 polynucleotide kinase [216]. Labeling of RNA at the 3' terminus is
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achieved by adding a [5'-32P]-pCp to the 3'-OH using T4 RNA ligase and ATP
[217].
Chemical and enzymatic probing provide valuable information about RNA.
These methods have been used extensively to map binding sites of RNA ligands
such as antibiotics or proteins [215]. The folding of RNA molecules into tertiary
structures has also been monitored by these techniques [215]. Advances in the
field such as time-resolved chemical probing have lead to a greater
understanding of RNA-folding processes [218,219]. Compounds that can
penetrate the cell wall have been useful in determining in vivo RNA structure
[220]. These probes are useful for providing RNA structural changes depending
on growth conditions. Overall, both chemical and enzymatic probing of RNA have
been invaluable to the research field.
2.2.2 Chemical Tools Used in RNA Probing
RNA creates complex folded tertiary structures, thus determining the solvent
accessible residues at equilibrium and under a variety of ionic conditions is
important. Chemicals can be applied to analyze these RNA structures. A
summary of the different chemical probes used for RNA structure analysis is
given in Table 2.1. Dimethyl sulfate (DMS) has been widely used in DNA and
RNA sequencing and RNA conformational analysis [221,222]. DMS primarily
reacts with G N7, A N1, and to lesser extent C N3. Further chemical treatment is
necessary for the detection of G N7 methylation using either end-labeled RNA or
by primer extension. The general reaction scheme for strand scission involves
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Table 2.1. Commonly used chemical probes for RNA structural analysis are
given [214,215,223].
Probe

Target

Detection
direct

RT

G N7

s

s

+

A N1

-

+

+

C N3

s

+

+

DEPC

A N7

s

+

?

kethoxal

G N1 N2

-

+

-

CMCT

G N7

-

+

-

U N3

-

+

-

Pb(II) acetate

cleaves phosphodiester bonds in
unpaired nucleotides and unstable
helices

+

+

+

ENU

phosphates

s

s

+

NMIA

2'-OH of flexible nucleotides, half life
8.5 min

-

+

+

1M7

2'-OH of flexible nucleotides, half life
14 s

-

+

+

BzCN

2'-OH of flexible nucleotides, half life
~1 s

-

+

?

Fe-EDTA
(•OH radicals)

cleaves at ribose C1' and C4'

+

+

?

in-line

cleaves phosphodiester bonds

+

+

?

NAIM

cleaves at phosphorothioate
substitutions

+

-

+

DMS

in vivo

DMS; dimethyl sulfate, DEPC; diethylpyrocarbonate, CMCT; 1-cyclohexyl-3-(2-morpholinoethyl) carbodiimide metho-p-toluene sulfonate, ENU; N-ethyl-N-nitrosourea, NMIA; Nmethylisatoic anhydride, 1M7; 1-methyl-7-nitroisatoic anhydride, BzCN; benzoyl cyanide.
NAIM; nucleotide analog interference mapping. Detection methods; (direct) modification
can be detected by using end-labeled RNA and (RT) modification is detected by primer
extension. (+) the specified detection method can be used. (S) chemical treatment is
required to split the polynucleotide chain. In vivo mapping; (+) probes diffuse through the
cell wall and membrane, (-) probes can only be used after permeabilization of the cell.
(?) probes might be adaptable for in vivo applications, BzCN half life is too short to be
used in vivo. Caution should be taken with DEPC as it can strongly modify proteins and
effect to their activity.
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sodium borohydride and aniline treatment following N7 methylation (Figure 2.4A).
The methylation adds a positive charge on the N7 position of a guanosine
nucleotide. Sodium borohydride treatment reduces the 7,8-double bond, and the
resulting dihydro-7-methyl guanosine is hydrolyzed to produce a hemiacetal. The
unstable hemiacetal then proceeds to ribose ring opening. Aniline treatment then
causes a β-elimination reaction to take place, thus cleaving the 3'-phosphodiester
bond. Dimethyl sulfate also methylates the N1 position of adenosine (Figure
2.4B). Primer extension can be used to monitor this modification directly, since
the reverse transcriptase is blocked in the major groove. DMS reacts with the N3
position of unpaired cytidines (Figure 2.4C). The N3-methyl cytidine can also be
detected directly by primer extension, while further treatment with hydrazine and
aniline is required when end-labeled RNA is used. Dimethyl sulfate is the primary
chemical probe used in this thesis work.
All of the chemical probes mentioned are limited to providing information
about solvent accessibility and/or flexibility of specific functional groups in RNA.
These chemicals fail to provide information about electrostatics of RNA, as they
are neutral in their active forms. Up to date, very few chemical probes have been
used to interrogate electrostatics of RNA [224]. The application of 2'aminoguanosine as an electrostatic probe revealed rigidity in the Tetrahymena
group I ribozyme active site [224]. One of the major goals in this thesis work was
to

use

platination

kinetics

as

a

microenvironments of RNA.

	
  

probe

to

investigate

electrostatic
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Figure 2.4. The use of dimethyl sulfate as a chemical probe is shown. A) The
general reaction scheme involves strand scission following DMS modification at
G N7. B) Methylation of adenosine N1 by DMS and C) methylation of cytidine N3
by DMS and subsequent hydrazine treatment are illustrated [214].
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2.2.3 In vivo Probing of RNA
RNA folding and ligand interactions are significantly affected by the
surrounding conditions, which could be considerably different in vivo compared to
in vitro conditions. In cellular environments, the speed of transcription and
translation, the presence of protein factors, small ligands, and other RNA
molecules, as well as cellular crowding, influence the RNA structure and function.
Therefore, determining RNA structures in vivo is important to identify
characteristics specific to their natural environment. It is also helpful to determine
structural adaptations in different cell types. Several different chemical probes
have been applied to in vivo studies. These include DMS, lead(II), and nucleotide
analog interference mapping (NAIM) reagents [220,225,226]. A variety of cell
types from bacteria, protozoa, yeast, and plants have been used for in vivo
chemical probing. The probes must penetrate the cell wall and membrane or be
introduced by microinjection techniques. Many chemical probes used to date
have limited uses in vivo. Therefore, high demand exists for developing or
introducing novel tools for in vivo RNA interrogation.
2.2.4 Enzymatic Probes for RNA
RNA structural information can be obtained by using different RNA-targeting
enzymes. RNases that cut strands at specific nucleobases (e.g., RNase T1,
RNase A) and non-specific enzymes like nuclease P1 have been employed to
acquire RNA structural information. Probing RNA with large enzymes reveals
less-structured regions of RNA. Some examples of commonly used RNases for
probing are discussed below.
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Ribonuclease T1 (RNase T1) is a small enzyme with a single polypeptide

chain of 104 amino-acid residues [227]. It contains two disulfide bonds that are
important for its structure [227]. The enzyme degrades single-stranded RNA at
guanosine residues to yield oligonucleotides with terminal 3'-phosphate groups
[228]. This nucleobase-specific RNA strand scission by RNase T1 has been a
valuable tool in RNA sequencing and mapping studies.
Generally, RNase T1 shows specificity towards guanosines in RNA. The rate
of GpC cleavage by RNase T1 is 150,000 times faster than an ApC fragment
[228]. However, RNase T1 is not completely specific for RNA-strand hydrolysis at
Gs. Kinetic studies carried out using dinucleotide monophosphates have shown
that RNase T1 catalyzes the hydrolysis of ApN dinucleotides [229]. A
crystallographic study using 2'-AMP has shown the adenine and ribose moieties
binding to a subsite in RNase T1 with the phosphate group located at the T1
catalytic site [230]. Therefore, RNase T1 probing is likely to generate non-specific
strand scissions as well. It is valuable in determining the binding of G-specific
ligands to RNA [176]. The G-specific ligand binding prior to enzyme treatment
can block the enzyme from cleaving the RNA. Therefore, the disappearance of
RNase T1 bands after cisplatin treatment was used to identify the drug binding
sites in the current dissertation work.
Ribonuclease A, or RNase A, is a small 124 amino-acid enzyme. RNase A is
specific for cleaving RNA strands on the 3' side of pyrimidine residues. Among
pyrimidines, RNase A has been reported to catalyze poly(C) cleavage faster than
poly(U) and can also degrade poly(A) [231]. Preference to bases other than
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pyrimidines has also been reported for RNase A due to the presence of subsites
as in the case of RNase T1 [232].
Table 2.2 lists available RNase structure probes. RNase VI is specific for
double-stranded regions and is the only probe that can provide evidence for
helical regions. RNase T2 has preference for unpaired adenosines.

Table 2.2. Enzymatic probes used for RNA structure analysis are listed [213].
Probe

Target

RNase VI

Paired or stacked N

Nuclease S1

Unpaired N

N. crassa nuclease

Unpaired N

RNase U2

Unpaired A>G>>C>U

RNase T2

Unpaired A>C,U,G

RNase T1

Unpaired G

RNase A

Unpaired pyrimidines (C>U)

2.3 Materials and Methods Used in Probing Studies of this Thesis Work
The following sections give detailed experimental protocols for generation of
buffers, metal complexes, and nucleic acid constructs used in this thesis work, as
well as experimental details of RNA 3'- and 5'-end radiolabeling. The large-scale
RNA platinations used in RNase T1 mapping with MALDI MS analysis, and
chemical probing will be discussed. Lastly, experimental details of dimethyl
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sulfate probing, alkaline hydrolysis, and RNase T1 digestion of radiolabeled RNA
will be given.
2.3.1 Buffers
Standard aqueous buffer solutions were prepared from KH2PO4 and K2HPO4
(Fisher Scientific, Fair Lawn, NJ) and Millipore water (ddH2O). The following
buffers were employed: buffer A (10 mM KH2PO4/K2HPO4, pH 6.2 [233], 20 mM
NaCl), buffer B (10 mM KH2PO4/K2HPO4, pH 6.2), 10× TBE (89 mM Tris-HCl, 89
mM boric acid, 2.5 mM EDTA, pH 8.3), and denaturing loading buffer (0.1%
bromophenol blue, 0.1% xylene cyanol, 1× TBE, 8 M urea).
2.3.2 Metal Complexes
Cisplatin, cis-[PtCl2(NH3)2], was obtained from Alfa Aesar (Ward Hill, MA).
Silver nitrate was purchased from Fisher Scientific (Fair Lawn, NJ). Dimethylformamide (DMF) was obtained from Acros Organics (Gibbstown, NJ). The
activated complex cis-[PtCl(NH3)2X]+/0, in which X is DMF or NO3-, was prepared
by mixing 1:1 eq. of cisplatin and AgNO3 dissolved in DMF and agitating in the
dark overnight at 37 °C. The resulting AgCl precipitate was removed by repeated
centrifugation. For all studies, the activated (monoaquated) complex 1 was
freshly prepared by dilution of cis-[PtCl(NH3)2X]+/0 to intermediate stock
concentrations with Millipore water just prior to the experiments (Figure 2.5).

Figure 2.5. The activation of cisplatin is shown. Cisplatin or cis-diamminedichloridoplatinum(II) forms cis-diammine(aqua)chloridoplatinum(II), complex 1, in water
by displacement of a chlorido ligand.
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2.3.3 Nucleic Acids
The following RNA constructs were used in this thesis work. Unmodified H69;
5'GGCCGUAACUAUAACGGUC3', modified H69; 5'GGCCGΨAACΨAΨAACGG
UC3', 790 loop; 5'GCAGGAUUAGAUACCCUGC3'. All RNA constructs were
obtained from Thermo Scientific Dharmacon (Lafayette, CO). Concentrations of
RNA solutions were calculated using the absorbance at 260 nm and singlestranded extinction coefficients obtained by the nearest-neighbor approach (H69
modified or unmodified, ε260nm = 189,400 M-1cm-1; 790 loop, ε260nm = 188,800 M1

cm-1) [75,84].

2.3.4 3'-End Labeling of RNA Constructs
RNA constructs were radiolabeled at the 3' end with T4 RNA ligase (New
England Biolabs, Ipswich, MA) and [5'-32P]-pCp (Perkin-Elmer Life Sciences, Inc.
Boston, MA). The labeling was performed in T4 RNA ligase buffer (50 mM TrisHCl, pH 7.5, 10 mM MgCl2, 1 mM dithiothreitol) with 50 pmol RNA, 10 µCi of [5'32

P]-pCp, 12 units of T4 RNA ligase, and 1 mM ATP in a 30 µL reaction at 4 °C

overnight. Labeled RNAs were ethanol precipitated and purified on 20%
denaturing (8 M urea) polyacrylamide gels. The labeled products were visualized
by autoradiography, then excised and eluted by the "crush and soak" method in
350 mM NaOAc, pH 5.3, 0.1 mM EDTA buffer overnight at 4 °C. The extracted
RNAs were desalted over C18 Sep-Pak cartridges (Waters, Milford, MA).
2.3.5 5'-End Labeling of RNA Constructs
RNA constructs were 5'-end labeled in T4 polynucleotide kinase buffer (70
mM Tris-HCl, pH 7.6, 10 mM MgCl2, 5 mM dithiothreitol, New England Biolabs)
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with 10 µCi of [γ-32P]-ATP (Perkin-Elmer Life Sciences, Inc.) and 3 units of T4
polynucleotide kinase (New England Biolabs, Ipswich, MA) in a total volume of
30 µL. After incubation at 37 °C for 30 min, the RNAs were ethanol precipitated
and purified as described for 3'-end labeling.
2.3.6 Large-Scale Platination and RNase T1 Mapping
The platination reactions of all RNA constructs for RNase T1 mapping studies
were performed in buffer A. Prior to platination, the RNAs were renatured by
boiling for 2 min followed by placement on ice. Platination was carried out in the
dark at 37 °C for 5 h with a 1:2 ratio of RNA:complex 1 and 3 nmol RNA. The
RNA products were separated on 20% denaturing polyacrylamide gels. The RNA
bands were visualized by UV shadowing and excised from the gel. Bands with
slower mobility than the unmodified RNAs were assigned as the platinated
products. The platinated RNA products were eluted in 550 mM NH4OAc, pH 5.5,
0.1 mM EDTA buffer and desalted with C18 Sep-Pak cartridges. RNase T1
digestion of platinated and unplatinated RNAs was performed in water for 20 min
at 37 °C using 1 unit of enzyme (Sigma, St. Louis, MO). Digested samples were
dried and resuspended in deionized water, mixed with saturated 3-hydroxy
picolinic acid (Sigma, St. Louis, MO) in 50% acetonitrile, and spotted on a MALDI
plate. MALDI MS analysis was performed on a Bruker Daltonics TOF-300 MALDI
Ultraflex instrument equipped with a nitrogen laser (λ 337 nm). The mass spectra
of all RNAs were acquired in the positive-ion reflector mode. Peak masses were
assigned using Flex Analysis version 2.0 software [210].
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2.3.7 Large-Scale Platination Reactions for Chemical Probing
Gel purified, radiolabeled RNAs (8 × 105 – 10 × 105 cpm) and unlabeled
RNAs (0.7 µM) were combined and renatured in buffer B containing 20 mM
NaClO4. Platination reactions were initiated by adding complex 1 (final
concentration 94 µM) to RNA in a final reaction volume of 60 µL. The reactions
were incubated in the dark at 37 °C for 3 h. Control RNA samples did not contain
platinum complex. Platinated RNA products and unreactive RNAs were
separated on 20% polyacrylamide gels, followed by elution with the "crush and
soak" method.
2.3.8 Chemical Probing of Platinated RNAs
Guanosine-specific reactions [222] on the platinated RNAs were performed in
dimethyl sulfate (DMS) buffer (50 mM sodium cacodylate, pH 5, 1 mM EDTA) in
the presence of 5 µg of carrier tRNA. The reactions were initiated by addition of 1
µL of 50% (v/v) DMS (Sigma, St. Louis, MO) in water and incubating for 60 s at
90 °C, followed by immediate quenching with stop solution (1.5 mM sodium
acetate, pH 7, 1 M β-mercaptoethanol). The RNAs were ethanol precipitated,
redissolved in 10 µL of 1 M Tris-HCl, pH 8.2, and then treated with 10 µL of
freshly prepared 0.2 M NaBH4 (Sigma, St. Louis, MO) and incubated on ice for
30 min in the dark. The RNAs were ethanol precipitated again and treated with
10 µL of 1 M aniline acetate, pH 4.5, at 60 °C for 30 min in the dark. The samples
were dried, lyophilized twice in water, and resuspended in denaturing loading
buffer. Samples (approximately 2 × 104 cpm) were run on high-resolution
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sequencing gels (20% denaturing polyacrylamide gels, 0.4 mm thickness, 1×
TBE, 8 M urea) and visualized by autoradiography.
2.3.9 Alkaline Hydrolysis of the Labeled RNA
RNA constructs labeled at the 3' or 5' ends (1 × 104 cpm) were mixed with
alkaline hydrolysis buffer (30 mM NaOH, 0.3 mM EDTA) and boiled for 90 sec
followed by quick freezing on dry ice. The samples were thawed and mixed with
denaturing loading buffer just prior to electrophoresis.
2.3.10 RNase T1 Mapping of Labeled RNA
End-labeled RNA (1 × 104 cpm) was mixed in RNase T1 buffer (20 mM
sodium citrate, pH 5.0, 7 mM urea, 1 mM EDTA). Hydrolysis was initiated by
adding 0.5 units of RNase T1 followed by incubation at 55 °C for 20 min. The
reaction products were mixed with denaturing loading buffer and loaded directly
onto 20% denaturing gels.
2.4 Determination of Cisplatin Coordination Rates to Nucleic Acids
There are many methods that have been used to determine the kinetics of
platinum binding to nucleic acids. These include HPLC, NMR, LC, and UV
spectroscopy [162]. HPLC is a widely used technique to determine the kinetics of
platination of nucleosides, nucleotides, nucleobases, and oligomers [164,234].
HPLC can be used to separate adduct isomers, and also allows for the
determination of platination rates of individual species [168]. However, the
analysis of all quenched samples by HPLC can be time consuming. Separation
of the reactants from products may not always be possible for certain sized
oligomers.
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NMR has also been widely used to study platination kinetics. NMR is a non-

invasive method that allows monitoring of several species at the same time,
therefore providing details on reaction pathways. Proton,

31

P,

195

Pt, and two-

dimensional [1H,15N]-HSQC NMR have been used in platinum kinetic studies with
small oligonucleotides [158,163,172,235]. Pre-requisites for the application of
NMR methods include well-resolved peaks for reactants, products, and
intermediates, and slow reaction rates compared to the acquisition time.
UV absorbance has also been used to measure the kinetics of platination
reactions with 5'-GMP, DNA fragments, and RNA [235-237]. Absorbance
measurements have been shown to be valuable for monitoring RNA reactivity
differences due to subtle structural changes [237]. However, the number of base
pairs in the vicinity of the platination site as well as the overall stability of the
oligonucleotide is likely critical for a clear absorbance change to occur during the
reaction. Thus, the technique may not be applied to a variety of RNA secondary
structures that possess single-stranded regions. The other methods used to
determine platination kinetics include circular dichroism spectroscopy and
fluorescence spectroscopy with ethidium bromide [238,239].
Determination of platination rate constants in kinetic experiments can also be
accomplished by using an electrophoretic mobility shift assay (EMSA), or gelshift assay. It is a simple, convenient, and efficient method used to separate and
quantify starting materials from products. The separation depends on the size,
shape, and charge of the biopolymers [240]. In this work, the platinated RNA
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migrates more slowly compared to the unreacted starting material on a
denaturing polyacrylamide gel.
A general overview of the experimental procedure carried out to determine
the rate constants in this work using EMSA is given in Figure 2.6. Experimental
details are given at the end of Section 2.4.

Figure 2.6. Determination of platination rate constants by gel-shift assays is
illustrated. A) A schematic of the experimental procedure used to monitor the
platination of RNA is shown. After renaturing a mixture of radiolabeled and
unlabeled RNA in buffer, complex 1 is added to initiate the reaction. Aliquots of
the reaction are then quenched in a mixture of loading dye and NaCl at different
time intervals. B) A representative denaturing polyacrylamide gel shows the
separated reactants and products, and disappearance of unreacted RNA band
intensity with simultaneous appearance of products with time. C) A
representative kinetic graph shows the decrease of unreacted RNA fraction with
time well described by mathematical models.
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2.5 Experimental Procedures for the Determination of Platination Rates
All kinetic experiments were carried out using 3'-labeled RNA (50,000-60,000
cpm) mixed with 40 pmol of cold RNA in buffer B (10 mM K2HPO4/KH2PO4 pH
6.2) and varying NaClO4 concentrations in a 60 µL reaction. The unlabeled RNA
was used to maintain the RNA concentration and desired Pt ratio, whereas the
radiolabeled RNA acted as a probe to visualize the consumption of starting
material. The RNA in buffer was boiled for 2 min, quickly placed on ice, and
incubated for 5 min. The reaction was spun down and allowed to reach to room
temperature. Reactions were initiated by adding freshly prepared complex 1 to
the tube wall. The final concentration of complex 1 was 94 µM, unless stated
otherwise. The reaction was mixed, spun down, and then incubated at 37 °C in
dark [176]. A control reaction was carried out similar to the platination reaction,
but using ddH2O instead of complex 1. Three µL aliquots from the reaction
mixture were taken out and added to a mixture of 200 mM NaCl and denaturing
loading dye, then quickly frozen on dry ice. The aliquots were thawed just prior to
loading onto a 20% denaturing polyacrylamide gel to minimize experimental
errors arise from longer thawed samples.
The platinated products were separated from the unreacted RNA by running a
polyacrylamide gel at 1300 V for about 3 h. The gels were developed for 24-48 h
and visualized by autoradiography, and quantified using ImageQuant software
(GE Healthcare Life Sciences) [124,177]. The bands of unreacted RNA and
products were quantified in each lane. The unreacted RNA fraction at any given
time, t, was calculated by using the following equation;
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Fraction of unreacted RNA =

[unreacted RNA countst – bkg counts]
  
unreacted RNA countst – bkg counts +[product countst – bkg counts]

Therefore, at t = 0 the unreacted RNA fraction was equal to 1. The gel counts
were determined by adding a rectangle around each band. The size of the
rectangle used to determine the counts was the same for either unreacted RNA
or products throughout the lanes. When smeared products were seen at longer
incubation times, larger rectangles were used to obtain the product counts, and
again, the size was consistent for each lane. A region where no bands were
found from the experiment was selected as the background (bkg counts) and
was subtracted from the reactant and product counts. The size of rectangles
used to obtain the background counts was identical to the corresponding
unreacted RNA or product bands. The fraction of unreacted RNA was then
graphed versus time using KaleidaGraph 4.1 software (Synergy Software). The
observed pseudo-first-order rate constant (kobs) was then determined by a singleexponential decay fit.
The equation used to fit the data is: fraction of unreacted RNA=A*(expkobs*t)+C, in which A, kobs, t, and C represent the amplitude of the reaction, the
pseudo-first-order rate constant in min-1, time in minutes, and the extent of the
reaction, respectively. When fraction of unreacted RNA versus time was fitted to
the above equation, the software provided the values for A, kobs and C. The
apparent second-order rate constant k2,app was then determined by dividing the
observed pseudo-first-order rate constant by the complex 1 concentration (k2,app
= kobs/[1]). This is the basic platination rate constant determination procedure
carried out in this thesis work (Chapter 4), and modified accordingly for Mg2+ or
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pH dependence, and neomycin-RNA interaction kinetic studies. The platination
reactions were carried out as mentioned in the previous section in buffer B either
in the absence or presence of 20 mM NaClO4 together with corresponding
Mg(ClO4)2 concentrations of 1, 3, 6, and 12 mM (Chapter 5). Kinetic experiments
between complex 1 and H69 RNA were carried out in buffer B made at either pH
5.8 or 6.8 and mixed with varying amounts of NaClO4 (Chapter 6) [233]. The pH
was adjusted by adding either dilute HClO4 or NaOH. Reactions were initiated by
adding freshly prepared ddH2O-diluted cisplatin complex 1 to a final
concentration of 6.6 µM. Following pseudo-first-order reactions at higher ratios
was limited by the fast kinetics at pH 5.8.
Prior to performing kinetic experiments, RNA and neomycin were incubated
as follows. After renaturing RNA in buffer B with 20 mM NaClO4, freshly prepared
neomycin was added to final concentrations of 1, 3, and 6 µM and incubated for
30 min at 37 °C. Platination was initiated by adding fresh complex 1 to a final
concentration of 188 µM. As the cationic neomycin may compete with positively
charged complex 1, the pseudo-first-order reaction was carried out at a higher
complex 1 concentration compared to the rest of the kinetic studies.
2.6

Determination of RNA Electrostatics Using Platination Kinetics
Analyzed by Brønsted-Debye-Hückel and Polyelectrolyte Theories
Nucleic acids are highly charged biopolymers. They show polyelectrolyte

behavior in solutions. Specifically, the approach and binding of charged
molecules like aminoglycosides, cations, and cationic platinum drugs can be
affected by RNA electrostatics. Currently, computational approaches are
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primarily applied to investigate RNA electrostatics [18,241]. Application of
platination kinetics as an experimental tool to monitor RNA electrostatics was
one of the objectives of this thesis work. Among different models available for
evaluating

nucleic

acid

electrostatics,

Brønsted-Debye-Hückel

and

polyelectrolyte theories have been applied extensively to analyze platination
reactions [176].
In ionic solutions, electrostatic interactions between oppositely charged ions
lower the number of "free" or available ions to react. Therefore, solution ionic
strength is important for reactions between charged species. When a reaction
takes place mediated by an electrostatic attraction between two ions in dilute
solutions, the Debye-Hückel theory together with the transition-state theory
predict a qualitative influence of ionic strength on the reaction rate [242-244]. The
Debye-Hückel limiting law (for conditions at infinite dilution) is applicable to
solutions with ionic strengths 0.01 M or less. For solutions with ionic strengths
greater than 0.01 M, modified Debye-Hückel equations have been derived [243].
The Brønsted-Debye-Hückel theory that is applicable to solutions with up to 0.1
M ionic strength was used in this thesis work. The electrolyte solutions with 0.5 M
and greater ionic strengths behave strikingly different from dilute solutions and
deviate from the Debye-Hückel law [243].
Nucleic acids are polyelectrolytes and interact strongly with positively charged
cations. Some ions interact at specific sites in a polyelectrolyte, while some of
them show Debye-Hückel-type interactions forming a diffuse ion atmosphere.
Unique to highly charged biopolymers such as nucleic acids, a third group of ions
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show a territorial binding and form a layer of condensed counterions (Figure 2.7)
[17].
In the 1970s, Manning developed a method to quantitatively interpret
interactions of polyanions and counterions with the counterion condensation
theory [188,245]. The basic assumption in counterion condensation theory is that
when a biopolymer carries a linear charge density greater than unity, counterions
will "condense" on the polyanion to lower the linear charge density to unity.
Hence, the counterion condensation does not depend on the solution ionic
strength. The residual polyion charge is screened by an additional layer of
diffusely bound counterions. Further theoretical developments to counterion
condensation theory have been reported by Record [246]. For short oligomers,
the end effects dominate the counterion condensation [247]. The end effect
describes that the average concentration of condensed counterions is a linear
function of 1/N for N>24, in which N is the number of nucleotides. Until N>>100,
the end effect does not become negligible [246].

Figure 2.7. Different types of nucleic acid-cationic interactions are shown. The
formation of counterion condensation layer by territorially bound cations is
indicated.
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When a reaction changes the linear charge density of a nucleic acid, a

fraction of condensed counterions should either be released or bound. This
uptake or release of cations is the predominant source of the salt dependence in
nucleic acid reactions. The polyelectrolyte theory provides a relationship to
quantify these salt-dependent reaction rates. In the case of platination reactions,
association of the Pt+ center displaces a fraction of counter-cations from the RNA
surface (Figure 2.8). Therefore, the basic application of polyelectrolyte theory is
the quantification of this fraction of counterions, which also depends on the linear
charge density of RNA in a particular medium, displaced by platinum
coordination.

Figure 2.8. The reaction mechanism of platinum complexes binding to nucleic
acids in accordance to the polyelectrolyte theory is shown. The association of Pt+
compounds on the nucleic acid surface displaces a fraction of surface condensed
cations (Kass). Then, the platinum compound coordinates to the nucleic acid (k2).
The ionic strength I was calculated using Equation 1, in which ci is the
concentration of each ion in molL-1 and Zi is the charge of the ion,
I = 1/2Σci Z2i

	
  

(1)
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The K+ concentration coming from 10 mM K2HPO4/KH2PO4 buffer was calculated
according to the pH. The Brønsted-Debye-Hückel theory used in this thesis work
is shown in Equation 2.
log k2 = log k0 + 2AZA ZB

I1/2
1/2

(1+I

)

(2)

The k2 is the reaction rate constant, k0 is the limiting rate constant, and A is a
constant that depends on the temperature [248]. The Brønsted-Debye-Hückel
equation predicts that the rate of a reaction between like-charged ions will
increase linearly with I1/2/(1+I1/2), while a reaction between unlike-charged ions
will decrease (Figure 2.9). For oppositely charged ions, the increasing ionic
strength poorly stabilizes the less-charged state and increases the activation
energy, therefore reducing the reaction rate [17]. This is the case for complex 1
and RNA platination reactions studied in this thesis work.
The slopes of linear fittings correspond to 2AZAZB, in which the product of the
charge of the reactants (ZAZB) can be determined. In platination reactions, the
activated platinum complex, 1, which carries a +1 charge, interacts with nucleic
acids. Hence, the ZAZB, should simply represent the charge density/effective
charge of the interacting RNA. This provides a method to evaluate the charge
density of RNA by using platination kinetics.
The intercept of the Brønsted-Debye-Hückel plot provides the platination rate
at limiting conditions or infinite dilutions (k0). Under such situations, the
platination reaction can be assumed to take place in the absence of electrostatic
influences from solution ions. Therefore, comparisons of k0 values determined by
platination kinetics under different solution conditions can provide an idea of the
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Figure 2.9. The Brønsted-Debye-Hückel plots for reactions between ions with
different charges are indicated.
electrostatic impact from salts on RNA-ligand interactions.
Equation 3 shows the relationship used to analyze platination kinetics
according to polyelectrolyte theory.
log k2 = log k'0 - nΨ'log[M+/2+ ]

(3)

The k2 is the rate constant and [M+/2+] is the total cation concentration in the
reaction medium. When calculating M+/2+ concentrations, all monovalent and
divalent cations were included. The slope (nΨ') of the polyelectrolyte fitting
(Figure 2.10) gives the fraction of cations that platinum compound 1 displaces
when associating on the RNA surface.
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Figure 2.10. The dependence of reaction rate on the cation concentration [M+/2+]
according to polyelectrolyte theory is shown.
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CHAPTER 3
IDENTIFICATION OF CISPLATIN TARGETS ON RIBOSOMAL
RNA HAIRPINS
3.1 Abstract
Cisplatin is a clinically important chemotherapeutic agent known to target
purine bases in nucleic acids. Cisplatin forms stable adducts with many types of
RNA including siRNA, spliceosomal RNAs, tRNA, and rRNA. All of these RNAs
play vital roles in the cell such as catalysis of protein synthesis by rRNA, and
therefore serve as potential drug targets. Identifying target preferences and
implications of drug binding are crucial to recognize novel drug targets as well as
design molecules with better efficacies. This chapter focuses on platination of
three rRNA constructs, pseudouridine-modified and unmodified helix 69, and the
790 loop of helix 24 from E. coli ribosomes. RNase T1 probing, MALDI MS, and
DMS mapping confirmed platination at GpG sites. Chemical probing studies also
revealed structural changes followed by cisplatin coordination. These findings
suggest that functionally significant regions of the ribosome are viable targets for
cisplatin, as well as similar compound classes, due to solvent accessibility and a
high level of sequence conservation. Collectively, the work reported in this
chapter shows that cisplatin binding to functionally significant rRNA regions
induces structural changes that could potentially be lethal to bacterial cells.
3.2 Introduction
Since

its

discovery

as

an

anticancer

agent

in

the

1960s,

cis-

diamminedichloridoplatinum(II), or cisplatin, has been used to treat a variety of
human carcinomas [141,148]. The cytotoxic activity of this platinum-based
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compound is believed to be associated with DNA lesions that influence key
cellular functions [148]. Cisplatin is a neutral molecule that becomes positively
charged upon displacement of a chlorido ligand with water to form the active
monoaquated complex (1) (Figure 2.5) [158,249]. The positive charge on 1
directs it to negatively charged nucleic acids. The active species coordinates to
the N7 of purine bases and forms stable adducts [250-252]. Although DNA is
considered to be the major target of cisplatin, RNA and proteins are also
susceptible to platinum-adduct formation [253-257]. Studies directed towards
understanding RNA-cisplatin interactions have revealed that different cellular
RNAs are targets of cisplatin and cisplatin analogues [176,177,181-184,258].
In this chapter, reactions of complex 1 with three rRNA constructs
representing H69 and the 790 loop of E. coli ribosomes were examined. The
influence from pseudouridine (Ψ) modifications and sequence alterations on
platination of rRNA was investigated by using these rRNA constructs. The
platination of unmodified H69, which contains uridines at positions 1911, 1915,
and 1917 (E. coli numbering), was compared to that of modified H69 possessing
Ψs at the same positions [75,259]. The impact of nucleotide sequences on
cisplatin coordination was evaluated using the 790 loop, which contained an
identical type and number of nucleotides (A5G5U4C5) to the unmodified H69.
Complex 1 formed two adducts with H69 RNAs and one adduct with the 790
loop. Mass spectrometry, RNase T1 digestion, and chemical-probing analysis
revealed consecutive Gs as platination sites in all rRNA hairpins. The DMSprobing

experiments

revealed

structural

	
  

changes

induced

by

cisplatin
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coordination to H69 rRNA hairpins. Work reported in this chapter showed that
H69 and the 790 loop are potential cisplatin targets in E. coli ribosomes and
possibly interfere with ribosome function and contribute to drug cytotoxicity.
3.3 Results and Discussion
3.3.1 MALDI Mass Spectrometry and RNase T1 Mapping Studies
The ribosome comprises the key protein synthesis machinery of the cell. A
number of studies revealed RNA as a target for platinum-based drugs, as well as
other drug classes [36,176,177,181-184,258]. In this chapter, the interaction of
cisplatin with three model rRNAs hairpins from E. coli, namely, unmodified H69,
modified H69, and the 790 loop, was investigated. Comparisons were made with
unmodified H69 to determine whether Ψs (modified H69) or altered nucleotide
sequences (790 loop) would influence platination. The data indicate minimal
influence of Ψs and sequence for platination target selectivity. However,
structural and/or stability effects on residues distant to the target sites were
observed, and a possible sequence influence to this effect was identified.
Platination was carried out between complex 1 and rRNA hairpins as
described in Section 2.3.6, and the products were isolated and characterized by
MALDI MS to first determine the number of adducts. The platination sites were
then determined through RNase T1 digestion. Mass increases for the fragments
obtained from enzyme digestion of platinated RNAs revealed the locations of the
adduct sites. Mass data were collected in the positive-ion mode, and analysis of
the H69 and 790 RNAs produced [M+H]+ and [M+2H]2+ peaks. The experimental
and expected masses of full-length RNA molecules and RNase T1 fragments are
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listed in Table 3.1 and Figures 3.1-3.3. Following the reaction with complex 1,
two molecular ion peaks ([M+Pt-H]+ or [M+2Pt-3H]+) were observed for both
unmodified and modified H69. Platination of the 790 loop produced a single
molecular ion peak ([M+Pt-H]+). The experimental masses obtained correspond
well to the predicted masses. An increase in mass by 229 or 458 Da corresponds
to coordination of one or two Pt(NH3)2 moieties to the RNA, respectively, with
loss of the aqua and chlorido ligands, indicating one or two platination sites for
each RNA [186,260]. This observation is supported by the addition of a Pt(NH3)2
group to DNA platinations detected by MALDI MS [212,261].
RNase T1 digestion occurs via a 2',3'–cyclic phosphate intermediate [228].
Therefore, under partial digestion conditions, RNase T1 treatment led to RNA
fragments containing either a 2', 3', or 2',3'–cyclic phosphate (indicated as >p in
Table 3.1). The digestion of H69 RNA produced mass peaks corresponding to
fragments CCG>p, (U/Ψ)AAC(U/Ψ)A(U/Ψ)AACG>p, and CCGΨAACΨAΨAACG>p (in modified H69 only). RNase T1 digestion of the 790 loop generated mass
peaks assigned as fragments CAG>p, AUUAG>p, and AUACCCUG>p. In
contrast, the mass spectrum obtained after treatment of platinated H69 RNAs
revealed

two

new

peaks

corresponding

(U/Ψ)AAC(U/Ψ)A(U/Ψ)AACGGUC+Pt(NH3)2.
platinated

790

loop

produced

a

to

GGCCG>p+Pt(NH3)2

RNase
new

T1

peak

digestion

and

of

the

corresponding

to

CAGGAUUAG>p+Pt(NH3)2.The production of RNase T1 fragments CCG>p,
(U/Ψ)AAC(U/Ψ)A(U/Ψ)AACG>p, and CCGΨAACΨAΨAACG>p (modified H69
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Table 3.1. Predicted and experimental masses of unmodified H69, modified H69,
and 790 loop RNAs parent strands, platinated products, and RNase T1 digestion
fragments are given.
Predicted Experimental
Construct
[RNA]+
massa
mass
m/z
m/z
Parent strand + H+
6061.7
6061.3
Parent strand + [Pt(NH3)2]2+ - H+
6288.7
6287.9
Parent strand + 2[Pt(NH3)2]2+ - 3H+
6515.7
6514.9
unmodified
+
5'CCG>p3' + H
956.6
957.2/956.9b
H69
5'UAACUAUAACG>p3' + H+
3521.1
3521.8
2+
+
5'GGCCG>p3' + [Pt(NH3)2] - H
1873.9
1874.7
5'UAACUAUAACGGUC3' + [Pt(NH3)2]2+ -H+
4642.7
4642.5
+
Parent strand + H
6061.7
6061.1
Parent strand + [Pt(NH3)2]2+ - H+
6288.7
6288.1
2+
+
Parent strand + 2[Pt(NH3)2] - 3H
6515.7
6515.0
5'CCG>p3' + H+
956.6
957.0/957.0b
modified
3521.1
3521.9
5'ΨAACΨAΨAACG>p3' + H+
H69
4476.7
4476.8
5'CCGΨAACΨAΨAACG>p3' + H+
2+
+
5'GGCCG>p3' + [Pt(NH3)2] - H
1874.0
1874.6
4642.7
4642.7
5'ΨAACΨAΨAACGGUC3' + [Pt(NH3)2]2+ - H+
+
Parent strand + H
6061.7
6061.5
2+
+
Parent strand + [Pt(NH3)2] - H
6288.7
6287.4
5'CAG>p3' + H+
980.6
981.0
790 loop
5'AUUAG>p3' + H+
1616.9
1617.4/1617.7b
5'AUACCCUG>p3' + H+
2532.5
2532.9/2533.4b
2+
+
5'CAGGAUUAG>p3' + [Pt(NH3)2] - H
3168.7
3169.9
a

The expected mass values for the parent RNA constructs and the digestion
fragments
were
obtained
from
Mongo
Oligo
Calculator
v2.06
(http://mods.rna.albany.edu/masspec/Mongo-Oligo) [210].
b

m/z values correspond to fragments derived from unplatinated/platinated RNA.
The production of cyclic phosphates at the 3' ends (or 2' or 3' phosphates) from
RNase T1 digestion is denoted as >p.
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Figure 3.1. Mass analysis of platinated unmodified H69 is shown. Mass spectra
of A) unmodified H69 parent RNA (unplatinated H69), B) RNase T1 digestion of
unplatinated H69, C) platinated unmodified H69, and D) RNase T1 digestion of
platinated unmodified H69 are given. Arrows indicate RNase T1 cleavage sites.

	
  
Figure 3.2. Mass analysis of platinated modified H69 is shown. Mass spectra of
A) modified H69 parent RNA (unplatinated RNA), B) RNase T1 digestion of
unplatinated H69, C) platinated modified H69, and D) RNase T1 digestion of
platinated modified H69 are given. Arrows indicate RNase T1 cleavage sites.
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Figure 3.3. Mass analysis of platinated 790 loop is shown. Mass spectra of A)
790 loop parent strand (unplatinated 790 loop), B) RNase T1 digestion of
unplatinated 790 loop, C) platinated 790 loop, and D) RNase T1 digestion of
platinated 790 loop are shown. Arrows indicate RNase T1 cleavage sites. 	
  
only) of H69 RNAs indicated G1907, G1910 and G1921 as the enzyme cleavage
sites (Figure 3.4). In contrast, the absence of fragments resulting from cleavage
between G1906-07 or G1921-22, as well as production of GGCCG>p and
(U/Ψ)AAC(U/Ψ)A(U/Ψ)AACGGUC fragments with a 229 Da mass increase,
indicated G1906-07 and G1921-22 as the platinum target sites on H69 RNAs.
The production of GGCCG>p with Pt(NH3)2 indicated that G1910 was still
available for RNase T1 cleavage and not a likely platination site. Combined,
these results demonstrate that the presence of Ψ does not alter the site
preference of 1 for H69 RNAs, and GpG sites are preferentially platinated in
these rRNA hairpins.
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Figure 3.4. Platination sites identified by mass analysis of RNase T1 digestions
are shown. The observed RNase T1 cleavage sites on A) unmodified H69, B)
modified H69, and C) the 790 loop are indicated by arrows. The RNase T1
digestion products of platinated D) unmodified H69, E) modified H69 and F) 790
loop are shown along with the platinum coordination sites.
The production of CAG>p, AUUAG>p and AUACCCUG>p fragments by
RNase T1 digestion on the 790 loop indicated G782, G785, G786, G791, and
G799 as the enzyme cleavage sites (Figure 3.4). Following platination and
digestion of the 790 loop, the AUACCCUG>p fragment was observed, indicating
cleavage at G791 and G799. In contrast, the intensity of the AUUAG>p fragment
peak diminished, suggesting blockage of RNase T1 cleavage at G786.
Production of the CAGGAUUAG>p fragment with an increased mass of 229 Da,
and blocked RNase T1 cleavage with concomitant loss of the CAG>p fragment
suggested platination at G785-86. The reaction at G782 was not blocked, thus
platination at this site is not likely. All of the RNase T1 fragments resulting from
platinated RNA digestion contain consecutive G residues (G1906-G1907 and
G1921-G1922 on H69, and G785-G786 on the 790 loop (Figure 3.4)), revealing
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that GpG sites are preferred for complex 1 coordination to the studied rRNA
constructs.
3.3.2 Dimethyl Sulfate Probing of Platination Sites
Guanine-specific chemical reactions were carried to provide further evidence
of platination of the H69 and 790 loop RNAs at nucleotide resolution. The RNAs
were treated with DMS, as indicated in Section 2.3.8, to methylate the accessible
G N7 positions, followed by sodium borohydride and aniline treatments to initiate
strand scission and allow identification of the modified sites [222]. In cisplatin
reactions with DNA, platination occurs at G N7 [250]. Therefore, similar adduct
formation on H69 or the 790 loop was expected to prevent DMS methylation and
cause a disappearance of cleavage bands in sequencing gels [174,176].
DMS probing was carried out on unplatinated and platinated versions of H69
and the 790 loop. Autoradiograms of 20% denaturing polyacrylamide gels
containing DMS-treated, 3'-end-labeled RNA constructs are shown in Figure 3.5.
Bands corresponding to G1921 and G1922 of H69 and G785 and G786 of the
790 loop were diminished in the DMS-treated platinated RNA samples. Due to
poor band resolution at the 5' end of the 3'-labeled RNA, DMS probing was also
carried out using 5'-labeled RNA, which revealed platination at G1906 and
G1907 (Figure 3.6). DMS treatment led to methylation and cleavage at G1910 for
both platinated and unplatinated H69 (Figures 3.5A and 3.5B, lanes 3 and 4),
indicating that G1910 is not a platination site, although its cleavage product shifts
due to presence of the platinum adduct at the 5' end. Similarly, DMS treatment of
the 790 loop produced a cleavage band at G791 (Figure 3.5C, lanes
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Figure 3.5. DMS probing of H69 and the 790 loop is shown. Autoradiograms
show the results for 3'-end-labeled A) unmodified H69, B) modified H69, and C)
790 loop (T1: RNase T1 reaction on unplatinated RNA; AH: alkaline hydrolysis
ladder on unplatinated RNA). Note that T1 and AH fragments migrate slower
than the DMS products due to different chemical composition of the ends (5' OH
vs. 5' phosphate, respectively). In panels a and b, the fragments corresponding
to DMS reaction and cleavage at G1910 migrate more slowly in lane 3 compared
to lane 4 because of the presence of the platinum adduct. Guanine residues that
show slower mobility (dots) or decreased DMS reactivity (boxes) due to
platination are indicated in red.
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Figure 3.6. Dimethyl sulfate (DMS) probing of H69 using 5'-labeled RNA is
shown. Autoradiograms show the DMS-probing results on 5'-end-labeled A)
unmodified H69 and B) modified H69 (T1: RNase T1 reaction on unplatinated
RNA; AH: alkaline hydrolysis ladder on unplatinated RNA). Guanine residues that
show differences due to platination are indicated with red boxes. Residue
A1918/19 (circled) is sensitive to DMS reactivity following platination.
3 and 4), indicating the absence of a platinum adduct at this site. In this case, the
DMS-cleavage products of both platinum-treated and non-treated samples were
observed to co-migrate, since these RNA fragments did not contain any platinum
adducts. Together, these results support a model in which complex 1 reacts
preferentially at consecutive Gs in RNA (G1906-G1907 and G1921-G1922 for
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H69 and G785-G786 for the 790 loop) and forms stable bis-adducts (intrastrand
adduct type 1,2-GpG), as observed with DNA (1,2-d(GpG)) [150].
In the determination of platinum coordination sites on 3'-labeled H69 through
DMS reactions, hydrolysis was observed at U/Ψ1915 and U/Ψ1917 (Figures 3.5A
and 3.5B, lanes 4 and 5). Hydrolysis at these sites did not occur on the platinated
H69 (Figures 3.5A and 3.5B, lane 3), suggesting that platination alters the
structure and/or chemical stability of H69 at or near these residues. In contrast,
reactivity at U/Ψ1911 and A1913 was observed in DMS probing of 5'-labeled H69
for both platinated and unplatinated RNAs (Figure 3.6A, lanes 2 and 3; Figure
3.6B, lanes 6 and 7), indicating a minimal influence of platination on DMSsensitivities of these nucleotides. However, a new fragment band corresponding
to either A1918 or A1919 appeared in the DMS-treated, platinated H69 RNA
samples (Figure 3.6A, lane 2; Figure 3.6B, lane 6). Collectively, these
observations show that H69 residues become either DMS unreactive, insensitive,
or sensitive after platination, indicating different responses of the RNA
nucleotides to drug binding.
These observations further suggest that platination of H69 in the stem region
induces a structural change in the loop region that leads to DMS sensitivity. The
effect on the loop residues upon cisplatin coordination at stem GpG sites is not
surprising. Aminoglycoside binding to a 2-aminopurine-modified H69 was shown
to affect the loop nucleotides, in which residue A1913 became more solvent
exposed [105]. These results were consistent with x-ray crystal structures of
bacterial 70S ribosomes with neomycin bound to the stem region of H69 near
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residues G1906, 1921, and 1922 and base exposure of A1913 (Figure 3.7A)
[106]. Therefore, complex 1 coordination to the same residues as shown by this
study could induce structural changes to H69 (Figure 3.7B). However, in the 2aminopurine modified H69 studies, changes at loop residues were prominent
only for modified H69, whereas in the current work, platination of both H69 RNAs
caused similar effects on loop reactivity. This result reveals that effects on RNA
structure likely depend on the drug types and their binding modes, as well as the
RNA composition.

Figure 3.7. The H69-drug interactions and structural changes are shown. A) The
interaction of neomycin with H69 residues G1906, G1921, and G1922 as seen by
x-ray crystal structures is illustrated together with A1913 flipped out from the
loop. B) The binding of cisplatin to similar residues, which could induce structural
changes to H69 is indicated. The figures were created by using PDB file 4GAQ
[127].
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Many structural effects such as bending, unwinding, helix destabilization, and

base destacking have been shown to result from cisplatin binding to DNA [151].
Likewise, the current study showed structural changes due to cisplatin
coordination to the three rRNA hairpins. The structural effects of platination on
DNA have been suggested to interfere with replication, transcription, and repair.
Similarly, the structural effects of platination on rRNA could interfere with protein
synthesis and recruit proteins that prevent repair, therefore contributing to drug
cytotoxicity.
The modified and unmodified H69 RNAs gave similar results for reactions
with 1, whereas differences in reactivity with the 790 loop were observed.
Although unmodified H69 and the 790 loop have identical types and numbers of
nucleotides (A5G5U4C5), these RNAs have different sequences, with the 790 loop
containing one and H69 having two GG sites. Chemical probing of both H69
RNAs showed platination-induced DMS sensitivity in the loop region, whereas no
significant differences in reactivity were observed for the platinated and
unplatinated 790 loop. Probing of modified and unmodified H69 revealed that
these two constructs have similar reactivities with 1 and DMS, suggesting similar
solvent accessibilities and chemical properties. A minimal influence from
pseudouridines on structural changes induced by cisplatin coordination was
seen. Collectively, these data indicate a greater impact of nucleotide sequences
than the modified nucleotides on RNA structure following small-molecule binding
in the studied RNAs.
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The DMS-probing experiments on the three RNA constructs confirmed the

RNase T1 mapping data, in which all GpG sites were platinated, whereas ApG
and single Gs remained unplatinated for all three RNAs. In a previously
published study, the 790 loop in free 16S rRNA, 30S, and 70S ribosomes was
found to have a different platination profile with complex 1 [181]. In subunits and
ribosomes, a minor reactivity at residue G786 was seen, whereas a likely bisadduct was formed in the present work. However, in free 16S rRNA, the same
residue showed stronger reactivity compared to complete ribosomes [181,262].
The G791 nucleotide in the ApG site was found to platinate in the full-length
rRNA, whereas no platination was observed on the short hairpin. Neither of the
single Gs was found to platinate on either full-length 16S rRNA or the model RNA
construct. These comparisons generally indicate that complex 1 interaction is
dependent on the rRNA context, thus microenvironments, bulk salts, and
availability of the drug.
3.4 Summary and Conclusions
The rRNA motifs investigated in this study are highly conserved throughout
phylogeny and important for proper ribosome function [41,43,73]. The loop Ψs in
H69 regulate RNA structure, dynamics, and stability [74-77,105]. In this chapter,
platination of modified H69, unmodified H69, and the 790 loop was probed by
using RNase T1 mapping and DMS reactions. Activated cisplatin 1 reacted with
the three 19-nucleotide rRNA motifs in a similar manner. Platination occurred at
consecutive Gs, namely G1921-G1922 and G1906-G1907 in the stem region of
H69 (unmodified and pseudouridylated), and at G785-G786 of the 790 loop, most
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likely as bis-adducts, in which the chlorido ligands are displaced by two G
residues. Previous studies with truncated tRNA molecules showed a kinetic
preference for platination at neighboring Gs within a G–C-rich wobble-base-pair
region [177]. Therefore, consistent with prior RNA studies, this work shows
preferential recognition of G residues by complex 1 [148].
Chemical probing studies also revealed structural alterations in the RNA
constructs following drug coordination, and the influence of nucleotide sequence
on such changes. Comparisons to previous reports on rRNA-cisplatin
interactions indicate that drug availability and electrostatics likely play a role in in
vivo drug binding. Overall, the data provided here show many similarities of
cisplatin coordination to DNA and RNA, such as target preference (e.g., GpG)
and impact on structure. The next set of studies focused on understanding the
influence from solution conditions and electrostatics on the platination reaction.
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CHAPTER 4
ELECTROSTATIC MICROENVIRONMENTS OF RIBOSOMAL RNA
HAIRPINS WITH MODIFIED NUCLEOTIDES DETERMINED BY
PLATINATION REACTIONS
4.1 Abstract
Electrostatic microenvironments are important for RNA biology. Each
nucleotide carries a negative charge, therefore interacting cations assist in
folding RNAs into their active states. Understanding RNA electrostatics and saltdependent ligand interactions is useful for identifying unique drug targets. In this
chapter, cisplatin coordination rates with bacterial ribosomal RNA (rRNA)
hairpins were examined. Salt-dependent platination profiles were affected by
changes in the rRNA sequence as well as modified nucleotide status, providing
information about the electrostatic microenvironments. This knowledge gives
insight on cationic drug interactions with RNA, and also reveals important factors
governing the mechanism of cisplatin coordination to RNA.
4.2 Introduction
RNA is a highly charged biopolymer with many unique biologically active
structures. Local electrostatic environments created by RNA folding are important
for ligand interactions, stability, and function [18]; however, few methods exist to
determine RNA electrostatic environments experimentally. Computational studies
on RNA molecules can predict electrostatic potentials on their surfaces where
intermolecular interactions take place [18,86]. The importance of electrostatics is
also revealed through examination of RNA-protein contacts such as Rev-RRE in
HIV or cationic drug binding [89,138]. Varying electrostatic potentials on
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ribosomes may influence key interactions with tRNA and mRNA, or impact the
recognition of antibiotics on bacteria rRNAs [88]. Therefore, the ability to monitor
electrostatic microenvironments within folded RNAs is important for a complete
understanding of their functions, as well as improving drug-RNA interactions.
Monovalent or divalent cations play important chemical and biological roles by
associating with RNA to screen negative phosphate groups, and by forming a
delocalized condensation layer, or ionic cloud, around the RNA [93]. Salts
neutralize polyion charge to an extent identified by the Debye-Hückel length [98].
For short oligomers, counterion condensation is dominated by end effects, in
which the local concentration of cations increases linearly from the oligomer end
to the interior [246]. The influence of added salts in nucleic acid structure and
function has been reported for many cases [263], revealing salt-dependent
binding and rate constants for DNA interactions with ligands such as lac
repressor, cationic peptides, and antibiotics [264-266]. Salt-dependent global
RNA structural changes and ligand interactions also occur [267-269].
Analogous to the impact of electrostatics and salts on charged RNA-ligand
interactions, a similar influence can be expected for coordination of metal
complexes such as cis-diamminedichloridoplatinum(II) (cisplatin). Cisplatin is well
known for DNA adduct formation [148], but an emerging number of studies have
also revealed RNA as a potential target [181,183]. Kinetic studies on cisplatin
binding

to

DNA

have

provided

deeper

insight

on

its

mechanism

[158,163,164,169,239], whereas reports on RNA interactions are still limited.
Given the importance of microenvironments in RNA-ligand interactions, this
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chapter focuses on platination rates for rRNAs containing modified nucleotides
and varying sequences. The impact of electrostatics on drug binding was
evaluated by using salt-dependent coordination rates. These results are valuable
for understanding cation interactions with RNA and developing tools to
investigate microenvironments of various RNA motifs.
4.3 Results and Discussion
Three bacterial (E. coli) model hairpin rRNAs were chosen for comparison of
platination rates and electrostatics because of their important biological roles and
known antibiotic or ligand interactions. Helix 69 (H69) from 23S rRNA plays a key
role in protein synthesis [69,70,270], and aminoglycoside binding [105,106]. H69
has three pseudouridine (Ψ) residues that impact structure, stability, and function
[75,77,259]. The contribution of Ψ to RNA electrostatic environments has been
examined previously by computational methods [241]. In that study, a high
electronegative potential localized to the major groove of a branch site in
pseudouridylated

RNA

was

determined.

Therefore,

such

electrostatic

environments in modified RNA might be expected to influence the initial
interaction and approach of platinum compounds on the studied RNAs. Therefore,
two H69 constructs containing either uridine (unmodified) or Ψ (modified) were
used to determine experimentally the influence of nucleotide modifications on
electrostatics and salt-dependent drug binding to rRNA. The 790 loop from 16S
rRNA is also important for ribosome function [83,271]. It has an identical size and
nucleotide composition but altered sequence compared to H69, and therefore
provides a means to examine the effect of nucleotide arrangement on salt-
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dependent characteristics of rRNA. The RNAs were platinated by reacting with
activated cisplatin, complex 1 (Figure 2.5), under pseudo-first-order conditions,
and the products were quantified with gel assays, as described in Section 2.5.
The salt influence on platination kinetics was determined by changing Na+
concentrations in the bulk medium. Electrostatic properties of model rRNAs were
then determined by evaluating the kinetic data according to Brønsted-DebyeHückel and polyelectrolyte theories [173,176].
4.3.1 Kinetics of Cisplatin Binding to Ribosomal RNA Hairpins
Addition of complex 1 to RNA resulted in a decrease of unplatinated RNA in a
time-dependent manner, with a concomitant increase in intensity of slowermigrating product bands (platinated RNA) on denaturing polyacrylamide gels
(Figure 4.1A-C). In a generally accepted mechanism, the reaction of complex 1
with RNA proceeds in two steps [163-168,173,175,176,179,180]. In the first step,
complex 1 displaces a fraction of surface-bound cations (nΨ') and associates
with RNA (Scheme 4.1, Equation 4), followed by the next rate-determining step
of direct reaction between 1 and the nucleic acid (Equation 5). Under these
conditions, the rate of conversion of unplatinated RNA to platinated RNA should
obey first-order dependence of the concentration of 1 and RNA with the rate law
according to Equation 6. Under conditions of excess platinum ([1] >> [RNA]), the
observed pseudo-first-order rate constant, kobs, can be obtained by Equation 7,
and the rate law can be rewritten as Equation 8, in which kobs = k2,app[1]t=0. Thus,
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Figure 4.1. Reaction kinetics of 1 and RNA constructs are shown.
Autoradiograms for A) unmodified H69, B) modified H69, and C) 790 loop are
shown (R: unreacted RNA; P1, P2, and P3: slower migrating Pt products; [RNA]
= 0.7 µM, [1] = 94 µM; 10 mM K2HPO4/KH2PO4, pH 6.2, with 20 mM NaClO4; 32
mM total monovalent cation concentration, [M+], 37 °C). Lanes 1–8; 0, 2, 4, 6, 8,
10, 15, and 30 min, respectively; lanes 9–12; 1, 2, 3, and 22 h, respectively; lane
13; 22 h control (no Pt) are indicated.
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Scheme 4.1. The reaction and kinetic model for complex 1 coordination to RNA
is given.
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the observed rate constant kobs can be obtained by a fit of a single-exponential
function to the time dependence of unreacted RNA.
The decrease of unreacted RNA over time fit well to a single-exponential
decay for all cation concentrations studied (Figure 4.2). Under pseudo-first-order
conditions ([1]>>[RNA]), the observed rate constant, kobs, was determined. For all
three RNA constructs, a linear relationship exists between kobs and initial complex
1 concentration (Figure 4.3). Therefore, the apparent second-order rate constant,
k2,app, was determined by the relationship k2,app = kobs/[1]t=0. Standard errors were
calculated from three independent experiments.

	
  
Figure 4.2. Single-exponential-decay fits show disappearance of unreacted RNA
A) unmodified H69, B) modified H69, and C) 790 loop as a function of time (min)
in 10 mM K2HPO4/KH2PO4, pH 6.2, and 0–100 mM NaClO4; 12–112 mM total
monovalent cation concentration.
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Figure 4.2.continued.

Figure 4.3. Determination of second-order rate constants for reactions of 1 with
RNA is shown. The observed pseudo-first-order rate constant, kobs, is plotted as
a function of increasing platinum concentration, [1], for the reaction of A)
unmodified H69, B) modified H69, or C) the 790 loop with complex 1 in 10 mM
KH2PO4/K2HPO4, 20 mM NaClO4, pH 6.2, 37 °C; 6.7 µM < [1] < 100 µM (9.5–143
times excess).

4.3.2 Salt-Dependent Platination Reactivities of rRNA
All three RNAs showed a decrease in 1 reactivity as total monovalent cation
concentration ([M+]) in the bulk medium increases (Figure 4.4, Table 4.1).
Specifically, a ca. one-order-of-magnitude decrease in reactivity was observed
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Figure 4.4. The apparent second-order rate constant, k2,app, versus total
monovalent cation concentration ([M+]), 12–112 mM, plot shows the saltdependent platination kinetics for unmodified H69 (black circles), modified H69
(blue squares), and the 790 loop (green diamonds).
Table 4.1. Observed pseudo-first-order rate constants, kobs, and second-order
rate constants, k2,app for the reactions between rRNA constructs and activated
cisplatin as a function of monovalent cation concentration.
Oligonucleotide

K+ (mM)a

Na+ (mM)b

kobs (10-4 s-1)

k2,app (M-1s-1)

12
0
85.0 ± 10.7
90.5 ± 11.4
12
20
13.3 ± 0.9
14.2 ± 0.9
12
40
4.7 ± 0.5
5.0 ± 0.6
unmodified H69
12
60
3.4 ± 0.4
3.6 ± 0.5
12
80
3.3 ± 0.2
3.5 ± 0.3
12
100
2.2 ± 0.2
2.4 ± 0.3
12
0
42.6 ± 3.1
45.4 ± 3.3
12
20
7.9 ± 0.9
8.4 ± 0.9
12
40
4.6 ± 0.4
4.9 ± 0.4
modified H69
12
60
2.6 ± 0.3
2.8 ± 0.3
12
80
2.4 ± 0.2
2.6 ± 0.3
12
100
1.8 ± 0.2
1.9 ± 0.2
12
0
52.8 ± 4.6
56.2 ± 4.9
12
20
16.2 ± 1.1
17.2 ± 1.2
12
40
8.7 ± 0.7
9.3 ± 0.7
790 loop
12
60
5.6 ± 0.5
5.9 ± 0.5
12
80
5.5 ± 0.4
5.8 ± 0.5
12
100
3.6 ± 0.5
3.8 ± 0.5
a
b
10 mM K2HPO4/KH2PO4 buffer, pH 6.2; 0–100 mM NaClO4, 37 °C
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with increase of bulk monovalent cation concentration from 12 to 112 mM.
Unmodified H69 was more sensitive to salt (38-fold decrease in k2,app) than
modified H69 (24-fold decrease) and 790 loop (15-fold decrease). A particularly
prominent salt dependence for all RNAs was seen between 12 and 32 mM total
monovalent cations. Modified H69 showed a ca. two- and 1.7-fold lower reactivity
than unmodified H69 at 12 and 32 mM monovalent cation concentrations,
respectively, whereas reactivity of the 790 loop was below that of unmodified
H69 only at the lower cation concentration. These results indicate that Ψ and the
nucleotide sequence (unmodified H69 vs. 790 loop) influenced the rate of
cationic complex coordination to RNA. The mechanism of cisplatin adduct
formation can be described by a two-step reaction (Scheme 4.1). In the first step,
positively charged 1 associates with RNA, replacing a fraction of surface-bound
cations (nΨ') (Equation 4; the symbol Ψ' is used to avoid confusion with
pseudouridine, represented as Ψ), which is followed by direct coordination of 1 to
RNA as the rate-determining step (Equation 5). The salt-dependent interactions
of nucleic acids originate from counterion release upon ligand binding
[264,265,272,273]. The entropic contribution from this displacement is a
significant driving force for complex formation [264,265,272,273].
4.3.3 Determination of Electrostatics in Cisplatin-rRNA Reactions
Salt-dependent platination kinetics were assessed by two electrostatic models.
The Brønsted-Debye-Hückel relationship is well suited for reactants described as
point charges [247], such as 1 interacting with a limited number of
phosphodiester linkages at the platination site. To analyze the kinetic data
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according to this theory (Chapter 2, Equation 2 and Section 2.6.1), the apparent
second-order rate constant (k2,app) was plotted as a function of ionic strength in
the medium (I) (Figure 4.5). When A is 0.5220 at 38 °C [248], the slope provides
ZAZB, which indicates the overall charge of each species interacting in the
product-formation reaction. The x intercept provides the rate constant at zero
ionic strength, k0 (Table 4.2).
The product of ZAZB was negative, as expected for a reaction between a
positively charged platinum complex and negatively charged RNA surface.
Although consistent with previously studied systems [173,175,176], the ZAZB
values, ranging from -6.6 (790 loop) to -9.5 (unmodified H69), were higher than
expected for interaction of +1 charged Pt center and single -1 charged
phosphodiester bond. This result suggests increased negative charge density of

	
  
Figure 4.5. Evaluation of salt dependence of RNA platination rates according to
electrostatic models is shown. A) A plot of log k2,app versus I1/2/(1+I1/2) assuming
the salt dependence according to the Brønsted-Debye-Hückel relationship. B) A
graph of log k2,app versus log monovalent cation concentrations, [M+], assuming
the polyelectrolyte behavior of RNA constructs, unmodified H69 (black circles),
modified H69 (blue squares), and 790 loop (green diamonds).
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the folded hairpin structures, which attracts the cationic metal complexes for
binding and coordination. The overall negative charge density in these rRNA
motifs could play a critical role in initial recognition and recruitment of other
charged molecules onto their surfaces.
Electrostatic interactions between charged ligands and polynucleotides can
also be described by the polyelectrolyte theory [98,246,247,265,274-276]. Saltdependent platination of RNA by 1 was evaluated by Equation 3 (Chapter 2 and
Section 2.6.1). The theory predicts a linear relationship between log k2,app and log
[M+] (Figure 4.5B), providing log k'0 and the fraction of surface-condensed cations,
nΨ' (Table 4.2), displaced by complex 1. Interactions of 1 with all three RNAs
were well described by this theory; however, higher nΨ' values were obtained
compared to previously investigated RNAs and DNAs (Table 4.3), indicating
higher electrostatic potentials and greater displacement of counterions from the
RNA surface following 1 binding. Increased displacement of condensed ions in
cationic peptide/protein-nucleic acid interactions has been attributed to formation
of

thermodynamically

stable

complexes

driven

by

entropic

effects

[264,265,272,273]. Therefore, a higher fraction of counterions released by 1

Table 4.2. Evaluation of the salt dependence of RNA reactivity with 1 using the
Brønsted-Debye-Hückel relationship and polyelectrolyte theory.
ZAZB

log k0

nΨ '

log k'0

unmodified H69

-9.5 ± 1.5

2.7 ± 0.5

1.5 ± 0.2

-1.2 ± 0.1

modified H69

-8.7 ± 0.5

2.5 ± 0.2

1.4 ± 0.1

-1.1 ± 0.1

790 loop

-6.6 ± 1.1

2.3 ± 0.3

1.0 ± 0.1

-0.4 ± 0.1

RNA
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Table 4.3. Comparison of nΨ' values of different oligonucleotides.
Pt
cmpd

Cation conditions

r(CGCGUUGUUCGCG)
r(CGCGTTGTTCGCG)

1
1
1
2
3

12 mM K+, 0 – 100 mM Na+
12 mM K+, 0 – 100 mM Na+
12 mM K+, 0 – 100 mM Na+
19 – 500 mM Na+
19 – 500 mM Na+

1.5
1.4
1.0
0.69 [176]
0.62 [176]

d(CGCGTTGTTCGCG)
d(CGCGTTGTTCGCG)

2
3

19 – 500 mM Na+
19 – 500 mM Na+

0.44 [176]
0.41 [176]

d(T8s6IT8)
d(T8s4UT8)

2
2

0.5 mM K+, 4.3 – 300 mM Na+
0.5 mM K+, 4.3 – 300 mM Na+

0.80 [175]
0.74 [175]

d(s6IT16)
d(s4UT16)

2
2

0.5 mM K+, 4.3 – 300 mM Na+
0.5 mM K+, 4.3 – 300 mM Na+

0.60 [175]
0.60 [175]

d(T8p(S)T8)
Native B-DNA

2
–

0.5 mM K+, 4.3 – 300 mM Na+
–

0.60 [175]
0.88 [98]

Single-stranded DNA
A-DNA

–
–

–
–

0.70
0.91

[98]
[96]

Poly(U)

–

–

0.68

[96]

Oligonucleotide
r(GGCCGUAACUAUAACGGUC)
r(GGCCGΨAACΨAΨAACGGUC)
r(GCAGGAUUAGAUACCCUGC)

nΨ '

ref.

1 = cis-[PtCl(NH3)2(OH2)]+; 2 = cis-[PtCl(NH3)(c-C6H11NH2)(OH2)]+;
3 = trans-[PtCl(NH3) (quinoline)(OH2)]+
interaction may also produce stable and favorable platination adducts with these
rRNA hairpins under in cellulo conditions. Analysis of platination kinetics by the
two electrostatic models revealed that both nucleotide modifications and
sequence influence the rate by which a common nucleophile (e.g., G-N7) is
targeted. This result is in line with the mechanism shown in Scheme 4.1, in which
the observed platination rate is affected by electrostatics during the initial
association step (Equation 4) and by other intrinsic RNA characteristics in the
rate-determining substitution step (Equation 5). Electrostatic comparisons
showed no significant differences in the ZAZB or nΨ' values for unmodified and
modified H69s, indicating that approach, association, and accumulation of 1
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should be similar for the two RNAs. However, different platination rates were
seen for the two H69 constructs (Figure 4.4 and Table 4.1), particularly in low salt.
Therefore, other factors such as target accessibility and inherent reactivity are
likely to influence direct coordination in the substitution step. Structure studies
revealed more pronounced stacking interactions from Ψ1915 to A1918 in
modified H69 compared to unmodified H69 [74,75], and probing analyses
showed that residues in unmodified H69 within complete ribosomes are less
constrained

and

more

reactive

to

chemical

modifying

agents

than

pseudouridylated H69 [76,77]. Hence, the less restricted structure, allowing for
increased target site access in the substitution step, would account for higher
platination rates of unmodified H69 compared to modified H69.
Since platination GpG sites [148,150] are located in the stem, whereas U/Ψ
are found in the loop, the differential H69 platination rates indicate crosstalk
between the stem and loop motifs. Previous fluorescence studies with 2aminopurine-substituted H69 also support the idea of crosstalk between the stem
and loop upon aminoglycoside binding [105], and ribosome crystal studies show
localization of these cationic drugs near the GpG sites of H69 [106]. Differences
in the H69 loop due to U/Ψ could be conveyed to the stem platination site,
thereby affecting coordination rates. With increasing salts, these structural
differences may be screened, leading to comparable reactivities for the two
RNAs. These findings indicate that Ψ, although located away from the target site
and not contributing to global electrostatics, can still influence the platination
mechanisms in rRNA through varying structure and dynamics. Since cellular
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RNA contains many modified nucleotides, those residues could also influence
cationic interactions in vivo.
The kinetics of 1 binding to the 790 loop showed an intermediate reactivity
profile compared to unmodified and modified H69 in low salt, combined with a
less pronounced salt dependence, providing further support that the local
structure is a determinant of cisplatin reactivity. We therefore conclude that
sequence effects may be more impactful than pseudouridylation with respect to
modulating the RNA electrostatic environments. Lower electrostatics (ZAZB or nΨ'
values in Table 4.2) of the 790 loop indicate reduced attraction and accumulation
of 1 during the association step, leading to lower platination rates. However, the
altered sequence of the 790 loop may also give rise to a structure in which
platinum target sites are more reactive and accessible, therefore restoring the
electrostatically lowered drug coordination rates to an intermediate platination
profile compared to H69 RNAs.
The k0 values, which indicate inherent reactivity of the target site in the
absence of counterion screening, were similar for all three RNAs. However, the
dissimilar kinetic profiles (k2,app in Figure 4.4) exhibited by the three RNAs as a
function of increasing salt indicated a significant contribution of target-specific
electrostatics to the kinetics during binding of charged compounds to RNA.
Overall, these findings strongly support the influence of electrostatics and
structure to the mechanism of platinum drugs binding to rRNA hairpins. The data
provided herein also show the impact of additional factors such as modified
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nucleotides and dynamics to the mechanism of platinum drug coordination to
rRNA hairpins.
4.4 Summary and Conclusions
Electrostatic interactions and salt-dependent properties play crucial roles in
RNA biochemistry. This work shows the utility of coordination complexes such as
cisplatin to probe RNA microenvironments and potential binding interactions.
While this thesis work focuses on metallo-drug interactions with RNA, these
results may be useful to understand the binding of non-metallic, cationic
compounds to the same RNA sites. Platination kinetics revealed how sequence
and nucleotide composition control drug binding through different mechanisms.
For example, sequence variations lead to global electrostatic changes that
impact cationic ligand binding, whereas modifications such as pseudouridylation
influence RNA reactivity through structural changes. The higher electrostatics of
H69 and 790 loop rRNAs suggest that they would be attractive targets for
cationic drug molecules. Although it is important to first understand the reactivity
at a basic secondary structure level with smaller RNA motifs, platination of larger
RNA constructs and complete ribosomes will be able to shed light on the roles of
the surrounding RNA tertiary structure on these processes [181,183].
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CHAPTER 5
THE IMPACT OF CATIONS ON KINETICS OF rRNA
PLATINATIONS
5.1 Abstract
Metal cations play an indispensable role for RNA. Dynamic cation interactions
can influence the global electrostatics of RNA. Consequently, the attraction and
binding of cationic drugs like cisplatin depend on the ionic conditions surrounding
the targets. In this chapter, complex 1 coordination rates to H69 RNAs were
studied under different salt media. The presence of divalent ions reduced the
cisplatin binding rate to RNA. Furthermore, platination rates were found to
decrease with increasing ionic strength. The analysis of kinetic data according to
electrostatic models showed increased RNA global charge and enhanced
counterion condensations under high salt conditions. However, nucleotide
modifications did not alter the platination rate or the electrostatic properties of
RNA. Overall, this kinetic study showed the effect from surrounding ionic
conditions, especially the presence of divalent cations, on cationic drug binding
rates, RNA microenvironments, and the application of platination kinetics to
probe such correlations.
5.2 Introduction
Cations play key roles in RNA [93,97,268,277,278]. Many different
monovalent and divalent cations such as K+, Na+, NH4+, and Mg2+ have been
identified as playing roles in electrostatics and ligand interactions of RNA [94,95].
The most common monovalent ion present in the E. coli cytoplasm, K+, serves
important roles for many RNAs [96,279-282]. Although Na+ is mainly found in
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extracellular fluids, many studies have revealed Na+ association with nucleic
acids within the cell [97,283-285]. The most common divalent ion found in the
bacterial cytoplasm is Mg2+ [96]. Due to its high charge density and low entropic
cost for charge neutralization compared to monovalent ions, Mg2+ is suggested to
play an important role in screening electrostatics of RNA [93,97,101]. The Mg2+
associations on RNA molecules have been identified either with local functional
groups or on surface electronegative patches [18,100,286-292].
In addition to roles in attenuating electrostatics, cations also impact nucleic
acid-ligand interactions. The effects of mono- and divalent cations on lac
repressor-operator,

peptide-RNA,

endonuclease-DNA,

and

antibiotic-DNA

interactions have been documented [266,269,273,293]. The displacement of
functionally important Mg2+ ions that complement the electrostatic potentials on
RNA has been attributed to inhibition of the hammerhead ribozyme by
aminoglycosides [126,136]. Although the site-specific binding of cations has been
identified to serve important roles such as regulating RNA conformation, the
contribution to the ionic cloud that surrounds and stabilizes RNA tertiary
structures is considered to be the dominant role of cations [294-298]. Similarly,
work reported in this chapter emphasizes the significance of non-specific ionic
interactions on RNA microenvironments, cationic ligand binding rates, and
application of platination kinetics to probe cation-dependent RNA dynamics.
In this chapter, the influence of Mg2+ on complex 1 binding rate to H69 RNAs
(modified and unmodified) was determined under two different monovalent cation
conditions. The Mg2+ dependence of platination rates was evaluated according to
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the two electrostatic theories. Platination was carried out under pseudo-first-order
conditions with excess complex 1. The reaction rate was determined by fitting the
fraction of unreacted RNA, determined by gel assays, to single-exponential
decay plots as described in Chapters 2 and 4. The addition of Mg2+ to the
reaction medium resulted in a decrease of the platination rates. Interestingly, the
analysis of platination kinetics according to the Brønsted-Debye-Hückel theory
revealed an increase of RNA charge density under the higher cationic conditions.
Under higher salt conditions, higher counterion condensation was observed,
which lowered the platination rates. The electrostatic effect on drug-RNA binding
rate was dependent on the salt conditions used. Taken together, the results show
that RNA electrostatics can be modulated by the surrounding ionic strength, and
thus target-ligand interactions can be heavily dependent on cellular cationic
levels.
5.3 Results and Discussion
5.3.1 The Impact of Mg2+ Ions on the Platination Kinetics of Ribosomal
RNA Hairpins
Salts are important for the activity of biomolecules. Specifically for highlycharged biopolymers such as RNA, cations are required to neutralize
electronegative potential. In turn, these cationic associations can alter the
electrostatic properties of RNA and their interaction with ligands. In this chapter,
the influence of Mg2+ on complex 1 coordination rate to rRNA was monitored
under two different monovalent cation conditions, K+ only and K+ + Na+, as
described in Chapter 2, Section 2.5. Evaluation of kinetic data according to the
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Brønsted-Debye-Hückel

and

polyelectrolyte

theories

allowed

for

the

determination of ionic influence on the electrostatic properties of rRNA.
The platination reaction was initiated by adding an excess amount of complex
1 ([1] >> [RNA]) to achieve pseudo-first-order conditions. The progress of
complex 1 binding to rRNA hairpins was monitored by gel electrophoresis.
Coordination of the platinum complex decreased the amount of unreacted RNA
with time and produced slow migrating product bands (Figure 5.1). The decrease
of unreacted

Figure 5.1. The kinetic plots of H69 RNA platination in the presence of Mg2+ are
shown. Autoradiograms of A) unmodified H69 and B) modified H69 in 10 mM
K2HPO4/KH2PO4 pH 6.2, (buffer B), [K+] = 12 mM, with 20 mM NaClO4 and 1 mM
Mg(ClO4)2 are shown (R: unreacted RNA, P: slower migrating platinated products,
lanes 1-8; 0, 2, 4, 6, 8, 10, 15, 30 min, respectively, lanes 9-11; 1 h, 3 h, 6 h,
respectively, and lane 12; 6 h con, no Pt). The corresponding single-exponential
decay fits of the autoradiograms for C) unmodified H69 and D) modified H69 are
shown.
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RNA fraction with time was well described according to single-exponential decay
fits (Figure 5.1). The observed pseudo-first-order rate constants (kobs) and
apparent second-order rate constants (k2,app) were determined by singleexponential decay plots and the k2,app = kobs/[1] relationship, respectively.
Standard errors were calculated from two or three independent trials.
The influence of Mg2+ on platination of the H69 rRNA hairpins was
determined under two monovalent ion conditions. In one condition, the medium
contained only K+ ions added from a 10 mM K2HPO4/KH2PO4, pH 6.2 (buffer B),
and the second buffer contained 20 mM NaClO4 in addition to 10 mM
K2HPO4/KH2PO4 (buffer B + Na+). The platination rate deceased with the addition
of Mg2+ for both H69 RNAs. The decreasing platination rate with increasing Mg2+
was observed for both monovalent conditions (Figure 5.2). The platination rate
(k2,app) was decreased by a ca. one-order-of magnitude in buffer B, and 1.5–2fold in buffer B + Na+ by addition of 1 mM Mg2+ (Table 5.1). In buffer B, both

Figure 5.2. The Mg2+-dependent platination kinetic plots are shown. Variation of
the apparent second-order rate constant, k2,app, with respect to Mg2+
concentration for A) unmodified H69 and B) modified H69 is shown. The filled
symbols with solid fittings represent data for buffer B (buffer B titrated with Mg2+)
and open symbols with dashed fittings represent buffer B with 20 mM NaClO4
(buffer B + Na+ titrated with Mg2+).
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Table 5.1. The observed pseudo-first-order rate constants, kobs, and apparent
second-order rate constants, k2,app, for the reactions between H69 rRNA
constructs and complex 1 as a function of Mg2+ concentrations studied under
different monovalent ion conditions.
K+
Na+
Mg2+
[a]
Oligonucleotide (mM)
kobs (10-4 s-1) k2,app (M-1s-1)
(mM)
(mM)
12
0
0
85.0 ± 10.7[b] 90.5 ± 11.4[b]
12
0
1
6.3 ± 0.4
6.7 ± 0.5
12
0
3
4.3 ± 0.5
4.6 ± 0.6
12
0
6
2.6 ± 0.5
2.7 ± 0.5
12
0
12
2.2 ± 0.4
2.3 ± 0.5
unmodified H69
[b]
12
20
0
13.3 ± 0.9
14.1 ± 0.9[b]
12
20
1
6.0 ± 0.6
6.4 ± 0.6
12
20
3
1.8 ± 0.6
1.9 ± 0.6
12
20
6
1.4 ± 0.2
1.4 ± 0.2
12
20
12
0.9 ± 0.1
0.9 ± 0.1
[b]
12
0
0
42.6 ± 3.1
45.4 ± 3.3[b]
12
0
1
6.2 ± 0.5
6.6 ± 0.5
12
0
3
4.1 ± 0.4
4.4 ± 0.5
12
0
6
2.5 ± 0.4
2.6 ± 0.5
12
0
12
1.9 ± 0.2
2.0 ± 0.3
modified H69
[b]
12
20
0
7.9 ± 0.9
8.4 ± 0.9[b]
12
20
1
5.1 ± 0.6
5.5 ± 0.7
12
20
3
2.1 ± 0.6
2.2 ± 0.6
12
20
6
1.5 ± 0.2
1.6 ± 0.2
12
20
12
0.8 ± 0.1
0.8 ± 0.1
[a]
[b]
10 mM K2HPO4/KH2PO4 buffer, pH 6.2 (buffer B), 37 °C, Data from Chapter 4.
RNAs showed ca. 3-fold decrease in platination (k2,app) going from 1 to 12 mM
Mg2+ and ca. 7-fold reduction in buffer B + Na+. Except for 1 mM Mg2+, the
platination rate in buffer B + Na+ was always lower compared to buffer B. No
significant differences in platination rates were observed for the two H69 RNAs
under all Mg2+ concentrations studied. The decrease of platination rate with the
addition of Mg2+ is supported by similar trends reported for other oligomer
systems [166,173,185].
In the mechanism of platinum complexes binding to nucleic acids (Chapter 4),
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complex 1 first associates with RNA by displacing the surface-bound cations
(Equation 4), and then coordinates to the target site in a rate-determining second
step (Equation 5) [163,164,168,179]. According to this pathway, the platination
rate should depend on the bulk salts, Kass, and k2. The Kass depends on the
electrostatic interaction between complex 1 and RNA, whereas intrinsic RNA
characteristics impact k2. As the cationic Mg2+ can electrostatically compete with
the positively charged complex 1, the decrease of platination rate in the presence
of Mg2+ should therefore arise due to decreased Kass and reduced drug
accumulation on RNA.
Ribosome crystal structures identified Mg2+ ions near G1921-22 of H69
(Figure 5.3), where complex 1 coordination was also observed (Chapter 3)
[104,299,300]. The G•U wobble base pairs in RNA have strong electronegative
potentials in the major groove to which Mg2+ ion binding has been reported [63].
Studies using small H69 RNA constructs suggested Mg2+ ion association at the
G1907•U1923 wobble pair [65,301]. Results from Chapter 3 also suggested
complex 1 coordination at G1906-07.
In general, Mg2+ ions tend to associate on the electronegative deep major
groove of RNA [302,303]. Based on results with DNA, cisplatin is believed to
access the base N7 position and coordinate in the major groove of RNA
[145,304]. Crystallographic studies have further suggested that diffusely bound
Mg2+ ions could interact with the solvent-exposed regions of ribosomes [284].
The direct associations of Mg2+ ions at or near the platinum target sites, as well
as accumulating in ionic clouds along the RNA backbone, are likely to pose steric
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Figure 5.3. The crystal structure of T. thermophilus 23S rRNA shows a Mg2+ ion
(shown in purple) located in between residues G1921 and G1922 (blue) of H69
(PDB: 3HUX) [104]. The distances from the Mg2+ metal center to N7 atoms of Gs
are indicated. Potential electrostatic and steric hindrance for approach of the Pt+
complex by the Mg2+ ion near the N7 positions of the 1921-22 Gs is indicated by
the open arrow.
and electrostatic barriers for complex 1 coordination, and therefore decrease the
platination rate (i.e., lowering Kass).
As mentioned previously, the Mg2+-dependent platination rates were
determined for two monovalent ion conditions. One monovalent ion condition had
only K+ ions present from the 10 mM K2HPO4/KH2PO4, pH 6.2, buffer (buffer B)
and the other solution contained 20 mM NaClO4 in addition to buffer B (buffer B +
Na+). Figure 5.2 shows that the platination rates in K+ + Na+ medium are
approximately two-fold lower compared to K+-only medium for all Mg2+
concentrations studied except at 1 mM. This result further supports an
electrostatic competition between solution cations and complex 1 interacting with
RNA, which reduces the overall platination rate.
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The addition of 20 mM Na+ to buffer B decreased the platination rate (k2,app)

by 6.4-fold for unmodified H69 (compare rows 1 and 6 in Table 5.1, data from
Chapter 4). In comparison, the addition of 1 mM Mg2+ to buffer B decreased the
reaction rate by 13.5-fold for the same H69 RNA (compare rows 1 and 2 in Table
5.1). Similarly, for the modified H69 addition of 20 mM Na+ to buffer B (compare
rows 11 and 16 in Table 5.1, data from Chapter 4) decreased the platination rate
(k2,app) by 5.4-fold, whereas the rate drop in 1 mM Mg2+ (compare rows 11 and 12
in Table 5.1) was 6.8-fold. These data showed that both Na+ and Mg2+ decreased
the platination rate, and the impact from Mg2+ was higher compared to Na+,
especially for the unmodified construct. Due to its higher charge density that
better neutralizes the RNA, Mg2+ ion is a stronger electrostatic competitor for Pt+
than Na+. Therefore, the rate decrease upon Mg2+ addition is greater compared
to Na+. Collectively, these results show an effect from Na+ and Mg2+ in
decreasing the platination rates of H69 rRNA hairpins.
The reactions of complex 1 with the two H69 RNAs in the presence of Mg2+
showed similar platination rates. In Chapter 4, different platination rates were
reported for the two H69 RNAs under low salt conditions. Those results indicated
screening of structural differences with added salts, which lead to similar
platination rates for the unmodified and modified RNAs. That observation is
further supported by the results in this chapter, in which no difference in
platination rates was observed under high salt conditions for the two H69 RNAs.
Therefore, the impact of Mg2+ appears to be larger for unmodified than modified
H69 due to the bigger rate differences in the absence of salt.
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5.3.2 Determination of Electrostatics of Cisplatin-RNA Interactions in the
Presence of Divalent Cations
A number of studies have shown the importance of electrostatics on platinum
drug-nucleic acid interactions [163-166,168,173,175,176,179,180]. Using a
similar approach, Mg2+-dependent platination kinetic data were analyzed
according to the Brønsted-Debye-Hückel and polyelectrolyte theories as
described in Chapter 2, Section 2.6.1. These analyses provide information
regarding the electrostatic properties of the RNAs. According to the BrønstedDebye-Hückel theory, the product of reactant charge (ZAZB) and k0, the limiting
platination rate at infinite dilution can be determined (Equation 2, Chapter 2)
[244,305]. Evaluation of the platination kinetics according to the polyelectrolyte
theory by a logarithmic plot of k2,app versus total cation concentration, [M+/2+] (i.e.,
the sum of cation concentrations in each addition of Mg2+ to corresponding
monovalent solutions), allowed determination of the fraction of counterions
condensed per phosphate (nΨ') on the RNA surface (Equation 3, Chapter 2).
The Mg2+-dependent platination kinetics in both monovalent ion conditions
can be explained by the two electrostatic theories. The equations after fitting the
data to electrostatic models and the corresponding R2 values are given in Figure
5.4. The ZAZB, log k0, and nΨ' values determined by the two electrostatic models
are provided in Table 5.2. Figure 5.5 shows a comparison of the electrostatic
parameters determined in the presence of Mg2+ (buffer B titrated with Mg2+ and
buffer B + Na+ titrated with Mg2+) to those obtained and reported in Chapter 4
(absence of Mg2+, in which buffer B was titrated with Na+) for the two H69 RNA
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Figure 5.4. Evaluation of salt-dependent platination kinetics of H69 RNAs with
two electrostatic models is shown. The Brønsted-Debye-Hückel plots for A)
buffer B and B) buffer B + Na+ (ionic strength is changed by addition of Mg2+) are
shown. The graphs using the polyelectrolyte theory in C) buffer B and D) buffer B
+ Na+ are shown. The total cation concentration, [M+/2+], was varied by adding
Mg2+.
Table 5.2. A comparison of electrostatic parameters determined by BrønstedDebye-Hückel (ZAZB and log k0) and polyelectrolyte (nΨ') theories for the H69
hairpin RNAs in different cationic conditions.
Oligonucleotide

Cation Conditions
[a]

buffer B + Mg2+
buffer B + Na+ + Mg2+
unmodified H69
buffer B + Na+
[a]
buffer B + Mg2+
buffer B + Na+ + Mg2+
modified H69
buffer B + Na+
[a]
buffer B: 10 mM K2HPO4/KH2PO4, pH 6.2

	
  

ZAZB

log k0

nΨ '

-6.5 ± 0.4
-13.8 ± 1.0
-9.5 ± 1.5
-7.2 ± 0.1
-14.2 ± 1.8
-8.7 ± 0.5

1.6 ± 0.1
2.9 ± 0.2
2.7 ± 0.5
1.6 ± 0.1
3.0 ± 0.3
2.5 ± 0.2

1.7 ± 0.1
4.8 ± 0.4
1.5 ± 0.2
1.9 ± 0.1
5.0 ± 0.5
1.4 ± 0.1
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Figure 5.5. Comparisons of electrostatic parameters derived from different saltdependent kinetic studies are shown. The A) -ZAZB and B) log k0 values obtained
using the Brønsted-Debye-Hückel theory and C) nΨ' values found employing the
polyelectrolyte theory are shown. The data represented by solid (black, blue) and
shaded (grey, light blue) bars were obtained in buffer B and buffer B + Na+
titrated with Mg2+, respectively, in this chapter. The open white bars show the
data obtained in Chapter 4, in which buffer B was titrated with Na+.
models. The electrostatic parameters were similar for the two H69 RNAs
(unmodified and modified) for all the conditions studied. The highest ZAZB and
nΨ' values were found when buffer B + Na+ was titrated with Mg2+. The log k0
was also about 1.5-fold higher in those same conditions compared to the
absence of Na+, but similar to conditions with buffer B titrated with Na+ only.
When a reduction in the reaction rate with increasing ionic strength is
observed, the Brønsted-Debye-Hückel theory, which is related to the activatedcomplex-theory (Chapter 2), suggests a reaction between unlike ions that goes
through a less-charged state [17]. The increasing ionic strength poorly stabilizes
the less-charged state and increases the activation energy, thereby reducing the
reaction rate [17]. Therefore, the decreasing platination rate with increasing ionic
strength is consistent with a reaction between negatively charged RNA and
positively charged complex 1 (Figure 5.4). Such a reaction provides a negative
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slope in the Brønsted-Debye-Hückel plot, which gives a negative ZAZB value
(Figure 5.4 and Table 5.2). The ZAZB value indicates the charge of the reactants
interacting in a chemical reaction. Therefore, in this study the ZAZB values
represent the charge of complex 1 and charge density of H69 RNA. The negative
ZAZB values are consistent with other studies [173,176] and data from Chapter 4.
Since the charge of the platinum complex 1 is +1, the product ZAZB represents
the charge density of the reacting H69 RNAs. The highest ZAZB values were
observed for buffer B + Na+ titration with Mg2+ (Table 5.2 and Figure 5.5A shaded
bars). The ZAZB values were about 1.4–2.1-fold lower for buffer B titrated either
with Mg2+ or Na+ (Figure 5.5A solid and open bars, respectively). This result
shows that a cation combination that includes K+, Na+, and Mg2+ has the highest
ZAZB value followed by K+ with Na+ and K+ with Mg2+, indicating an increased
effect from Na+ and Mg2+ on the charge density of H69 RNA. Table 5.3 lists
previously reported ZAZB values for RNA and DNA. For the phosphorothioate
oligomers in which Na+ or Mg2+ ions were used as the prominent cations, the
ZAZB values were dependent on the choice of counterions in the reaction medium
[173]. It should be noted, however, that the platination compounds used in those
studies are different from complex 1. Similar to previous studies, data presented
in this chapter shows that cation choice influences the ZAZB value. Extending this
knowledge, the current study shows that Na+ and Mg2+ combined increase the
ZAZB values, hence the RNA charge density, than when they are present
individually.
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Table 5.3. Reported ZAZB values for nucleic acids under different cation
conditions [173,176].
Predominant
Nucleic acid
Pt cmpd
ZAZB
cation
2
-3.7 ± 0.2
r(CGCGUUGUUCGCG)
Na+
3
3.7 ± 0.1
2
-3.8 ± 0.1
d(CGCGTTGTTCGCG)
Na+
3
-3.4 ± 0.4
+
Na
2
-4.9 ± 0.5
d(T8p(S)T8)
Mg2+
2
-3.6 ± 0.8
+
Na
2
-5.0 ± 0.8
d(T8p(S)T8)
Mg2+
2
-4.0 ± 0.2
+
2 = cis-[PtCl(NH3)(c-C6H11NH2)(OH2)] ; 3 = trans-[PtCl(NH3) (quinoline)(OH2)]+
The ko is obtained as the intercept when graphing the data according to the
Brønsted-Debye-Hückel theory. This value represents the limiting reaction rate or
the platination rate at infinite dilution conditions. Such a condition provides the
intrinsic reaction rate in the absence of electrostatic screening by the counterions.
The highest log k0 values observed for buffer B + Na+ titrated with Mg2+ and
buffer B titrated with Na+ conditions (Figure 5.5B, shaded and open bars) indicate
that K+, Na+, and Mg2+, and K+ and Na+ cation combinations have the greatest
electrostatic suppression of the platination rates. The 1.8-fold lower log k0 value
of buffer B titration with Mg2+ (Figure 5.5B, solid bars) indicates that the
electrostatic impact from the K+ and Mg2+ combination is lower compared to the
other two conditions.
The nΨ' value indicates the fraction of counterions condensed on the
oligomer surface. In this chapter, highest nΨ' value was obtained when buffer B +
Na+ was titrated with Mg2+ (Figure 5.5C, shaded bars). The nΨ' values for buffer
B titrated with Mg2+ and Na+ separately (Figure 5.5C, solid and open bars,
respectively) are similar to each other and 2.6–3.5-fold lower than in buffer B +
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Na+ titrated with Mg2+. As mentioned previously, due to the higher charge to
volume ratio compared to monovalent ions, Mg2+ more effectively screens the
negative charge of RNA. Therefore, twice the amount of K+ ions are needed to
screen RNA charge as Mg2+ [93]. However, this is applicable to situations in
which mono- and divalent cations are used separately. The behavior of monoand divalent ions in mixtures are more complex [93]. The current study showed
that whereas in mixtures of K+/Mg2+ (buffer B titrated with Na+) and K+/Na+ (buffer
B titrated with Na+) the nΨ' values are similar, the nΨ' value is higher in the
mixture of K+/Na+/Mg2+ (buffer B + Na+ titrated with Mg2+). This result indicates
that Na+ and Mg2+ in combination have a higher counterion condensation
compared to when they are present individually.
When comparing the platination rates, reactions in buffer B + Na+ titration with
Mg2+ were 1.6–2.5-fold slower compared to those in buffer B titrated with Mg2+.
The former condition showed a 2.6–3-fold higher nΨ' value compared to the
latter. These data can be interpreted as the Pt+ center experiencing a greater
competition from the higher amount of condensed counterions constituting K+,
Na+, and Mg2+, resulting in lower platination rates in buffer B + Na+ titrated with
Mg2+ compared to buffer B titrated with Mg2+ only conditions.
The highest ZAZB and nΨ' values were found under buffer B + Na+ titrated
with Mg2+. The number of counterions retained by oligomers has been shown to
be determined by the packaging of phosphate charges or the charge density of
RNA [93,306]. An increase from 0.84 K+ to 0.94 K+ per phosphate going from
single stranded poly(U) to double-helical RNA has been observed due to the
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close charge packing on the latter molecule [93]. This observation indicates a
connectivity between RNA structure and counterion condensation. Consistent
with these studies, work reported in this chapter shows that condensed
counterions in ionic clouds impact RNA structure and affect the charge density
[93]. This result further suggests that the association of cations likely
"compresses" (or stabilizes) the RNA molecule and increases the effective
charge or charge density of the nucleic acid.
Comparison of ZAZB values of RNAs (Table 5.2) studied in this work to other
oligomers (Table 5.3) shows that H69 has higher ZAZB values, thus higher charge
density under the studied cation conditions. Similarly, a comparison of the nΨ'
values reported for other RNA and DNA oligomers (Chapter 4, Table 4.3) also
indicates higher counterion condensation on H69 RNAs under the studied
cationic conditions. Together, the higher ZAZB and nΨ' values observed for H69
RNAs indicate that these RNAs possess higher electrostatic potentials, which
may be preferred for cationic drug targeting.
The ZAZB, log k0, and nΨ' values determined in the presence of Mg2+ are
similar in the bulk range for the two H69 RNAs. This indicates a minimal
influence from Ψs on H69 electrostatics in the presence of Mg2+. However, the
absence of observable electrostatic differences between the two H69 RNAs in
the presence of Mg2+ is somewhat surprising. In a 2-aminopurine substituted
modified H69 titration with Mg2+, an increased exposure of residue 1913 to
solvent was reported with the addition of the divalent ion [105]. Electrostatic
properties are dependent on the structure and shape of RNA molecules [18].
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Therefore, high exposure of residue 1913 in the presence of Mg2+ could change
the electrostatics of modified H69 RNA. However, the absence of global
electrostatic differences between the two H69 RNAs in the presence of Mg2+ as
determined by platination kinetics indicates that such electrostatic changes
resulting from A1913 exposure are probably localized to the loop region. This
observation indicates that platination kinetics are valuable to determine whether
local structural changes have an impact on global electrostatics of RNA.
5.4 Summary and Conclusions
In summary, the kinetic data showed a decrease in platination rates with the
addition of Mg2+ indicating electrostatic competition and steric barriers for Pt+
association on RNA. Supporting the findings from Chapter 4, the prominent Mg2+dependent platination rate decrease observed in K+ + Na+ conditions compared
to K+-only conditions showed that Na+ decreases the platination rate.
Comparison of the platination rate decrease in the presence of Mg2+ determined
in this chapter to Na+ (Chapter 4) showed that the divalent ion has a greater
impact, likely due to higher electrostatic competition with the Pt+ center.
Therefore, in solutions in which both Na+ and Mg2+ are present, an increased
effect from Mg2+ and Na+ was observed. The nΨ' values indicated that an ionic
atmosphere composed of K+, Na+, and Mg2+ greatly decreases the platination
rate compared to K+ and Mg2+ or K+ and Na+, again indicating an increased effect
from Mg2+ and Na+. The electrostatic data revealed that deposition of cations can
"compress" the nucleic acid and increase the RNA charge density. The data did
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not indicate a major influence from pseudouridine either on platination rate or on
the global electrostatic properties of H69 RNA.
Collectively, these data show that the sequence and global folding likely play
a bigger role than local structural deviations in charged ligand-RNA interactions.
The combined impact of monovalent and divalent metal ions in regulating the
electrostatic environment is important to consider when studying cationic ligand
interaction with RNA. As the electrostatic models used in this study take the
"non-specifically" associated ions into account, data from this chapter support the
significant contribution of such ionic interactions on the structure, stability, and
drug reactivity of RNA. This study further revealed the application of platination
kinetics as a tool to probe the cation-dependent global microenvironment
changes in RNA.
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CHAPTER 6
pH-DEPENDENT PLATINATION KINETICS OF RIBOSOMAL RNA
HAIRPINS
6.1 Abstract
Biochemical interactions are influenced by various factors including pH. The
changes in bulk pH levels can cause protonation/deprotonation of large
biomolecules as well as small ligands, which affects their biological interactions.
In this chapter, the pH-dependence of H69 RNA platination reactions was
studied. The platination rate was higher at pH 5.8 compared to pH 6.8. At each
pH, salt dependence of the reaction rate was determined by changing the Na+
concentration. Platination rates decreased with increasing ionic strength at both
pH values. Electrostatic analyses carried out using the Brønsted-Debye-Hückel
and polyelectrolyte theories showed higher RNA charge density and counterion
condensation at pH 5.8 compared to pH 6.8. The pH-dependent platination
kinetics and electrostatics were insensitive to pseudouridine modifications in the
H69 RNA constructs. Collectively, this study showed that H+ ions can influence
the platination rates and electrostatics of RNA. These findings provide insight into
the pH influence on rRNA platinations and support the application of platination
kinetics as a probe to monitor RNA microenvironments at different pH levels.
6.2 Introduction
Structure, dynamics, and function of biomolecules are sensitive to their
surrounding environments. Factors that influence the structure and activity of
RNA include temperature, concentration and identity of salts, cofactors (such as
metal ions), and pH. Both bulk and local pH are important for stability,
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conformational changes, ligand binding, and catalysis of RNA [307,308]. RNAs
that have been studied with respect to varying pH environments include yeast
tRNAPhe, E. coli tRNATyr, ribozymes, viral RNAs, and rRNA [309-316]. In one
temperature-jump experiment, E. coli 5S rRNA showed release of H+ ions during
RNA melting [316].
Bulk ionic strength plays a critical role in pH-dependent nucleic acid
dynamics. Salt-dependent studies revealed that for every proton released, ~0.3
K+ ions are taken up by an A+•C wobble pair in DNA, indicating that both cations
and H+ ions collectively modulate the dynamics of nucleic acids [317]. A number
of pH-dependent platination reactions have been reported to date. The
platination rates of 1-methylinosine and inosine with certain platinum compounds
decrease with pH [318]. Platination of cytosine, CMP, N1- and N7-bound 1:1
inosine-Pt complexes, 7-methylguanosine, and 7-methylinosine show bellshaped curves for pH-dependent reactions [318-320]. In contrast to results with
individual nucleosides, nucleic acids have shown either insensitivity or a
decrease in platination rates with increasing pH [158,164,174]. Platination of
chicken erythrocyte DNA with cisplatin has shown no difference in reactivity at
pH 6.5 and 7.4 [158]. DNA oligomers with 13 to 16 nucleotides have shown
decreasing platination rates with increasing pH [164,174].
In this chapter, platination of H69 rRNAs (unmodified and modified H69) at pH
5.8 and 6.8 was studied. The salt-dependent platination reactivity at each pH was
determined by changing the Na+ concentration. Platination reactions were carried
out under pseudo-first-order conditions with the use of excess complex 1. The
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reactions were monitored by using gel assays, and rate constants were
determined as described in Chapters 2 and 4. The kinetic data at each pH value
were analyzed by Brønsted-Debye-Hückel and polyelectrolyte theories. The
platination rate was higher at pH 5.8 compared to pH 6.8 for all Na+
concentrations studied. Furthermore, addition of Na+ decreased the reaction
rates in both pH conditions. A higher RNA charge density, limiting reaction rate
and counterion condensation were observed at pH 5.8 compared to pH 6.8.
Perhaps not surprising, these results indicated that RNA microenvironments and
corresponding platination reactions are sensitive to bulk pH. This study further
revealed

the

possibility

of

using

platination

kinetics

to

monitor

RNA

microenvironments in response to changes in bulk pH.
6.3 Results and Discussion
Protonation/deprotonation events can impact the structure and function of
biomolecules, as well as the pH-dependent properties of small molecules. In
previous studies, modified H69 showed pH-dependent structural changes with a
pKa value of 6.3 ± 0.2 [75,76]. The aquated cisplatin complex 1, cisdiammine(aqua)chloridoplatinum(II) exists in aqua/hydroxo equilibrium with a pKa
value of 6.41 [321,322]. Therefore, solution pH would likely impact the H69complex 1 interaction. In this chapter, pH-dependent platination rates of H69
RNAs were determined at pH 5.8 and 6.8 as described in Chapter 2, Section 2.5
Given the pKa of 6.3 ± 0.2 and with the assumption that average conformation
may not exist, pH 5.8 and 6.8 were selected to represent the two different
conformations of modified H69 in high percentage at each pH. In contrast, the
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unmodified H69 did not show conformational shifts with changing pH. Therefore,
these pH values were chosen to carry out the platination reactions. Platination
kinetics were carried out under pseudo-first-order conditions using excess
complex 1, in which [1] >> [RNA]. The platination rate constants were obtained
by gel assays. The impact of salt on the platination kinetics at each pH value was
determined by varying the Na+ concentration and evaluating by the BrønstedDebye-Hückel and polyelectrolyte theories.
6.3.1 Determination of Platination Rate Constants at pH 5.8 and 6.8
The rate of complex 1 reacting with H69 RNAs was monitored by gel assays
as described in Chapter 2, Section 2.5. Briefly, after refolding the RNA, the
platination reaction was initiated by adding freshly prepared, activated cisplatin,
or complex 1. The pseudo-first-order conditions were maintained by using a 1:10
molar ratio of RNA:complex 1. Under these conditions, a linear dependence
between the reaction rate and complex 1 concentration was observed (Chapter
4, Figure 4.3), and also allowed us to monitor experimentally the faster
platination kinetics at the lower pH value of 5.8. The unreacted RNA fraction
versus time was fit to a single-exponential decay to obtain the pseudo-first-order
rate constant (kobs).
Figure 6.1 shows the autoradiograms of H69 platination reactions carried out
at pH 5.8 and 6.8. The addition of complex 1 to RNA produced slower migrating
platinated product bands on polyacrylamide gels. The unreacted RNA
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Figure 6.1. The determination of platination rates of H69 RNAs at different pH
values is shown. Autoradiograms of unmodified H69 at pH A) 5.8 and B) 6.8, and
modified H69 at pH C) 5.8 and D) 6.8 are shown. All gels represent the kinetic
experiments carried out in 10 mM K2HPO4/KH2PO4 and 5 mM NaClO4. R,
unreacted RNA, and P, platinated products, in lanes 1-8 (0, 2, 4, 6, 8, 10, 15, 30
min, respectively), lanes 9-11 (1, 3, 6 h, respectively), and lane 12 (6 h con, no
Pt) are indicated.
band intensity decreased with time while the intensity of product bands
increased. The decrease of unreacted RNA fraction over time was well described
by single-exponential decay fits for both H69 RNAs (Figure 6.2). The decrease of
unreacted RNA fraction was greater at pH 5.8 compared to pH 6.8 for both H69
RNAs, indicating a faster platination rate at pH 5.8.
The aqua ligand of cis-diammine(aqua)chloridoplatinum(II), complex 1, used in
this study has a reported pKa value of 6.41 for deprotonation (Figure 6.3) [321].
Given this pKa for complex 1 and assuming that all activated cisplatin species
exist between these two forms (without further hydrolyzing to the bis-aquated
compound), Henderson-Hasselbalch calculations at pH 5.8 suggest that about
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Figure 6.2. Determination of the observed pseudo-first-order rate constant (kobs)
for the platination reaction of H69 RNAs at pH 5.8 and 6.8 is shown. The singleexponential decay fits for the unreacted RNA fraction over time for A) unmodified
H69 (black) and B) modified H69 (blue) are shown. Both graphs correspond to
the kinetic experiments carried out in 10 mM K2HPO4/KH2PO4 and 5 mM NaClO4.
The solid and dashed fits indicate kinetic data obtained at pH 5.8 and 6.8,
respectively.

Figure 6.3. The acid-base equilibrium of cis-diammine(aqua)chloridoplatinum(II),
complex 1, is illustrated. The aqua ligand of 1 deprotonates to form cisdiammine(chlorido)hydroxoplatinum complex, 1a.
80% of complex 1 exists in the aqua (H2O) form. At pH 6.8, the percentage of
aqua complex drops to about 30%, with formation of the hydroxo complex. The
Pt-H2O bond is kinetically more labile compared to the Pt-OH bond
[158,318,323]. Therefore, the aqua complex of cisplatin reacts readily with
nucleic acids, whereas the hydroxo complexes are less reactive [151,324].
Hence, the lower platination rates observed at pH 6.8 compared to pH 5.8 likely
result from higher amounts of the inactive hydroxo complex at basic pH.
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The pH-dependent reactivity profiles for many platinum complexes with

different targets are available. In platinations of individual nucleosides 1methylguanosine, inosine, and 1-methylinosine with [Pt(dien)(H2O)]2+, cis[Pt(NH3)2(H2O)2]2+, and trans-[PtCl(NH3)2(H2O)]+, the reaction rates decreased
with increasing pH [318,320,323,325]. Similarly, several reports showed pHdependent reactivity of nucleic acid-platinum interactions. For examples, the rate
constants for reactions between phosphorothioate-containing poly(T) and cis[Pt(NH3)(NH2C6H11)Cl(OH2)]+ decreased with increasing pH [164]. Platination of a
small DNA hairpin with cis-[Pt(NH3)(NH2C6H11)Cl(OH2)]+ showed a lower reaction
rate at pH 6.3 compared to pH 4.1 for a range of salt concentrations studied
[174]. In all of these cases in which the platination rates declined with pH, the
results were interpreted as a consequence of inactivation of the aqua platinum
complexes by deprotonation at high pH. Therefore, consistent with previous
reports, the lower platination rate observed at pH 6.8 compared to pH 5.8 could
originate due to the generation of inactive hydroxo platinum complexes at high
pH.
An alternative hypothesis is that high surface H+ concentrations near platinum
targets increase the reaction rates by forming aqua complexes. Mathematical
calculations have shown high H+ concentrations in the major groove near N7 of
G of a G–C base pair [111]. The local pH values were found to decrease by 2-3
pH units near the base pair when the bulk pH was 7.5 [111]. The pH maps
calculated at pH 5.7 or 7.0 showed that acidity near the surface of B-DNA was
higher than the bulk pH [112]. This result indicated that low bulk pH levels could
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create even lower pH environments near nucleic acids. The presence of such
acidic domains was explained due to increased water pKa values by extremely
negative surface electrostatic potentials of DNA [112]. For RNA, which could
have even higher electronegative exteriors due to their higher-order structures
[18,88], the pH values within local environments could be further lowered.
Therefore, such low pH environments near platinum target sites, especially the
N7 of Gs to which complex 1 coordination is observed (Chapter 3), could
potentially increase the platination rates.
6.3.2 The Impact of Salts on the Platination Rates at Different pH
Conditions
The impact of salts on the platination rate of H69 RNAs at pH 5.8 and 6.8 was
determined by changing the Na+ concentration. The observed pseudo-first-order
rate constant (kobs) was obtained by single-exponential decay fits (Figure 6.4)

Figure 6.4. The salt-dependent reactivity of H69 RNAs at different pH values is
shown. The single-exponential decay fits for the unreacted RNA fraction over
time for unmodified H69 (black) at pH A) 5.8 and B) 6.8, and for modified H69
(blue) at pH C) 5.8 and D) 6.8 are shown. The solid and dashed lines represent
fittings for pH 5.8 and 6.8, respectively. The pH was maintained by using a 10
mM K2HPO4/KH2PO4 buffer [233]. The different Na+ concentrations and total
cation concentrations, M+, are indicated.
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as described in Chapter 4. The activated form of cisplatin, cis-diammine(aqua)
chloridoplatinum(II) or complex 1, has an acid/base equilibrium with a pKa value
of 6.41 (Figure 6.3) [321]. When determining the apparent second-order rate
constant (k2,app) under different pH conditions, the acid dissociation of complex 1
was taken into consideration. The acid dissociation equilibrium (Equation 10) and
complex 1 binding to RNA (Equation 11) can be written as shown in Scheme 6.1.

Scheme 6.1. The acid dissociation equilibrium (Ka) and complex 1 coordination
to RNA (k2).
The acid dissociation constant (Ka) and the rate of platination reaction can be
written as;
1a [H+ ]
Ka   =  
[1]

   (12)

rate = k2 1   [RNA]
Under pseudo-first-order conditions in which [1]>>[RNA], the concentration of
complex 1 becomes a constant and the observed rate constant, kobs, is equal to;
kobs = k2 1

(13)

The total platinum concentration [Pt] can be written as;
Pt = 1 +[1a]
[1a]  =   Pt − 1

(14)

Substituting Equation 14 into Equation 12 and deriving for [1] gives;
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Ka   =

[1] =

Pt - 1 [H+ ]
[1]

[Pt] [H+ ]
Ka   +  [H+ ]

     (15)

Substituting Equation 15 into Equation 13, gives a relationship to calculate the
experimentally determined apparent second-order rate constant, k2,app, by taking
the H+ and thus the pH into consideration (Equation 16) [164].
kobs Ka +[H+ ]
k2,app =
[Pt]
[H+ ]

(16)

As mentioned previously, the observed pseudo-first-order rate constant, kobs, was
determined by fitting the unreacted RNA fraction versus time to a singleexponential decay. Substituting the kobs value into Equation 16 then allows
determination of the apparent second-order rate constant (k2,app) of platination
reactions at different pH levels.
At both pH conditions studied, both RNA constructs showed decreasing
reactivity with complex 1 when the total cation concentration, [M+], was increased
in the medium (Figure 6.5). The observed pseudo-first-order and apparent
second-order rate constants at different salt conditions for H69 RNAs at pH 5.8
and 6.8 are given in Tables 6.1 and 6.2. A ca. one-order-of-magnitude decrease
in platination rate (k2,app) was observed for both H69 RNAs between the lowest
and highest total cation concentration at pH 5.8. At the same pH, a prominent
salt-dependence in the interval of 0.016 to 0.031 M total cation concentration was
observed. At pH 6.8, H69 RNAs showed a 2.5–2.3-fold decrease in platination
rate (k2,app) between the lowest and highest total cation concentration. Therefore,
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Figure 6.5. The salt-dependent platination rates of H69 RNAs in different pH
conditions are shown. The apparent second-order rate constant (k2,app) versus
the total cation concentration, [M+], for A) unmodified H69 and B) modified H69 at
pH 5.8 and 6.8 is shown. The error bars represent the standard error calculated
from two to three independent experiments.

Table 6.1. The observed pseudo-first-order rate constant (kobs) and the apparent
second-order rate constant (k2,app) of unmodified H69 determined as a function of
Na+ and total cation, M+, concentrations.
unmodified H69

0.005

[M+]c
(M)
0.016

pH 5.8b
K+ = 0.11 M
kobs
k2,app
-4 -1
(10 s )
(M-1 s-1)
27.9 ± 4.3
518.4 ± 80.9

[M+]c
(M)
0.020

pH 6.8b
K+ = 0.015 M
kobs
k2,app
-4 -1
(10 s )
(M-1 s-1)
1.6 ± 0.1 80.4 ± 7.7

0.02

0.031

6.1 ± 0.3

113.2 ± 6.6

0.035

1.4 ± 0.2

72.0 ± 8.5

0.04

0.051

4.3 ± 0.4

81.4 ± 8.3

0.055

0.8 ± 0.3

40.8 ± 14.0

0.06

0.071

4.8 ± 0.7

88.4 ± 13.1

0.075

0.6 ± 0.2

32.2 ± 8.7

[Na+]a
(M)

a

Na+ was added from a NaClO4 solution. bThe pH was maintained by using a 10
mM K2HPO4/KH2PO4 solution [233]. cTotal cation concentration ([M+]) was
calculated by combining Na+ and K+ concentrations.
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Table 6.2. The observed pseudo-first-order rate constant (kobs) and the apparent
second-order rate constant (k2,app) of modified H69 determined at different Na+
and total cation, M+, concentrations.
modified H69

0.005

[M+]c
(M)
0.016

pH 5.8b
K+ = 0.11 M
kobs
k2,app
-4 -1
(10 s )
(M-1 s-1)
31.7 ± 4.0
590.3 ± 74.4

[M+]c
(M)
0.020

pH 6.8b
K+ = 0.015 M
kobs
k2,app
-4 -1
(10 s )
(M-1 s-1)
1.7 ± 0.2 89.5 ± 13.3

0.02

0.031

6.1 ± 0.3

113.2 ± 5.7

0.035

1.5 ± 0.2

80.0 ± 8.4

0.04

0.051

5.1 ± 0.9

95.5 ± 16.8

0.055

0.7 ± 0.2

34.2 ± 9.6

0.06

0.071

4.7 ± 0.6

86.9 ± 11.0

0.075

0.8 ± 0.1

38.9 ± 3.3

[Na+]a
(M)

a

Na+ was added from a NaClO4 solution. bThe pH was maintained by using a 10
mM K2HPO4/KH2PO4 solution [233]. cTotal cation concentration ([M+]) was
calculated by combining Na+ and K+ concentrations.
the salt-dependent reactivity at pH 6.8 was not as prominent as pH 5.8. However,
a subtle drop in platination rate was observed between 0.035 to 0.055 M total
cation concentration. The platination rates and impact of salt on unmodified and
modified H69 RNAs were similar at both pH values. Therefore, the presence of
pseudouridine did not appear to affect the H69 platination rate or response to
salt. For all cation concentrations, the platination rate was higher at pH 5.8
compared to pH 6.8. The largest platination rate (k2,app) difference between two
pH values was observed at the lowest salt condition (approximately one-order-ofmagnitude difference at 0.016 M total cation concentration compared to a 1.4–
2.8-fold difference at higher salt concentrations).
Salt-dependent platinations have been rationalized due to the polyelectrolyte
properties of nucleic acids [176]. Nucleic acids are highly charged biopolymers
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that behave as polyelectrolytes in solution. RNAs acquire high negative charge
densities as they fold into compact structures, thus attracting solution cations
[188,245,246]. With added salt, the increasing electrostatic competition between
the two cations (e.g., Pt+ and Na+) to associate with RNA would therefore
decrease the platination rate.
The prominent salt dependence of the platination rate observed at pH 5.8
compared to pH 6.8 indicates a sensitivity to H+ concentration. At low Na+
concentrations (0.005 M) and low pH (pH 5.8), the platination rate could be high
due to the dominant effect from H+ ions favoring the aqua Pt complexes, and lack
of competing cationic species for RNA association. At higher Na+ concentrations
(>0.02 M) and low pH (pH 5.8), the electrostatic competition from Na+ on Pt+
would dominate, causing the platination rate to drop. At pH 6.8, in which the H+
concentration is lowered, the electrostatic competition from Na+ dominates at all
salt conditions, thus lowering the platination rate. The higher platination rate at
pH 5.8 compared to pH 6.8 observed in all Na+ concentrations suggests that H+
may not be as competitive as Na+ for Pt+ to associate on RNA. However, of note
is that association of H+ ions on H69 will also depend on the pKa values of RNA
sites. The lower platination rates at pH 6.8 compared 5.8 could also occur due to
reduction of aqua species in the former pH.
The data presented in this chapter showed that platination reactivity at both
pH levels is similar between the two H69 RNAs at all salt conditions studied. As
shown in Chapter 4, unmodified H69 showed a higher platination rate compared
to modified H69 at low salt (<0.052 M total cation concentration). It should be
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noted that at pH 6.2, the conditions in which that study was initially carried out,
more than one conformation of modified H69 exists (pKa for the conformational
shift was 6.3 ± 0.2 [75]) and both aqua and hydroxo forms of complex 1 (pKa =
6.41 [321] are present. At low pH, residue A1913 stacks in the helix in a "closed"
conformation, whereas at high pH this residue flips out and forms an "open"
conformation in modified H69 [75]. Therefore, the lowered platination rate of
modified H69 could be a combined effect of about 50% of complex 1 reacting
with mixed conformations of modified H69. The pH-dependent conformational
study on modified H69 also revealed a slight enhancement (0.5 kcal/mol) in
stability at pH 5.5 compared to pH 7.0 [75], which suggests that the closed
conformation may not be as reactive towards platination as the open
conformation.
At pH 5.8, although a less reactive, closed conformation of modified H69 may
dominate, the more reactive and more highly available aqua complex could in
turn increase the platination rate of modified H69 comparable to unmodified H69.
When the pH is altered to 6.8, the open conformation of modified H69 dominates
and may be more reactive towards modifying agents. However, at this pH (6.8),
the availability of active complex 1 decreases, thus lowering the platination rate
and leading to overall similar rates of platination for the unmodified and modified
H69 RNAs. Under high salt conditions, the electrostatic competition from Na+
towards Pt+ dominates above all and results in comparable reactivity for the two
H69 RNAs. The similar rates observed for the two H69 RNAs in Mg2+-dependent
kinetics (Chapter 5) is consistent with such a hypothesis. With the addition of 1
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mM Mg2+, which could be an even stronger electrostatic competitor for Pt+, the
platination rates between H69 RNAs are similar at pH 6.2. Collectively, these
observations indicate that H69 platination reactivity depends on the combined
effects from pseudouridylation, presence of cations (Na+ and Mg2+), and solution
pH, but the individual impacts of these solution conditions are not possible to
discern.
6.3.3 Evaluation of Salt-Dependent Platination Rates by Electrostatic
Models
Electrostatics are important for the structure and function of biomolecules.
Especially for highly charged molecules such as RNA, interactions with charged
ligands can be strongly governed by electrostatics. The Brønsted-Debye-Hückel
and polyelectrolyte theories can be used to determine the electrostatic properties
of charged biopolymers by evaluating their reaction rates at different ionic
strengths. Assessment of electrostatics in RNA-ligand interactions can provide
valuable information regarding salt-dependent macromolecule dynamics and
ligand-binding characteristics.
The analysis of kinetic data according electrostatic models was carried out as
described in Chapter 2, Section 2.6.1. Briefly, the logarithm of apparent secondorder rate constants (log k2,app) determined at different salt conditions was
graphed versus I1/2/(1+I1/2), in which I is the ionic strength (Chapter 2, Equation 2)
to evaluate the kinetics according to the Brønsted-Debye-Hückel theory. A graph
of logarithm of apparent second-order rate constants (log k2,app) versus logarithm
of total cation concentration, [M+] (Chapter 2, Equation 3) was used to analyze
kinetic data according to the polyelectrolyte theory. The slope (ZAZB) of the

	
  

	
  

144

Brønsted-Debye-Hückel plot indicates the charge (Z) of species (A and B)
interacting in a reaction, and the intercept (log k0) denotes the rate constant at
infinite dilution conditions. The slope of the polyelectrolyte theory plot gives the
nΨ' value, which reveals the fraction of counterions condensed, or thus displaced
by complex 1 binding. Analysis of the salt-dependent platination rates according
to the two electrostatic theories is shown in Figure 6.6.
The equations after fitting the data to electrostatic models and their
corresponding R2 values are given in each figure. The quantified electrostatic
parameters for the two H69 RNAs at different pH conditions are given in Table
6.3. Figure 6.7 shows a comparison of the electrostatic parameters, ZAZB, log k0,
and nΨ', for the two H69 RNAs at pH 5.8 and 6.8. All electrostatic parameters
were higher at pH 5.8 compared to pH 6.8 for both H69 RNAs. The ZAZB values
were 1.6-fold higher at pH 5.8 compared to pH 6.8 for both H69 RNAs. The two
H69 RNAs showed 1.3- and 1.7-fold higher log k0 and nΨ' values, respectively, at
pH 5.8 in comparison to pH 6.8. The electrostatic properties were similar
between the two H69 RNAs indicating no effect from pseudouridine on the global
H69 electrostatics, which govern the platination reactions.
The ZAZB value given by the Brønsted- Debye-Hückel plot reveals the charge
(Z) of species A and B reacting in a chemical reaction. In this thesis work, these
values represent the charge of platinum complex 1 and the charge density of
H69 RNA. Similar to the results reported in Chapters 4 and 5, the ZAZB values in
this pH-dependence study were negative. This observation is consistent for a
reaction between oppositely charged ions, the positively charged complex 1 and
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Figure 6.6. Determination of electrostatic properties of H69 RNAs is shown. The
plots according to the Brønsted-Debye-Hückel theory for A) unmodified H69 and
B) modified H69, and polyelectrolyte theory for C) unmodified H69 and D)
modified H69 at different pH conditions are shown.

Table 6.3. The quantified electrostatic properties of H69 RNAs according to the
Brønsted-Debye-Hückel and polyelectrolyte theories.
unmodified H69

modified H69

pH 5.8

pH 6.8

pH 5.8

pH 6.8

ZAZB

-7.5 ± 1.2

-4.8 ± 0.2

-7.8 ± 1.3

-4.9 ± 0.1

log k0

3.4 ± 0.2

2.6 ± 0.1

3.5 ± 0.3

2.7 ± 0.1

nΨ'

1.2 ± 0.2

0.7 ± 0.1

1.3 ± 0.2

0.8 ± 0.1

	
  

	
  

146

Figure 6.7. Comparisons of the electrostatic parameters at pH 5.8 and 6.8 are
shown. The A) -ZAZB and B) log k0 values obtained from the Brønsted-DebyeHückel theory and C) nΨ' values determined from the polyelectrolyte theory are
shown. The data represented by solid (black, blue) bars were obtained at pH 5.8
and shaded (grey, light blue) bars were obtained at pH 6.8.
negatively charge RNA. Since, the charge of the reactive platinum complex 1,
cis-diammine(aqua)chloridoplatinum(II) is +1, the ZAZB value represents the
charge density of H69 RNA.
The more negative ZAZB values for both H69 constructs at pH 5.8 therefore
suggests that a higher amount of counterions, including H+ ions, have deposited
and increased the effective charge of RNA. This result further suggests that
counterion associations at pH 5.8 may compress or stabilize the RNA molecules
and increase the RNA charge density. The higher counterion condensation is
supported by the higher nΨ' values obtained at pH 5.8. The observation of higher
ZAZB values at pH 5.8, which contains a higher amount of cationic H+ ions,
compared to pH 6.8 is supported by similar trends reported in Chapter 5. In that
chapter, higher ZAZB values were observed at high cationic conditions (buffer B +
Na+ titrated with Mg2+) compared to low cationic conditions (buffer B titrated
either with Mg2+ or Na+). Therefore, these comparisons suggest that similar to

	
  

	
  

147

metal cations, association of H+ ions under acidic conditions increases the
charge density of RNA.
The limiting rate constant, k0, obtained as the x-intercept of Brønsted-DebyeHückel plot, represents the rate constant at infinite dilution. Under such
conditions in which electrostatic screening by counterions is absent, log k0
indicates the intrinsic reactivity of RNA with complex 1. The log k0 values
determined in this pH-dependence kinetic study are 1.3-fold higher at pH 5.8
compared to pH 6.8 for both H69 RNAs. This result indicates that in the absence
of electrostatic influences, counterions, which include H+ ions, impact the
platination rate. This result probably indicates that the higher availability of the
aqua complex increases the reaction rate at pH 5.8 in the absence of an
electrostatic impact from counterions.
The nΨ' value determined by the slope of polyelectrolyte plot designates the
fraction of counterions condensed on the nucleic acid surface. The current study
showed 1.7-fold higher nΨ' values at pH 5.8 compared pH 6.8. This result
indicates that a higher amount of counterions, including H+ ions, are deposited on
the RNA surfaces at pH 5.8. The higher counterion condensation (including H+
ions) at pH 5.8 observed in this study, is supported by the presence of acidic
domains on DNA when the bulk pH is 5.7 [112]. These data indicate that H+ ions
impact the counterion deposition on RNA.
In Chapter 5, the higher counterion condensation observed at higher cationic
conditions (buffer B + Na+ titrated with Mg2+) was partly used to explain the lower
platination rate in that medium. Those results indicated that electrostatic
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competition between the condensed metal cations such as Na+ and Mg2+, and
Pt+ lower the platination rate. In contrary, this study shows that under higher
acidic levels (pH 5.8), in which higher amount of H+ ions are condensed, the
platination rate is faster compared to low acidic conditions (pH 6.8). This result
suggests that condensed H+ ions may not electrostatically compete with Pt+ ions
to reduce the platination rate. Combined, these results indicate that while metal
cations such as Na+ and Mg2+ in condensation layers reduce the platination
rates, deposited H+ ions may not decrease platinum interactions with RNA. As
discussed in Section 6.3.2, the higher platination rates observed at pH 5.8
compared to pH 6.8 supports this conclusion.
The higher nΨ' values observed at pH 5.8, which resemble those at higher
counterion condensations, also indicate that a higher fraction of counterions
should be displaced during complex 1 binding [176]. The counterion
displacements are reported to drive other nucleic acid-ligand interactions by
entropic effects [272]. Therefore, faster platination rates observed at pH 5.8
compared to pH 6.8 may originate, at least in part, due to entropic driving forces
of counterion displacements. These data provide evidence for the impact of bulk
pH levels on the electrostatic properties of RNA, which might modulate the
platination binding kinetics. The nΨ' and ZAZB values of H69 RNAs at pH 5.8 and
6.8 are higher compared to other oligomer systems (Tables 4.3 and 5.3). This
observation provides evidence for the higher electrostatic potentials that H69
RNAs carry, which could be useful targets for cationic drugs.

	
  

	
  

149
Similar to the results in Chapters 4 and 5, no difference in electrostatic

parameters was observed between the two H69 RNAs. However, the modified
H69 shows pH-dependent structural conformations, whereas no such dynamics
are reported for unmodified H69 [75]. The electrostatics of RNA molecules are
dependent on their structures [18]. Hence, pH-dependent structural dynamics of
modified H69 RNA could lead to different electrostatic properties compared to
unmodified H69. The platination kinetics monitor the global electrostatics of RNA.
The absence of electrostatic differences between two H69 RNAs determined by
platination kinetics therefore indicates that pH-dependent electrostatic changes in
modified H69 may be limited to the loop region. This result indicates that
platination kinetics are a valuable tool to monitor the influence of local
electrostatic changes on global environments.
6.4 Summary and Conclusions
In summary, this kinetic study showed that bulk pH conditions influence the
platination rates of rRNA. The platination kinetics at pH 5.8 were faster compared
to pH 6.8. This result was supported by other nucleobase and oligomer
platination studies, which reported faster rates at low pH compared to high pH
[164,174,318,320,323,325]. This observation was explained due to the formation
of inactive hydroxo platinum complexes in which the Pt–OH bond is inert to
substitutions compared to the Pt–H2O bond [318,323]. The existence of acidic
domains near nucleic acid surfaces that are 2-3 units lower than bulk pH could
also increase the fraction of active cisplatin complexes and increase the reaction
rate at pH 5.8 [111,112]. The similar platination rates between the two H69 RNAs
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were explained due to combined effects from pH-dependent properties of H69
RNA and cisplatin.
A prominent salt-dependent reactivity was observed at low pH, suggesting
that salt-dependence of the platination reaction is also sensitive to H+
concentration in the medium. However, a more detailed comparison of the saltdependent platination profiles at pH 5.8 and 6.8 indicated that H+ ions are not
stronger competitors of Pt+ compared to Na+. Comparison of Mg2+-dependent
(Chapter 5) and pH-dependent platination profiles further supported the idea that
H+ ions are not strong competitors of Pt+ ions compared to Mg2+ and Na+.
Analysis of salt-dependent kinetics by the Brønsted-Debye-Hückel and
polyelectrolyte theories revealed higher RNA charge density and counterion
(including H+ ions) depositions at pH 5.8 compared to pH 6.8. Collectively, these
observations suggested that unlike Na+ and Mg2+, H+ ions may not decrease the
platination

rates

through

electrostatic

competitions

with

Pt+.

However,

electrostatic properties of RNA depend on the H+ ion conditions in the medium.
The log k0 data indicated that in the absence of electrostatic influence by H+ ions,
the greater abundance of aqua platinum complexes could increase the
platination rates. The electrostatic properties between the two H69 RNAs were
similar. This result indicated that electrostatic changes originating from pHdependent structural changes in modified H69 may be limited to the loop region.
In conclusion, the current study showed that H+ ions impact platination
reactions via combined effects on platinum compounds and RNA. These findings
provided insight into a more detailed mechanism of platinum complex binding to
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RNA. Further, this study showed the application of platination kinetics to probe
RNA electrostatics under different acidic environments.
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CHAPTER 7
THE INVESTIGATION OF AMINOGLYCOSIDE-RNA
INTERACTIONS USING PLATINATION KINETICS
7.1 Abstract
Cationic antibiotics such as aminoglycosides target many RNAs. Biochemical
and computational studies have revealed that electrostatic interactions play an
important role in aminoglycoside mode of action. In this chapter, platination
kinetics were applied to probe an aminoglycoside-H69 interaction. Platination
rates were monitored on H69 RNAs with or without pseudouridine modification
pre-incubated with aminoglycoside. The complex 1 binding rate decreased in the
presence of RNA-neomycin interactions. The fold-decrease in platination rate
was higher for unmodified H69 compared to modified H69. This study revealed
the application of platination kinetics to evaluate the impact of pseudouridine on
RNA-aminoglycoside interactions.
7.2 Introduction
Since the early 1960s, aminoglycosides have been used to treat bacterial
infections [326]. They are bactericidal antibiotics that bind primarily to rRNA
regions in the ribosome [117,327]. Aminoglycosides have been identified to bind
to the A site of 30S subunits in bacterial ribosomes [117,327]. Aminoglycoside-Asite interactions interfere with the tRNA anticodon-mRNA codon recognition
[328]. This leads to misincorporation of amino acids into the growing polypeptide
chain and reduces the accuracy of translation [329]. Neomycin, one of the
aminoglycosides that targets the bacterial ribosome, also binds to H69 of the 50S
subunit (Figure 1.22) [127]. The neomycin-H69 interaction interferes with subunit
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rotation

and

also

impacts

the

ribosome

recycling

process

[106,127].

Fluorescence studies using 2-aminopurine-containing H69 RNAs have shown
conformational changes upon aminoglycoside binding [105]. Beside rRNA,
aminoglycosides also bind to introns, ribozymes, and HIV RNAs [131,330-333].
Aminoglycosides are a class of antibiotics that contain 2-deoxystreptaminecontaining (2-DOS) amino sugars. The chemical structure of neomycin
(aminoglycoside used in this study) is shown in Figure 7.1. Aminoglycosides
contain 5 to 6 amino groups. The pKa values of the amino groups range from 5.79.5 [120,121]. Therefore, aminoglycosides exist as oligocations at physiological
pH.

As

highly

charged

polycations,

electrostatics

are

important

for

aminoglycoside interactions with RNA. Many experimental and theoretical
studies have shown that aminoglycoside binding is strongly governed by
electrostatic interactions via charged amino groups [122-126,136,330].
The work reported in this chapter focused on probing neomycin-H69
interactions using platination kinetics. The H69 RNAs (unmodified and modified
H69) were incubated with neomycin prior to platination. Platinations were carried
out under pseudo-first-order conditions. The platination kinetics were monitored
using gel assays. The observed pseudo-first-order rate constant (kobs) and
apparent second-order rate constant (k2,app) was determined as described in
Chapter 2, Section 2.5. Platination rates were lower in the presence of
aminoglycoside-RNA complexes compared to RNA alone. The fold-decrease of
platination rate was higher in unmodified H69 compared to modified H69.
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Figure 7.1. The chemical structure of neomycin at pH 7 is shown. The pKa
values of amino groups are indicated [131]. The aromatic ring numbering system
is denoted in Arabic numerals. Ring I is the 2-deoxystreptamine moiety (2-DOS).
7.3 Results and Discussion
Many researchers have reported that electrostatic interactions are crucial for
RNA-aminoglycoside interactions [122-126,136]. With the aim of testing the
application of platination kinetics to probe aminoglycoside-RNA interactions,
complex 1 binding rates to antibiotic-bound, modified and unmodified H69 RNAs
were determined in this chapter. Experimental details are given in Chapter 2,
Section 2.5. Briefly, after incubating H69 RNAs with neomycin at 37 °C for 30
min, complex 1 was added to initiate the platination reaction. The platination
kinetics was monitored under pseudo-first-order conditions. The ratio of complex
1 to RNA was 1 to 268, which allowed us to experimentally determine the slower
platination rates in the presence of highly cationic neomycin. Aliquoted reaction
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mixtures at different time intervals were run on polyacrylamide gels, and
unreacted and platinated RNA was quantified. Single-exponential decay fits were
used to obtain the observed pseudo-first-order rate constant, kobs. The apparent
second-order rate constant (k2,app) was determined by using k2,app = kobs/[1]t=0
relationship.
The addition of complex 1 to the neomycin-H69 complex resulted in a
decrease of the unreacted RNA band with time (Figures 7.2A and B). The
decrease of unreacted RNA with time is well explained by single-exponential
decay fits (Figures 7.2C and D), and was used to obtain the observed pseudofirst-order rate constants. The observed pseudo-first-order, kobs, and apparent
second-order rate constant, k2,app, values are given in Table 7.1. Standard errors
were calculated using two or three independent experiments.
In the absence of neomycin, the platination rates between the two H69 RNAs
were similar. Due to the slower platination rate in the presence of neomycin, a
higher ratio of cisplatin:RNA was used in this work compared to Chapter 4. This
change can lead to a higher amount of active complex 1 compared to conditions
used in Chapter 4. The platination rate of unmodified H69 is similar to that
reported in Chapter 4 under the same cation conditions (Table 4.1, 10 mM
K2HPO4/KH2PO4, pH 6.2 and 20 mM NaClO4). However, under the same salt
conditions, the platination rate of modified H69 was 1.7-fold slower than the
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Figure 7.2. Kinetics of cisplatin binding to H69-neomycin complex is shown.
Autoradiograms of A) unmodified H69 and B) modified H69 incubated with 1 µM
neomycin are shown (R: unreacted RNA; P: slower migrating platinum products;
[RNA] = 0.7 µM, [1] = 188 µM; 10 mM K2HPO4/KH2PO4, pH 6.2, and 20 mM
NaClO4). Lanes 1-3; 0, 15, and 30 min, respectively; lanes 4-9; 1, 3, 6, 8, 24, and
24 h control, respectively are indicated. The single-exponential decay fits for the
disappearance of unreacted RNA for C) unmodified H69 and D) modified H69
versus time are shown.
Table 7.1. The observed pseudo-first-order (kobs) and apparent second-order
(k2,app) rate constants for the reaction between complex 1 and neomycinincubated RNA.
Oligonucleotide

[Neomycin]
(µM)

kobs (10-4 s-1)a

k2,app (M-1s-1)b

0
28.8 ± 2.7
15.3 ± 1.4
1
1.7 ± 0.3
0.9 ± 0.2
unmodified H69
3
1.1 ± 0.1
0.6 ± 0.1
6
1.3 ± 0.3
0.7 ± 0.2
0
25.1 ± 2.2
13.3 ± 1.2c
1
3.0 ± 0.5
1.5 ± 0.2
modified H69
3
1.4 ± 0.1
0.8 ± 0.1
6
1.3 ± 0.5
0.7 ± 0.3
a
All rate constants were determined in 10 mM K2HPO4/KH2PO4, pH 6.2, and 20
mM NaClO4 at 37 °C. bk2,app was determined by using k2,app = kobs/[1]t=0 relationship.
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unmodified H69. The pH-dependent platination study carried out in Chapter 6

suggested that the availability of active aqua complex could affect the platination
rate of modified H69. The pH value used in Chapter 4 and in this chapter was the
same (6.2), but the complex 1:RNA ratio was higher in the latter. Therefore, the
higher platination rate observed for the modified H69 in this chapter could be due
the presence of a higher amount of aqua complex 1 present in the medium
compared to the conditions used in Chapter 4.
Upon addition of neomycin, the platination rate of H69 RNAs decreased
(Figure 7.3A). Specifically, a ca. one-order-of-magnitude rate decrease was
observed with the addition of 1 µM neomycin to both H69 RNAs (Table 7.1). At 1
µM neomycin, the platination rate (k2,app) of modified H69 was 1.7-fold faster
compared to unmodified H69. Except 1 µM neomycin, in all other concentrations
the platination rates between the two H69 RNAs were similar in the bulk range. In
the 2-aminopurine substituted studies, A1913 in modified H69 showed increased
fluorescence intensity with neomycin binding [105]. This result suggested that
with neomycin binding, A1913 flips out of the H69 loop, which forms a structure
similar to the "open" conformation. This conformation is slightly less stable [75]
and probably less constrained. Therefore, the higher platination rate observed
after neomycin binding to modified H69 could be due to this less constrained
structure. With further addition of aminoglycoside, the increasing competition
between highly cationic neomycin and Pt+ may decrease the platination rates
(similar to data observed in the Mg2+ dependence kinetic study) resulting in
comparable reactivities between the two H69 constructs.
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Figure 7.3. The platination of the H69-neomycin complex is shown. A) The
decrease of apparent second-order rate constant (k2,app) with increasing
neomycin concentration is shown. B) The fold-decrease of platination rate (k2,app)
versus neomycin concentration is shown.

The decrease of platination rate upon addition of neomycin is not surprising.
Crystallographic studies have revealed neomycin binding to the H69 stem, with
ring II closely interacting with G1906, G1921, and G1922 through the major
groove (Figure 1.22) [127]. Complex 1, as shown in Chapter 3, also binds to
these residues of H69. According to studies with DNA, cisplatin accesses the
base N7 through the major groove [149]. Therefore, preoccupation of the same
target site by neomycin would be expected to decrease the platination rate.
Neomycin could carry at least a +5 charge at pH 6.2, the conditions in which this
kinetic study was carried out. The active form of cisplatin, complex 1, carries only
a +1 charge (Figure 2.5). Therefore, the higher charge of neomycin could reduce
the platination rate by electrostatic competition.
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To compare the inhibitory effect of neomycin on platination, the fold-decrease

of complex 1 reactivity (k2,app) was determined (Figure 7.3B). A ca. 16, 26, and
22-fold decrease in unmodified H69 and 8, 17, and 18-fold decrease in modified
H69 was observed by adding 1, 3, and 6 µM neomycin, respectively. Therefore,
the fold-decrease of platination rate is lower for modified H69 compared to
unmodified H69. As mentioned previously, the binding of neomycin to modified
H69 forms an "open" conformation, which is likely less constrained. No such
conformational change is reported for unmodified H69. Therefore, the "open"
conformation could react faster with complex 1 compared to slightly more stable
"closed" conformation. Hence, the fold-decrease of platination rate for modified
H69 could be less compared to unmodified H69. The similar fold-decrease at
higher neomycin concentrations (6 µM) may indicate a strong electrostatic
competition from the aminoglycoside towards Pt+.
7.4 Summary and Conclusions
Aminoglycosides are used to treat many bacterial infections [326]. Their
primary mode of action results from binding to rRNA [117,327]. Electrostatic
interaction between aminoglycoside amino groups and RNA is crucial for drug
binding and inhibition [122-126,136,330]. In this chapter, the neomycin-H69 RNA
interaction was probed using platination kinetics. The study revealed slower
platination rates in the presence of neomycin. The platination rate of modified
H69 at low neomycin concentrations (1 µM) was 1.7-fold higher compared to
unmodified H69. This result was explained due to the less-constrained structures
that might occur in modified H69 after neomycin binding. The inhibitory effect
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from neomycin was determined by using the fold-decrease of platination rate.
The unmodified H69 showed higher fold-decrease in platination rate compared to
modified H69. This result further supported the hypothesis of a fast-reacting and
less-constrained structure of neomycin-bound modified H69, which leads to a
lower-fold-decrease in platination due to electrostatic competition. Collectively,
this work supports the application of platination kinetics to probe Ψ-dependent
drug reactivities of H69 RNAs, although further work is needed to have a better
understanding of this system.
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CHAPTER 8
OVERALL CONCLUSIONS AND FUTURE DIRECTIONS
8.1 Overall Conclusions
RNA is essential for many biological functions. Therefore, RNA is an effective
drug target [334]. Although well known to bind to DNA, many recent studies
report that cisplatin can also coordinate to RNA [149,150]. Detailed kinetic
studies on RNA-cisplatin interactions are limited. In this thesis work, a broad
kinetic study was carried out to investigate the platination of rRNA. The
application of this kinetic study is two-fold. The kinetic data are useful to
understand the impact of intrinsic RNA characteristics such as modified
nucleotides and sequences, as well as bulk conditions such as cations and pH,
on platination reactions. The analysis of kinetic data by Brønsted-Debye-Hückel
and polyelectrolyte theories was used to illustrate the application of platination
kinetics as a probe to interrogate RNA microenvironments.
Three model RNA hairpins were selected representing the E. coli ribosome.
Helix 69 (H69) of the large ribosomal subunit is essential for protein synthesis
and a known drug target [65]. The wild-type H69 carries three pseudouridine (Ψ)
modifications in the loop, which are implicated in structural dynamics [74,75]. The
impact of pseudouridine on platination kinetics was evaluated by using two H69
models: unmodified H69 (without pseudouridine) and modified H69 (with
pseudouridine). The 790 loop in the small subunit is important for translation and
also a known antibiotic target [79-82,129]. The size and nucleotide composition
of the 790 loop is identical to unmodified H69, but the sequence is different.
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Therefore, these models allowed us to evaluate the impact of Ψs and RNA
sequence on platination kinetics.
Prior to kinetic studies, the platinum targets on each RNA were identified
using RNase T1 mapping with MALDI MS, and dimethyl sulfate (DMS) probing
(Chapter 3). Consistent with DNA platination profiles [150], MALDI MS and
chemical probing revealed that GpG sites are the likely targets of cisplatin.
Chemical probing further revealed a structural impact on rRNA by platination,
which was also dependent on pseudouridylation and RNA sequence.
The structure of the ribosome is crucial for protein synthesis [335]. Nucleotide
modifications in rRNA are located in the functionally important regions of the
ribosome [72]. The sequence determines the higher-order structure of RNA,
which ultimately impacts the ribosome function [64,271]. Therefore, rigidity or
alterations to rRNA structure after platinum coordination can impact translation.
Initial studies by Rosenberg have shown inhibitory effects of cisplatin on protein
synthesis [253]. Structural effects from platinum complex binding to DNA have
been implicated in the drug mode of action [151]. Sharp bends induced by
cisplatin coordination in DNA were shown to recruit HMG-domain proteins, which
prevents them from their normal cellular functions and sequesters platinum
adducts from repair proteins [151,336,337]. HMG proteins are also reported to
bind to RNA [338]. Therefore, cisplatin-induced structural changes in rRNA may
recruit similar proteins that could ultimately contribute to drug cytotoxicity.
The kinetic study was carried out with two objectives. First, a broad kinetic
study was designed to gain insight on RNA platination reactions, for which only
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limited reports are available. The kinetic study reported in Chapter 4 showed that
changes in rRNA structures due to Ψs can lead to subtle differences in
platination rates, under low salt concentrations. The impact from RNA sequence
was prominent compared to nucleotide modifications. The intracellular cation
concentration varies, depending on the cell stage, type, and external conditions
[339-341]. In Chapter 5, platination rates of H69 RNAs were determined under
different salt conditions. The electrostatic competition between Mg2+/Na+ and Pt+
was shown to decrease the platination rate.
The pH is important for normal cell growth, development, and proliferation, as
well as for tumor survival [342,343]. Therefore, interactions between pH-sensitive
larger biomolecules and smaller ligands can depend on bulk acidity levels. The
higher platination rate at pH 5.8 was interpreted as greater formation of reactive
aqua species of complex 1 in the bulk as well as local acidic environments on
RNA (Chapter 6). The comparable reactivities of H69 RNAs were explained due
to the combined effect from pseudouridylation, availability of reactive aqua
cisplatin species, and electrostatic competitions between Na+ and Pt+ ions.
Lastly, in this thesis work platination kinetics were applied to probe neomycinRNA interactions (Chapter 7). The kinetic data indicated that altered
conformations of modified H69 upon neomycin binding could lead to higher
platination rates compared to unmodified H69, although, under higher neomycin
concentrations electrostatic competitions may lead to comparable reactivities.
The fold-decrease in platination rate was determined to evaluate the inhibitory
effect of neomycin on platination. The fold-decrease data also suggested that
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H69 structure and electrostatic competitions impact the inhibitory effects by
neomycin.
Second, the application of platination kinetics as a probe for the RNA
microenvironment was explored. This was accomplished by analyzing the saltdependent

kinetic

data

using

different

electrostatic

models.

To

date,

computational-based approaches are primarily used to evaluate the electrostatic
properties of RNA [18,88]. These methods may not reflect the true environment
of biomolecules. Although some solution-based methods such as small-angle xray scattering and spectroscopic techniques are available, they provide limited
electrostatic information [192-195]. Chapter 4 showed a prominent impact from
nucleotide sequence on electrostatic properties over pseudouridylation. Analysis
of Mg2+-dependent platination data by electrostatic models revealed effects from
Na+ and Mg2+ that increase the RNA charge density and the counterion
condensation (Chapter 5).
The higher RNA charge density and counterion condensation at pH 5.8
compared to 6.8 indicated that H+ ions impact the electrostatic microenvironment
of RNA (Chapter 6). Throughout the thesis work, the global electrostatic
parameters between unmodified and modified H69 RNAs were found to be
similar. This result indicated that electrostatic changes originating from altered
structures of modified H69 could be limited to the loop region. Electrostatic data
further revealed that platination rates in the absence of electrostatics depend on
target characteristics, cation combinations, and active Pt complex availability.
Collectively, this thesis work showed RNA platination kinetics are dependent on

	
  

	
  

165

the intrinsic nucleic acid characteristics and surrounding bulk environment, and
also supported for its application to determine the dynamic electrostatic
properties of RNA.
This thesis work showed the capability of using platination kinetics to study
microenvironment properties of RNA. Cisplatin is a relatively small ligand.
Therefore, it can be used to determine the microenvironment properties in large
RNA molecules. For comparison, lac repressor binding to DNA showed
involvement of 12 ± 2 phosphate groups, whereas cisplatin very likely interacts
with 1-2 phosphate groups as shown by crystal structures [149,264]. The
possibility of finding a target site for cisplatin in a studied RNA can be relatively
easy, as cisplatin shows many targets such as GpG, ApG, and stretches of Gs
on nucleic acids [150]. As kinetic studies are carried out under pseudo-first-order
conditions and data are fitted to single-exponential decays, complications arising
from the presence of many platination sites may also be avoided. Overall, this
thesis work showed that cisplatin kinetics could be a valuable method to study
electrostatic microenvironments of various RNA architectures.
8.2 Future Directions
Although model rRNA constructs were used to monitor platination kinetics
and electrostatic properties, rRNA is much larger and structurally complex. The
microenvironments of rRNA therefore can be drastically different from model
systems. As RNA microenvironments are dependent on the structure and
sequence shown by this thesis work and other studies, and they are important for
ligand interactions, it is necessary to probe these local environments in
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ribosomes [18]. Sequencing-based approaches are the primary methods used to
interrogate larger RNAs [214]. However, determination of platination kinetics in
large rRNA by primer extension could be challenging. For example, use of
multiple primers (thus multiple gels pictures) to generate cDNA can produce
unreliable quantitative data during normalization. Thus, generating a cDNA readthrough across the whole rRNA is necessary. A simultaneous determination of
adduct site is also required. A recent report shows measurement of adductinduced misincorporation rates during cDNA synthesis using massively parallel
sequencing [344]. This method seems to be a good approach to find platination
rates in ribosomes. The study used Moloney murine leukemia virus reverse
transcriptase

with

Mn2+,

which

made

the

enzyme

read

through

and

misincorporate nucleotides at SHAPE adducts. The authors optimized conditions
to have a complete readthrough across the complete rRNA. The misincorporation
rates were then used to predict the secondary structures of large RNA molecules.
Similar experimental design which determines misincorporation rate/frequency at
a platinated adduct using next-generation sequencing technique can therefore be
applied to determine platination rates and electrostatics in complete ribosomes.
There are many other methods that have been applied to monitor platination
kinetics of larger nucleic acids. Bancroft et al. reported determination of
platination rates of chicken erythrocyte DNA by cisplatin using

195

Pt NMR [158].

Platination kinetics of salmon sperm DNA have been determined by using atomic
absorption spectroscopy on acid hydrolyzed DNA [345]. Other techniques have
been employed to monitor platination kinetics of salmon testis DNA include DNA
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polymerase standard assay, circular dichroism, ethidium bromide fluorescence,
and endonuclease digestion combined with HPLC analysis [239,346]. Although
complex data fittings and kinetic model derivations were necessary, important
information regarding the pathways of platinum adduct formation and differences
between different platinum compound coordinations have been shown by these
kinetic studies. Therefore, application of these techniques to determine
platination kinetics of rRNA in ribosomes is also feasible.
Many electrostatic studies of nucleic acids are based on computational
modeling methods [18,88,125,189,241,347,348]. Although very limited reports
exist investigating the counterionic atmospheres and electrostatic properties of
nucleic acids by non-computational approaches such as x-ray scattering,
spectroscopic

techniques,

and

small

molecule

probes,

experimental

determination of these environments are reported to be challenging [192195,224]. Now that electrostatic parameters are available for H69 RNA from
platination kinetic studies, these results can be used as a benchmark to compare
computational calculations and results from other methods such as small-angle
x-ray scattering. Comparison of experimental and theoretical work may provide
clues for differences between the two approaches and may help to improve
computational predictions.
Electrostatic interactions between cationic amine groups in aminoglycosides
and RNA are important for drug binding [124,125,136,137]. Aminoglycoside
derivatives generated by deoxygenation of amine-adjacent hydroxyls, which
increases the basicity of amines, are strong inhibitors of hammerhead ribozyme
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compared to the parent compounds [124]. Similarly, substitution of hydroxyl
groups in aminoglycosides with amino groups has shown to convert poor binders
to stronger inhibitors [349]. For self-cleaving catalytic RNAs, the impact from
aminoglycosides on the chemical reaction can be directly determined. However,
for other non-catalytic RNAs such as H69, which also show aminoglycoside
interactions, such straightforward determinations are not possible due to the
absence of a chemical reaction. Therefore, with the application of platination
kinetics as a tool, the impact of electrostatics on RNA binding can be determined.
Similar to previous reports, compounds with different numbers and combinations
of hydroxyl and amino groups on aminoglycosides can be used to probe the
strength of electrostatic interactions in drug-rRNA complexes. Further,
performing salt-dependent platination kinetics can provide details on the impact
of RNA charge density and counterion displacements on aminoglycoside-rRNA
bounding. These data can be compared to the work reported in this thesis work
to determine the microenvironment effects by polycationic drug binding.
This thesis work showed that aminoglycoside binding reduces the platination
rate. Comparing the previously published crystallographic structures and probing
results from this thesis work indicate that both compounds target the same region
of H69 [127]. These residues include G1906, G1921, and G1922. Therefore, it is
likely that neomycin preincubation competitively inhibits complex 1 binding. To
test this hypothesis, an inhibition assay, as been carried out on Group I intron,
can be performed [350,351]. In those experiments, the Lineweaver-Burk graphs
obtained by plotting the rate of splicing reactions in the presence of different
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competitor amounts at varying guanosine concentrations allowed determination
of the type of competition between the two molecules. Similarly, for the system
studied in this thesis work, pseudo-first-order rate constants can be determined
at different complex 1 concentrations for H69 RNA incubated with varying
aminoglycoside concentrations. In relation to Lineweaver-Burk plots, a graph of
1/kobs versus 1/[1] for H69 RNAs should be able to indicate the type of
competition between aminoglycoside and complex 1.
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APPENDIX
This appendix shows the determination of K+ concentration under different pH

levels. A 10 mM KH2PO4/K2HPO4 buffer was used to maintain the pH in the
kinetic studies of this thesis work. The pKa of potassium phosphate buffer is 6.86
[233]. In Chapters 4 and 5 the pH was 6.2 and in Chapter 6 two pH conditions,
5.8 and 6.8 were used. The pH of each buffer was maintained by mixing different
volumes of 1 M solutions of KH2PO4 and K2HPO4 [233]. The 10 mM
KH2PO4/K2HPO4 buffer was made by diluting this mixture. The following table
shows the volume of each species mixed, their final concentrations in 10 mM
buffer, and the total concentration of K+ ions. This K+ concentration was used
when calculating the ionic strength in the medium at each pH.
pH

Table. Determination of K+ concentrations under different pH.
1 M K2HPO4 1 M KH2PO4 Concentration of species
[K+] mM
(mL)
(mL)
in 10 mM buffer

5.8

8.5

91.5

[K2HPO4]
(mM)
0.85

6.2

19.2

80.8

1.92

8.08

12

6.8

49.7

50.3

4.97

5.03

15

	
  

[KH2PO4]
(mM)
9.15

11
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RNAs are crucial for many cellular functions. Thus, studying ligand-RNA
interactions and their dynamics in response to changes in the surrounding
environment is important. In spite of the well-known DNA coordination, current
research also indicates cisplatin binding to RNA. Kinetic studies of rRNA
platination reactions are largely unexplored. This research was conducted to
achieve two objectives. First, a broad kinetic study was carried out to investigate
the cisplatin-rRNA interactions. The structure, function, and ligand interactions
depend on RNA microenvironments. Second, the application of platination
kinetics as a tool to interrogate RNA electrostatic environments was explored.
Three model rRNA hairpins from E. coli ribosome were selected. Two helix 69
(H69) constructs, modified H69 (with pseudouridine) and unmodified H69
(without pseudouridine), and the 790 loop, which has an identical size and
nucleotide composition to unmodified H69, were used. Prior to kinetic studies,
cisplatin targets on each RNA were determined using RNase T1 mapping
combined with MALDI MS, and dimethyl sulfate (DMS) probing. The kinetic
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studies were carried out under pseudo-first-order conditions and electrostatic
properties were evaluated using Brønsted-Debye-Hückel and polyelectrolyte
theories.
RNase T1 mapping with MALDI MS and dimethyl sulfate (DMS) probing
revealed GpG sites as cisplatin targets on RNA. The DMS probing further
revealed platination-induced structural changes in RNA. Both the RNA sequence
and modified nucleotides showed an impact on platination rates. Kinetic data
showed that the platination rate is dependent on cations and the abundance of
active cisplatin complexes. Structure, pseudouridylation, availability of active
cisplatin species, and cation/Pt+ electrostatic competitions all impact platination
of the two H69 RNAs. Probing neomycin-H69 interactions by platination kinetics
indicated that structural changes in modified H69 upon aminoglycoside binding
could also impact the platination kinetics. Electrostatic models revealed that
nucleotide sequence, cations, and H+ ions impact the global RNA electrostatics.
The similar global electrostatic properties between the two H69 RNAs indicated
that structure-dependent electrostatic changes in modified H69 could be limited
to the loop region.
In conclusion, this thesis work showed that both intrinsic RNA characteristics
such as structure, sequence, and dynamics, as well as bulk solution conditions
(e.g. cations and pH), impact cisplatin-RNA interactions. The RNA electrostatic
parameters determined in this thesis work illustrated platination kinetics can be
used as an informatory tool for probing dynamic RNA microenvironments.
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